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Introduction and Summary 
 
Innovation is the use of new knowledge to offer a new product or service that 
customers want (Afuah, 2003). Earlier, Schumpeter (1934) defined innovation as ideas 
applied successfully in practice. My favorite definition for innovation comes from Freeman 
and Soete (1997):  
 
Innovation = Invention + Commercialization 
 
This dissertation is a combination of three independent chapters on the subjects of 
management control systems (MCS1), entrepreneurship, and innovation. This dissertation has 
a special focus on radical innovation, therefore it is important to make the distinction between 
incremental and radical innovation. Incremental innovation is represented by minor changes 
or adjustments to existing technology (Munson & Pelz, 1979). In contrast radical innovation 
depicts revolutionary changes in technology and markets, contributing considerable 
improvements to existing practices and products (Duchesneau, Cohn, & Dutton, 1979; Ettlie, 
1983). Furthermore, radical innovation introduces major new value propositions that disrupt 
existing consumer habits and behaviors (Markides & Geroski, 2005). But why is this 
important? Does it matter? The answer to this last question is yes. It does matter! Day (2007) 
reported that incremental innovation represents 85% to 90% of companies’ new product 
development (NPD) portfolios. However it rarely generates the growth companies seek. This 
concentration on incremental innovation can affect a firm’s innovative capacity by delaying 
all projects, stressing the organization, and failing to achieve high growth revenue goals. Still 
these incremental innovation projects are necessary for continuous improvement even though 
                                                 
1 Simons’ (1995) definition. MCS are interpreted as ‘formal, information-based routines and procedures managers use to 
maintain or alter patterns in organizational activities’.  
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they do not provide companies with a competitive edge or contribute much to profitability 
(Cooper, 2003). On the other hand radical innovations provide firms with new market 
opportunities that can generate profits. According to a study by Kim and Mauborgne (1999), 
only 14% of NPDs are radical innovations, but these account for 61% of all profit from 
innovation. Consequently, radical innovation is important because firms that rely on purely 
continuous improvement and incremental innovations could aspire to maintain their market 
position while firms that pursue radical innovation can position themselves advantageously 
apart from competition and become market leaders. 
Porter (1985) described how firms outperform rivals through competitive advantages. 
In order to understand how competitive advantages are generated by organizations, we need 
to take strategy from a broad vision to an internal consistent configuration of processes which 
represent the building blocks of competitive advantage (Ghemawat, Rivkin, & School, 1998). 
Researchers such as (Davila, Epstein, & Shelton, 2006) have also been interested in the 
inputs, processes, and outputs of innovation. In the literature innovation inputs have 
traditionally focused on the role and contribution of internal research and development 
(R&D) (Griliches, 1979; Hall, 1992; Himmelberg & Petersen, 1994). However, R&D is only 
one of the innovation inputs (Dushnitsky & Lenox, 2005b). More and more scholars  
(Chesbrough, 2002a, b; Chesbrough & Rosenbloom, 2002; Chesbrough & Tachau, 2002; 
Chesbrough, 2002c; Cohen & Levinthal, 1990; Davila, Epstein, & Shelton, 2005; Henderson 
& Cockburn, 2000; Teece, Pisano, & Shuen, 1997) acknowledge the ability to exploit 
external knowledge as a fundamental element of innovation strategy. Their research 
contributes to better understand the innovative inputs beyond the boundaries of the firm on 
what is commonly known as Open Innovation2. In this respect scholars e.g. (Cohen, Nelson, 
& Walsh, 2002b; Keil, 2002) have studied innovative external inputs contributing to open 
                                                 
2 Chesbrough’s definition of open innovation: “a paradigm that assumes that firms can and should use external ideas as well 
as internal ideas, and internal and external paths to market, as they look to advance their technology. Open Innovation 
processes combine internal and external ideas into architectures and systems.” 
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innovation. Some examples of these inputs are the interaction between firms and universities, 
mergers & acquisitions, and strategic alliances. Research on Corporate Venture Capital3 
(CVC) as a source of open innovation is limited and has recently attracted scholar interest 
(Dushnitsky & Lenox, 2006).  
The aim of this dissertation is to look at different managerial practices to generate 
radical innovation and to assess its contribution to value creation. More specifically, the 
purpose of this study is firstly to understand why firms invest billions of dollars in startups. In 
particular, we aim to understand the internal and external determinants influencing CVC 
investment activity. Secondly, we extend research by looking at the value creation of CVC 
and its interaction with R&D. We study the business sectors and regions in which these create 
value. Finally, we seek to identify what it is that a firm does in terms of processes, MCS, and 
organizational structure to generate radical innovation. 
  
The main research questions are:  
I. What influences CVC?  
II. What is the contribution of CVC, and its interaction with R&D to value 
creation?  
III. How is radical innovation organized and managed? 
 
Summary 
 
One of the key emphases of these three essays is to provide practical managerial 
insight. However, good practical insight, can only be created by grounding it firmly on 
                                                 
3 Gompers and Lerner (1998) CVC’s definition: External equity investments made by established firms in privately-held 
entrepreneurial start-ups. 
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theoretical and empirical research. Practical experience-based understanding without 
theoretical grounding remains tacit and cannot be easily disseminated. Theoretical 
understanding without links to real life remains sterile. My studies aim to increase the 
understanding of how radical innovation could be generated at large established firms and 
how it can have an impact on business performance as most businesses pursue innovation 
with one prime objective: value creation. My studies focus on large established firms with 
sales revenue exceeding USD $ 1 billion. Usually large established firms cannot rely on 
informal ways of management, as these firms tend to be multinational businesses operating 
with subsidiaries, offices, or production facilities in more than one country.  
 
I. Internal and External Determinants of Corporate Venture Capital Investment 
The goal of this chapter is to focus on CVC as one of the mechanisms available for 
established firms to source new ideas that can be exploited. We explore the internal and 
external determinants under which established firms engage in CVC to source new 
knowledge through investment in startups. We attempt to make scholars and managers aware 
of the forces that influence CVC activity by providing findings and insights to facilitate the 
strategic management of CVC. There are research opportunities to further understand the 
CVC phenomenon. Why do companies engage in CVC? What motivates them to continue 
“playing the game” and keep their active CVC investment status. The study examines CVC 
investment activity, and the importance of understanding the influential factors that make a 
firm decide to engage in CVC. The main question is: How do established firms’ CVC 
programs adapt to changing internal conditions and external environments. Adaptation 
typically involves learning from exploratory endeavors, which enable companies to transform 
the ways they compete (Guth & Ginsberg, 1990). Our study extends the current stream of 
research on CVC. It aims to contribute to the literature by providing an extensive comparison 
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of internal and external determinants leading to CVC investment activity. To our knowledge, 
this is the first study to examine the influence of internal and external determinants on CVC 
activity throughout specific expansion and contraction periods determined by structural 
breaks occurring between 1985 to 2008. 
Our econometric analysis indicates a strong and significant positive association between 
CVC activity and R&D, cash flow availability and environmental financial market 
conditions, as well as a significant negative association between sales growth and the 
decision to engage into CVC. The analysis of this study reveals that CVC investment is 
highly volatile, as demonstrated by dramatic fluctuations in CVC investment activity over the 
past decades. When analyzing the overall cyclical CVC period from 1985 to 2008 the results 
of our study suggest that CVC activity has a pattern influenced by financial  factors such as 
the level of R&D, free cash flow, lack of sales growth, and external conditions of the 
economy, with the NASDAQ price index as the most significant variable influencing CVC 
during this period.  
 
II. Contribution of CVC and its Interaction with R&D to Value Creation 
The second essay takes into account the demands of corporate executives and 
shareholders regarding business performance and value creation justifications for investments 
in innovation. Billions of dollars are invested in CVC and R&D. However there is little 
evidence that CVC and its interaction with R&D create value. Firms operating in dynamic 
business sectors seek to innovate to create the value demanded by changing market 
conditions, consumer preferences, and competitive offerings. Consequently, firms operating 
in such business sectors put a premium on finding new, sustainable and competitive value 
propositions. CVC and R&D can help them in this challenge.  
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Dushnitsky and Lenox (2006) presented evidence that CVC investment is associated 
with value creation. However, studies have shown that the most innovative firms do not 
necessarily benefit from innovation. For instance Oyon (2007) indicated that between 1995 
and 2005 the most innovative automotive companies did not obtain adequate rewards for 
shareholders.  
The interaction between CVC and R&D has generated much debate in the CVC 
literature. Some researchers see them as substitutes suggesting that firms have to choose 
between CVC and R&D (Hellmann, 2002), while others expect them to be complementary 
(Chesbrough & Tucci, 2004). This study explores the interaction that CVC and R&D have on 
value creation. This essay examines the impact of CVC and R&D on value creation over 
sixteen years across six business sectors and different geographical regions. Our findings 
suggest that the effect of CVC and its interaction with R&D on value creation is positive and 
significant.  
In dynamic business sectors technologies rapidly relinquish obsolete, consequently 
firms operating in such business sectors need to continuously develop new sources of value 
creation (Eisenhardt & Martin, 2000; Qualls, Olshavsky, & Michaels, 1981). We conclude 
that in order to impact value creation, firms operating in business sectors such as Engineering 
& Business Services, and Information Communication & Technology ought to consider CVC 
as a vital element of their innovation strategy. Moreover, regarding the CVC and R&D 
interaction effect, our findings suggest that R&D and CVC are complementary to value 
creation hence firms in certain business sectors can be better off supporting both R&D and 
CVC simultaneously to increase the probability of generating value creation.  
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III. MCS and Organizational Structures for Radical Innovation 
Incremental innovation is necessary for continuous improvement but it does not 
provide a sustainable permanent source of competitiveness (Cooper, 2003). On the other 
hand, radical innovation pursuing new technologies and new market frontiers can generate 
new platforms for growth providing firms with competitive advantages and high economic 
margin rents (Duchesneau et al., 1979; Markides & Geroski, 2005; O'Connor & DeMartino, 
2006; Utterback, 1994). Interestingly, not all companies distinguish between incremental and 
radical innovation, and more importantly firms that manage innovation through a one-size-
fits-all process can almost guarantee a sub-optimization of certain systems and resources 
(Davila et al., 2006). Moreover, we conducted research on the utilization of MCS along with 
radical innovation and flexible organizational structures as these have been associated with 
firm growth (Cooper, 2003; Davila & Foster, 2005, 2007; Markides & Geroski, 2005; 
O'Connor & DeMartino, 2006). 
Davila et al. (2009) identified research opportunities for innovation management and 
provided a list of pending issues: How do companies manage the process of radical and 
incremental innovation? What are the performance measures companies use to manage 
radical ideas and how do they select them? The fundamental objective of this paper is to 
address the following research question: What are the processes, MCS, and organizational 
structures for generating radical innovation? Moreover, in recent years, research on 
innovation management has been conducted mainly at either the firm level (Birkinshaw, 
Hamel, & Mol, 2008a) or at the project level examining appropriate management techniques 
associated with high levels of uncertainty (Burgelman & Sayles, 1988; Dougherty & Heller, 
1994; Jelinek & Schoonhoven, 1993; Kanter, North, Bernstein, & Williamson, 1990; Leifer 
et al., 2000). Therefore, we embarked on a novel process-related research framework to 
observe the process stages, MCS, and organizational structures that can generate radical 
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innovation. This article is based on a case study at Alcan Engineered Products, a division of a 
multinational company provider of lightweight material solutions.  
Our observations suggest that incremental and radical innovation should be managed 
through different processes, MCS and organizational structures that ought to be activated and 
adapted contingent to the type of innovation that is being pursued (i.e. incremental or radical 
innovation). More importantly, we conclude that radical can be generated in a systematic way 
through enablers such as processes, MCS, and organizational structures. This is in line with 
the findings of Jelinek and Schoonhoven (1993) and Davila et al. (2006; 2007) who show that 
innovative firms have institutionalized mechanisms, arguing that radical innovation cannot 
occur in an organic environment where flexibility and consensus are the main managerial 
mechanisms. They rather argue that radical innovation requires a clear organizational 
structure and formal MCS. 
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1.  Internal and External Determinants of Corporate Venture Capital 
Activity 
 
1.1.  Introduction 
Firms innovate to differentiate themselves and advantageously set themselves apart 
from competition. Consequently, activities that allow them to renew and adapt their 
innovation strategy to internal and external changing conditions are critical to firm survival 
(Schumpeter, 1951). 
Corporate entrepreneurship (CE) refers to the process of organizational renewal 
(Phan, Wright, Ucbasaran, & Tan, 2009). According to Guth and Ginsberg (1990) CE 
encompasses two distinct dimensions. On the one hand corporate venturing (CV) activities 
focus on the processes related to creating new businesses and integrating these into the parent 
company (Narayanan, Yang, & Zahra, 2009). According to Sharma and Chrisman (1999), 
CV can be divided into internal and external CV. Internal CV involves the creation of new 
businesses within the boundaries of the firm (Phan et al., 2009), while external CV, also 
referred to as Corporate Venture Capital (CVC), involves an investment in a young high-
growth firm defined as a startup (Phan et al., 2009). On the other hand CE takes into account 
the organizational renewal activities that improve a firm’s ability to compete, which may or 
may not involve adding new businesses to a parent company. Kuratko and Audretsch (2009) 
define this CE approach as strategic entrepreneurship, which involves identification and 
exploitation of new innovative opportunities within firm boundaries and in which the main 
source of organizational renewal consists of research and development (R&D).  
Nowadays even the largest and most technologically advanced firms require 
knowledge beyond their boundaries seeking to optimally combine internal and external 
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sources of knowledge to benefit from the positive effects that internal and external sources 
have to offer (Cassiman & Veugelers, 2002). 
R&D has been the traditional activity conducted by firms to exploit internal 
knowledge and generate innovation (Griliches, 1979; Hall, 1992; Himmelberg & Petersen, 
1994). Nonetheless firms can alternatively use a large range of activities to implement their 
innovation strategy (Dushnitsky & Lenox, 2005a), in particular, activities aimed at exploiting 
external knowledge. These activities have recently caught the attention of scholars 
(Chesbrough, 2002a; Chesbrough, 2002c; Cohen & Levinthal, 1990; Davila et al., 2006; 
Henderson & Leleux, 2002; Henderson & Cockburn, 2000; Teece et al., 1997) especially 
under the lens of innovation activities beyond the boundaries of the firm. For example, 
Chesbrough’s (2003a, b) concept of ‘Open Innovation’ suggests that firms use external and 
internal ideas as well as internal and external paths to market as they look to advance their 
technology. In that respect, partnerships with universities and state-run research facilities 
(Cohen et al., 2002b), mergers & acquisitions, and strategic alliances (Keil, 2002) are the 
traditional activities conducted by firms to gain access to and exploit external knowledge. 
CVC is also defined as external equity investments made by established firms in 
privately held entrepreneurial startups (Gompers & Lerner, 1998a; Gompers & Lerner, 
1998c). This alternative way to exploit external knowledge has also attracted the attention of 
scholars (Dushnitsky & Lenox, 2006). CVC investment provides several benefits because it 
increases financial returns (Allen & Hevert, 2007), provides growth options (Allen & Hevert, 
2007; Burgelman & Välikangas, 2005; Hurry, Miller, & Bowman, 1992), increases 
innovation output and new product development opportunities (Maula, Autio, & Murray, 
2005; Maula, Autio, & Murray, 2009; Roberts & Berry, 1985; Wadhwa & Kotha, 2006), and 
creates market value (Dushnitsky & Lenox, 2006). CVC investment also provides strategic 
flexibility relative to R&D as it involves an equity investment that can be restructured or 
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exited in case of changing internal or external conditions (Folta, 1998). In addition, it gives 
firms access to information that reduces market and technology uncertainties. Kogut (1991) 
considers that this information reduces uncertainty, giving partners (e.g. in the case of a CVC 
between a large firm and a startup) an advantageous position to scale the CVC activity up or 
down in response to environmental changes. According to Chesbrough (2002a), firms can 
justify CVC investment if it creates value for their shareholders in ways they cannot replicate 
themselves due to lack of exposure to technology and markets, or inferior knowledge of 
technologies and commercialization. CVC investment also allows firms to extend their core 
business or improve their next generation of products complementing internal R&D activities 
(Basu, Phelps, & Kotha, 2011). In some cases, CVC investment helps mitigate the 
technological and market uncertainty risks related to new product development. Finally, firms 
benefit from CVC investment by being able to gain access to people working for startups 
with a particular set of skills beyond the firms’ internal capabilities, allowing them to 
increase their knowledge and better assess new product development opportunities 
(Dushnitsky & Lenox, 2005b).  
These benefits explain why CVC investment by established firms4 has drastically 
increased in the last four decades. As reported by the Thomson Reuters Venture Expert 
database, which compiles CVC investment worldwide, the amount of money invested by 
publicly-listed firms from 27 countries5 increased from less than $ 1 billion in 1997 to $4 
billion in 2008 with a peak of $16 billion in 2000 (see Figure 1). 
 
 
 
                                                 
4 CVC investments are typically made by large established firms (Dushnitsky and Lenox, 2006). Consequently we focus our 
study on such firms. 
5 Available data of publicly listed companies with central offices domiciled in the following countries: Australia, Austria, 
Belgium, Canada, China, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Israel, Italy, Japan, Malaysia, 
Mexico, Netherlands, Norway, Singapore, South Korea, Spain, Sweden, Switzerland, Taiwan, United Kingdom, and Unites 
States of America. 
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----------------------- 
INSERT FIGURE 1 
----------------------- 
 
However, despite all the benefits previously described, CVC activity experiences 
strong investment activity fluctuations. In the early 1970s, 25% of the Fortune 500 companies 
had a CVC program (Fast, 1979). During the mid-70s these programs where greatly reduced 
until 1978 when favorable changes to investment legislation led to an increase in venturing 
investments by independent venture capitalists as well as CVC (Dushnitsky & Lenox, 2005a). 
By the early 1980s firms renewed their interest in CVC. However by the mid-80s CVC was 
again reduced, accentuated by the financial market downturn of 1986 and 1987. Afterwards 
the “bullish” Internet market period of the 1990s ignited CVC momentum and corporations 
re-introduced CVC (Yost & Devlin, 1993). After the collapse of the Internet bubble in 2000, 
corporations once again headed out of CVC (Chesbrough, 2002b). Recently between 2005 
and 2008 there was a new CVC expansion cycle. By the year 2000 the CVC activity peaked 
to more than 450 established firms actively investing in CVC (see Figure 2).  
 
----------------------- 
INSERT FIGURE 2 
----------------------- 
 
The purpose of this study is to understand why firms such as high-tech companies 
(e.g., Apple, Intel, and Motorola), automotive giants (e.g., BMW, Ford Motor Company, and 
Honda), food and beverage leaders (e.g., Nestlé, Starbucks, and, Carlsberg), machinery 
companies (e.g., Caterpillar and Honeywell), pharmaceuticals (e.g., Johnson & Johnson, 
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Roche, and GlaxoSmithKline) among others invest billions of dollars in startups. In 
particular, we aim at studying the internal and external determinants influencing CVC 
investment activity. To do so we build a robust data set and perform tests through a Probit 
variable reflecting CVC investment activity to explore whether internal and external 
conditions impact CVC activity. Studying 399 large firms that follow a simultaneous R&D 
and CVC innovation strategy, we analyzed a panel of publicly listed companies between 
1985 and 2008, and found that internal and external conditions are associated with CVC 
activity.  
Our study extends the current stream of research on CVC. The goal is to make 
scholars and managers aware of the internal and external determinant forces influencing 
CVC. Our study provides findings and insights to facilitate the strategic management of 
CVC. To our knowledge, this is the first study that examines the influence of internal and 
external determinants on CVC investment activity between 1985 and 2008, a period 
characterized by several expansion and contraction periods of CVC activity.  
The paper has the following structure. In Section 2 we look at the literature relevant to 
our subject and develop hypotheses. We describe our data in section 3 and our methodology 
and variables in section 4. In section 5 we discuss the results obtained from our quantitative 
analysis. In section 6 we expand on the discussion and provide conclusions and managerial 
implications in section 7.   
 
1.2. Literature Review and Hypotheses 
We base our study on theories and previous research that have tried to explain why 
organizations invest in innovative startups. Through institutional theory, Ensley and Carr 
(2006) analyzed the internal and external drivers that create isomorphic pressures influencing 
organizational investment in startups. Institutional theory takes into account the 
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institutionalized environments as well as the conformity and legitimacy pressures that lead 
firms to isomorphism (DiMaggio & Powell, 1983). Mimetic isomorphism applied to CVC 
investment behavior can be further related to explain conformity and legitimacy seeking 
because mimetic isomorphism is generally considered a response to uncertainty; the more 
technological uncertainty and goal ambiguity, the greater the rate of isomorphism (DiMaggio 
& Powell, 1983). When studying CVC behavior, mimetic pressures could be explained as the 
need to follow what the rest of firms do. An established firm could feel urged to follow other 
leading organizations due to reputation consequences in case they do not follow (Scharfstein 
& Stein, 2000). A more recent theoretical approach that complements the study of corporate 
practices and diffusion is that of Ansari et al. (2010) in which population-level and 
organizational-level mechanisms are linked by diffusion and implementation factors 
influencing the adaptation of practices. These scholars explore the importance of both 
economic and rationale factors on the diffusion of corporate practices. This theory relates to 
our paper as they suggest studying the firm’s internal factors to explain the adoption and 
diffusion of management practices. In our case we study the internal factors that influence the 
adoption of CVC considered as a sophisticated managerial practice to explore external 
knowledge and generate innovation. According to Burgelman and Valikangas (2005), CVC 
investment can be influenced by the internal financial conditions of the firm, such as 
availability of free cash flow and lack of growth. However, Bruton and Ahlstrom (2003) 
concluded that the process and behavior of a large firm investing in a startup is also 
influenced by external environmental conditions such as the financial market conditions. 
Based on this argumentation, we hypothesize that there are some key internal and external 
determinants linked to CVC activity.  
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1.2.1. Shortage of Growth Opportunities and CVC Activity  
According to Wennekers and Thurik (1999) the economic decline of the 80s caused a 
renewed interest for entrepreneurial practices that could reinforce and alleviate the lack of 
growth. More importantly they analyzed the role of startups as a means of growth in times of 
economic stagnation.  
According to Zahra (1991) firms that seek corporate growth can engage in CVC as it 
provides external knowledge and growth platforms. Tsai and Wang (2008) reported that large 
firms eagerly seeking growth opportunities utilize external knowledge as a source of new 
growth opportunities. In addition, McGrath et al. (2006) reported that in 1998 Nokia 
communicated that their CVC unit Nokia Ventures Organization (NVO) was established to 
look for growth opportunities beyond the existing business, but within their vision.  
CVC activity can also strengthen a firm's ability to create new growing business 
opportunities. Large firms gain access to proprietary technologies from startups that can then 
be combined with existing internal R&D technologies to create new products (Gompers & 
Lerner, 2001a). Chesbrough (2002c) also proposed that firms seeking for a catalyst to boost 
growth could engage in CVC. In their research, Lin and Lee (2011) found that firms seeking 
growth can employ CVC to support corporate growth. Contrary to investments for financial 
reasons, CVC can serve as a mechanism to identify emerging technologies and an innovation 
enhancer, which in turn assists established firms to acquire future growth opportunities. They 
found that there was no significant relationship between CVC and growth. However, they 
concluded that firm growth was not affected by increasing the amount of CVC. Studies on 
growth and strategic benefits including technology acquisition (Chesbrough, 2003b), 
knowledge accumulation (Wadhwa & Kotha, 2006), and organizational renewal (Siegel, 
Siegel, & MacMillan, 1988) indicate that these all contribute to company growth, hence firms 
with shortages of growth can engage in CVC. Growth opportunities can be exploited 
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internally through R&D or externally through CVC where a startup can be developed and 
become a direct growth vehicle leading to the development of a new business unit (Campbell, 
Birkinshaw, Morrison, & van Basten Batenburg, 2003). A large firm can make R&D 
technological resources available to a startup, as R&D technological resources can be 
leveraged by the nascent novel external innovation represented by startups’ new technology 
(Hill & Birkinshaw, 2006). These internal resources can be represented by in-house R&D as 
previous research shows that large firms’ innovation intensity is a way to mitigate future low 
growth opportunities (Garner, Nam, & Ottoo, 2002; Yew Kee, Tjahjapranata, & Chee Meng, 
2006). 
Furthermore, for firms experiencing a loss in growth, CVC can facilitate the 
formation and expansion of a firm’s “ecosystem” consisting of suppliers, customers and other 
providers, thus stimulating demand for their core products (Lin & Lee, 2011). An example of 
this “ecosystem” expansion is developed by Campbell et al. (2003) as Intel Capital invests in 
startups that in turn increase the demand for Intel microprocessors for the new products being 
developed by growing startups. Another study focusing on a firm is DuPont's CVC initiative. 
Bhardwaj et al. (2006) reported that DuPont invested rapidly but selectively in startups to 
explore growth opportunities to help them mitigate growth stagnation within specific sectors. 
In other words, DuPont CVC invests in multiple new startups in order to alleviate shortages 
of organic growth (Vassolo, Ravara, & Connor, 2005; Vassolo, Anand, & Folta, 2004).  
Burgelman and Valikangas (2005) explain that CVC activity is often started by large 
established firms as a form of “insurance” against the possibility of the existing mainstream 
businesses failing to support corporate growth. In other words, insufficient prospects to meet 
corporate growth objectives foster CVC investment activity. Hence we present the following 
hypothesis related to firms’ growth: 
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H1.  A firm experiencing shortages of growth is prone to engage in CVC activity. 
 
1.2.2. Resource Availability and CVC Activity  
Burgelman and Valikangas (2005) addressed the linkage between free cash flow and 
CVC investment, stating that the amount of capital to be invested through CVC varies 
depending on cash flow availability. They propose a quadrant for CVC situations (see Figure 
3). Both “CVC orphans” and “CVC drive” rely on availability of financial resources. “CVC 
orphans” refers to situations in which companies have uncommitted financial resources (e.g. 
free cash flow availability with no specific project allocation) and growth prospects of core 
mainstream businesses are sufficient hence there is little motivation to support CVC. “CVC 
drive” refers to situations in which companies have sufficient free cash flow and growth 
prospects are expected to be insufficient. Top management is then likely to form and support 
CVC. The lower quadrants indicate that there are no financial resources available, “CVC 
irrelevance” refers to situations in which there is no free cash flow, but the growth 
opportunities look sufficiently promising, and therefore top management is likely to consider 
CVC irrelevant. Finally “CVC desperate” occurs when there is a lack of financial resources 
combined with inadequate growth prospects making top management prone to desperately 
commit to the first reasonable looking startup for which, given the substantial uncertainty 
associated with CVC, the likelihood of failure would be high.  
Previous studies on innovation activities and cash flow have analyzed the relationship 
between R&D and cash flow (Cohen, 2010; Fazzari, Hubbard, & Petersen, 1988; Szewczyk, 
Tsetsekos, & Zantout, 1996). These conclude that corporate investment, including R&D, is 
sensitive to cash flow availability. Moreover, Jensen (1986) indicated that free cash flow 
induces managers to approve innovation projects. However, there is a different school of 
thought with contrary predictions. For example, Hall (1992) and Himmelberg and Petersen 
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(1994) reported low sensitivity of R&D to cash flows because firms want to protect this 
difficult to replicate intangible asset. Therefore, even if firms could potentially make their 
R&D expenditures vary with cash flow availability, they tend not to do so to preserve their 
innovation capabilities. 
Dushnitsky and Lenox (2005a) mention that, in contrast to R&D, CVC activity does 
not face the problem of retaining highly technical R&D staff. Therefore CVC professionals 
can be prone to terminate their employment should the firm go through financial cash flow 
difficulties. They also provide evidence that firms with greater cash reserves have the 
resources that can be invested in CVC without compromising internal operations. More 
specifically, they find that cash flow has a positive effect on CVC investments. They add as 
an anecdote that even Intel, investing hundreds of millions in startups, commits no more than 
10% of its cash flow to equity investments. In addition, Dushnitsky and Lenox (2005a) argue 
that the cost of financing via external investor funds (e.g. external venture capitalists) is 
higher than the cost of financing through internal cash flow due to information asymmetry on 
technological and market knowledge therefore justifying the financing of startups via CVC 
internal means i.e. cash flow, instead of external venture capitalists. For these reasons, we 
expect CVC investment to exhibit a high sensitivity to a firm's cash flow. Therefore we 
present the following hypothesis: 
 
H2.  Financial resource availability positively impacts the CVC activity of the firm. 
 
----------------------- 
INSERT FIGURE 3 
----------------------- 
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1.2.3. R&D and CVC Activity 
R&D and CVC activities are both important to firms for growth and value creation 
(Burgelman & Välikangas, 2005). Sahaym et al. (2010) conclude that R&D influences the 
use of CVC finding that R&D expenditure increases the number of CVC deals in an industry, 
particularly in those industries which are growing rapidly and changing technologically. CVC 
also limits the commitment to R&D expenditure in emerging technologies that tend to be 
uncertain while maintaining the potential to increase large firm involvement as the market 
and technology potential become clearer (Basu et al., 2011). Essentially, CVC provides the 
flexibility to use a step-by-step investment commitment mitigating a potential large exposure 
to R&D expenditure losses, while maintaining the option to further invest should prospects 
for the novel technology appear to be attractive (McGrath & Nerkar, 2004). 
Moreover, Sahaym et al., (2010) found that business sectors with greater absorptive 
capacity developed by prior R&D expenditure display greater efforts towards pursuing 
innovations using CVC. In this sense we identified studies on motivations to undertake R&D 
to create the foundation for organizational absorptive capacity that equips firms with 
mechanisms toappropriate returns and make R&D worthwhile (Levin, Klevorick, Nelson, & 
Winter, 1987). Jaffe (1986) also conducted research on R&D and its linkage to profitability 
and market value, finding that firms with lower R&D activity suffer from lower profits and 
lower market value than firms with higher R&D activity. R&D expenditures signal firm 
commitment to technology that in turn generates valuable resources such as patents, 
laboratory facilities, and specialized technology staff all of which can attract startups that lack 
such technological resources creating a symbiotic relationship in terms of innovation and 
knowledge exchange between large established firms and startups. From this interaction 
established firms gain access to new technologies from startups that can then be combined 
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with internal R&D to create new products (Henderson & Cockburn, 2000; Stuart, Ha, & 
Hybels, 1999).  
Nowadays even the largest and most technologically advanced firms require 
knowledge beyond their boundaries seeking to optimally combine internal and external 
sources of knowledge to benefit from the positive effects that both sources have to offer 
(Cassiman & Veugelers, 2002). Large firms and startups cooperate while aware of the 
potential hazards of intellectual property leakage (Cassiman & Veugelers, 2006). This notion 
is particularly problematic because CVC investors are often viewed suspiciously by startups 
due to the perception that a CVC investor's goal can be to expropriate a startup’s technology 
(Dushnitsky & Shaver, 2009; Katila, Rosenberger, & Eisenhardt, 2008). However despite this 
hazard, R&D and CVC can in fact be seen as complementary activities with R&D and CVC 
being respectively focused on internal and external knowledge. Ennen and Richter (2010) 
suggest that complementarities result from the skillful matching of heterogeneous resources 
which generate positive returns above and beyond the effect of each resource generated on its 
own. Chesbrough (2002c) proposes that due to their exposure to technology and markets, 
large firms can have superior knowledge of technologies and commercialization, and be able 
to invest in CVC and leverage on existing R&D resources. Such firms with deep 
technological expertise derived from R&D have more competences to evaluate startups and 
create value (Sykes, 1986a, b, 1990), and by investing simultaneously in R&D and CVC 
develop the complementary skills to identify promising startups (Gans & Stern, 2003a). In 
the same line of reasoning, McGrath (1997) argues that large firms with R&D activities have 
the complementary technological and commercial knowledge for startups to grow 
successfully and create value. To further illustrate the benefits of pursuing R&D and CVC 
simultaneously, Dushnitsky and Lenox (2006) establish that between 1990 and 1999, CVC 
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and R&D presented a positive significant relationship with value creation. Based on this 
argumentation, we formulate the following hypothesis: 
 
H3.  The more a company spends on R&D, the more it becomes prone to engage in 
CVC activity. 
 
1.2.4. Financial Market and CVC Activity  
External conditions influence the behavior and process of large established firms 
investing in startups (Aldrich, 1979; Bruton & Ahlstrom, 2003). Population ecology is a 
theory that takes into account the external condition factor. Hannan and Freeman (1977) 
studied why some corporations adapt to changing environments by applying appropriate 
practices not only to survive, but also to outpace competition. Using population ecology, 
Klepper and Simmons (1997) addressed the technological extinction of firms by studying the 
causes that influence firms to engage in activities pursuing innovation. Romanelli and 
Tushman (1994) went further to explain the organizational transformation influenced by 
external conditions through population ecology. In other words, managers of CVC units can 
increase or reduce investments to minimize or maximize the effects of financial market 
fluctuations representing an external disturbance to firm operations. In this way organizations 
seek to balance organizational structures (e.g. such as a CVC unit within a large firm 
interacting with startups) and external conditions that can be represented by fluctuations on 
the financial market.  
Gompers and Lerner (1998a; 1998c) documented that the evolution of the financial 
market has an impact on the investment behavior of independent venture capitalists (VC), and 
that the VC industry is highly volatile. One study from the 1975 to 1998 period found that 
venture capitalists with the most industry experience increase their investments when 
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financial market signals become more favorable (Gompers, Kovner, Lerner, & Scharfstein, 
2008). These findings are consistent with the view that venture capitalists respond positively 
to attractive investment opportunities signaled by favorable financial market shifts. 
Furthermore, an increase in initial public offerings (IPOs) leads VC firms to raise and invest 
more funds. The high VC activity of 1969 to 1972, 1981 to 1983, and 1998 to 2000 provide 
illustrations of these cycles (Gompers & Lerner, 1998a; Gompers & Lerner, 1998c).  
Similar to independent VC, corporate investment has also been studied and proven to 
be affected by volatility of stock prices (Baker, Stein, & Wurgler, 2003). An example of these 
cycles is the CVC activity in the USA which boomed in the early 1970s and the early 1980s 
and which fell off in the in-between periods growing again in the mid-1990s. These cycles 
seem to mirror those of VC but to a magnified extent (Gompers et al., 2008). However, 
despite volatility and cyclical economic downturns that can reduce the viability of CVC 
investment, several large firms decided to maintain their CVC units as a window on 
technology (Chesbrough, 2002a).  
We also found studies where an increase in IPO activity attracts more potential 
entrepreneurs (Ritter & Welch, 2002) thereby increasing the pool of potential startup 
investments and the likelihood that a CVC will find an attractive startup. Therefore we 
formulate the following hypothesis: 
 
H4.  Favorable financial market conditions positively impact the CVC activity 
conducted by firms. 
  
1.3. Data 
To test our hypotheses, we explore the relationship between four internal and external 
factors (i.e. firm growth, cash flow availability, R&D expenditure, and financial market 
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conditions) and CVC activity. We build a large panel data and use a Probit model. Because 
CVC investments are typically made by large established firms (Dushnitsky & Lenox, 2006) 
we focus our study on publicly listed firms investing in CVC. Due to lack of reliable data 
prior to 1985, our period study ranges from 1985 to 2008. To the best of our knowledge, our 
dataset is unique in that it provides detailed information on financial and corporate venturing 
activities made by international publicly listed established firms. The database contains 
financial information on firms drawn from the Thomson Reuters DataStream and we combine 
these data with CVC data collected from the Venture Economics' Venture Expert database 
which includes a comprehensive coverage of CVC investment, exit, and performance activity 
in the private equity industry. Several studies on VC and CVC have used this database (Basu 
et al., 2011; Dushnitsky & Lenox, 2005a, b; Gompers, 1995; Wadhwa & Kotha, 2006). 
For our study we dropped the established firms when financial accounting data was 
missing. Our sample also evolved as some firms ceased to exist or were acquired during the 
sample period. We searched the population of all CVC investments made by large established 
firms. We collected data on the annual CVC activity (i.e. CVC investment and number of 
new startups in their portfolio). By applying the above criteria, we reached a total of 976 
CVC units that invested US$ 54.3 Billion. In Figure 4 we report the number of CVC units 
being created by established firms from 27 countries, reaching a peak in 1999 and 2000 in 
which over 180 and 140 new CVC units respectively were created. In Figure 5 we show the 
total number of startups financed by CVC units, having 15,648 startups between 1985 and 
2008. In 2000 the CVC activity peaked with more than 3,000 startups being financed by 
CVC.  
In order to combine DataStream and Venture Expert, we utilized an automated 
matching algorithm and a hand-checking procedure. This operation resulted in 407 matches 
of established firm-CVC pairs. We also decided to exclude real estate and financial 
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institutions from our CVC sample to focus on firms that pursue new product development. 
After these adjustments our sample had 399 publicly listed firms investing in R&D and CVC.  
 
----------------------- 
INSERT FIGURE 4 
----------------------- 
 
----------------------- 
INSERT FIGURE 5 
----------------------- 
 
Previous studies on CVC have been conducted mainly with a U.S. focus (Dushnitsky 
& Lenox, 2005b, 2006), while our research encompasses a global scope with firms from 
different countries. For sample description purposes we group them by Anglo-Saxon vs. non 
Anglo-Saxon countries. In Table 1 we observe that between 1985 and 2008, the established 
firms in our sample were predominantly from Anglo-Saxon countries (i.e. 65.16%) while 
34.84% pertain to Non Anglo-Saxon countries. This difference can depict country 
characteristics such as judicial system including the kind of law (i.e. common law or code 
law), language, as well as other varying characteristics such as technology transfer policy, 
and tax incentives (Armour & Cumming, 2006; Klette & Moen, 2000; Lerner, 2010; Poterba, 
1989). 
 
----------------------- 
INSERT TABLE 1 
----------------------- 
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Regarding business sectors prone to engage in CVC activity, Dushnitsky and Lenox 
(2005b) presented the total cumulative dollars invested in CVC between 1969 and 1999. 
Firms such as Intel, Microsoft, Cisco, Xerox, Ford Motor Co., Sony, Motorola, AOL, Dell, 
and Johnson & Johnson led the list in total investments revealing that the top 20 companies 
engaged in CVC belong to the electronics, information communication technology (ICT), 
automotive, and pharmaceutical business sectors (see Table 2). Our sample also comprises 
firms in high technology sectors (see Table 3), for example, close to 90 percent of all CVC 
investments by companies went into ventures within the following six sectors: ICT, business 
and engineering services, machinery and electronics, chemicals, devices, and 
pharmaceuticals. Only a relatively small portion (i.e. 11.28%) of CVC investment came from 
business sectors such as vehicles, metals, printing, publishing, food, beverage, and tobacco.  
 
----------------------- 
INSERT TABLE 2 
----------------------- 
 
----------------------- 
INSERT TABLE 3 
----------------------- 
 
1.4. Methodology and Variables 
Our dependent variable is CVC activity represented by a dichotomic variable taking the 
value of one for each public listed firm in which annual CVC investment in millions of 
dollars and the numbers of startups in portfolio are greater than zero. We consider 
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independent variables to include: annual figures for the parent companies’ sales growth 
representing growth, free cash flow for financial resources, and R&D expenditure measured 
by the annual R&D expenditure in millions of dollars. We normalized R&D expenditure and 
free cash flow by assets to negate the absolute variable's effect on the data, and because we 
had data in different currencies, hence allowing underlying characteristics of the data sets to 
be compared by normalizing them to a common scale. To capture the external financial 
market effect, we chose the NASDAQ index as an independent variable reflecting technology 
trading companies usually composed of startups conveying an IPO and large innovative 
established firms with intensive R&D expenditure. We also lagged by one year NASDAQ 
and free cash flow to capture the lag between CVC activity and both financial resource 
availability and external financial market conditions that could influence firms decision to 
invest via CVC. We consider firm size measured by number of employees (log) as a control 
variable. In Table 4, we present the description of the variables. 
 
----------------------- 
INSERT TABLE 4 
----------------------- 
 
We chose different periods because the number of firms making CVC investments and 
the average investor's volume of CVC activity fluctuated overtime suggesting ample within 
firm-industry sector variation in CVC activity. Unlike prior studies6 this research includes 
expansion and contraction periods. To verify the sub-periods we performed a Chow test to 
see if estimates were different between periods presenting an expansion and those presenting 
a contraction in CVC activity. Due to the effects on the time series measuring CVC over four 
                                                 
6 e.g. Zahra (1991) analyzed the CVC contraction period 1986 to 1989, and Dushnitsky and Lenox (2005a) studied the CVC 
expansion period 1990 to 1999.  
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sub-periods - 1994 to 2000 and 2005 to 2008 as expansion periods as well as 1985 to 1993 
and 2001 to 2004 as contraction periods - we propose the cut-off points based on the 
structural breaks. An example of these cut-off points is the deep plunge that the stock market 
experienced in 2000 after the “Internet bubble” burst. The test statistics for Chow breakpoint 
confirmed a structural change in the parameters during these structural break years. The F 
statistics rejected the null hypothesis of no structural change for all models at the five percent 
level of significance (see Appendix Table A1). Using the Chow test, we determined that the 
independent variables have a change in parameters when comparing expansion and 
contraction periods; contraction period 1985-1993 vs. expansion period 1994-2000 and 
contraction period 2001-2004 vs. expansion period 2005-2008. For both cases the probability 
was significant at F (7, 450) = 2.68 Prob > F = 0.0099, and F (7, 761) = 2.06 Prob > F = 
0.0842 respectively. In contrast, when comparing two CVC contraction periods and two 
expansion periods we cannot reject the null hypotheses as results for contraction period 1985-
1993 vs. contraction periods 2001-2004, have a value of F(7, 418) = 0.48 Prob > F = 0.8507, 
and for the two expansion periods 1994-2000 and 2005-2008 a value of F(7, 793) = 0.81 Prob 
> F = 0.5808. After confirming the different periods we decided to analyze each period 
separately. Consequently we identified 1994-2000 and 2005-2008 as expansion periods and 
we consider 1985-1993 and 2001-2004 as CVC contraction periods.  
 
 
----------------------- 
INSERT TABLE A1 
----------------------- 
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To test our research hypotheses we used a Probit regression. For every year a new data 
table was developed and we performed regression calculations for each expansion and 
contraction period. Following Mitchell and James (2001), we gathered financial market data 
that corresponded directly to the point in time at which the Venture Expert data was 
collected. For the regressions we considered the firm observation years with and without 
CVC activity. Finally, in order to choose either a fixed-effect or random-effect in our data to 
make our model capable of estimating the likelihood of established firms to engage in CVC, 
we performed a Hausman test (Hausman, 1978). The Hausman test is based on the difference 
between the random-effect estimator and the fixed effect estimator in which observationally 
equivalent firms may differ on some unobservable or unmeasured characteristic. This test 
enabled us to correct for unobserved heterogeneity using random- and fixed-effect 
estimations. The Hausman test results met the asymptotic assumptions converging to our 
data, and were highly significant (Prob>chi2 = 0.0001). Therefore we used the consistent 
estimator for fixed effect, and not the efficient estimator for random effect. For all models we 
implemented a firm-industrial sector fixed effect at a two-digit SIC code and included year 
dummies to control for unobserved period effects.  
  
1.5. Analysis and Results 
In Table 5 we present descriptive statistics for our dependent and independent 
variables for the total selected cyclical period between 1985 and 2008. The sample consists of 
399 large established firms from 27 countries7 and 10 business sectors8. CVC activity is a 
dichotomic variable taking the value of one for each observation where annual CVC 
                                                 
7 Full country sample includes: Australia, Austria, Belgium, Canada, China, Denmark, Egypt, Finland, France, Germany, 
Hong Kong, India, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Norway,  Singapore, South Korea, Spain, Sweden, 
Switzerland, Taiwan, United Kingdom, and Unites States of America. 
8 Sample business sectors include: Information communication and technology, pharmaceuticals, vehicles, food beverage & 
tobacco, industrial machinery & electronics, chemicals, metals, printing & publishing, devices, and business & engineering 
services. 
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investment or the number of startups in which an established firm invested in a particular 
year is greater than zero; otherwise the dependent variable equals zero. Sales growth is 
defined as the annual change in sales ($ million) over previous year sales ($ million) 
presenting in our sample a minimum of 88.9% sales reduction, while at the maximum there 
was a firm showing an annual growth of 588% year-to-year. Free cash flow is lagged one 
year and normalized by assets and we have observations varying from -0.988 to 2.805. R&D 
expenditure is also normalized by assets and it reports years with zero expenditure in R&D 
and a maximum of 7.643, while the average is 0.080. NASDAQ index lagged one year as the 
stock market index for high growth technology companies shows a value range from 249.50 
to 3197.29. Finally, firm size used as a control variable is the log of number of employees at 
the established firm, and it has a mean value of 4.15.  
For a more comprehensive description of firms in our sample, Table 6 presents 
descriptive statistics on the profile of the established firms. In this table, CVC investment is 
the total corporate venture capital invested in ($ million) and startups is the number of young 
high-growth firms that were financed through CVC. Both CVC and startups reflect a value of 
zero as a median as in most years our observations presented no CVC activity. The average 
annual CVC investment and number of startups being financed by each established firm was 
US$ 2.67 million and 4.23 startups (in absolute terms). At the extreme, Intel Capital invested 
over US$ 1.28 billion during 2008. For comparing purposes we normalized sales by assets to 
negate the absolute variable's effect on the data, and because we had data in different 
currencies, hence allowing underlying characteristics of the data sets to be compared by 
normalizing them to a common scale. Sales normalized by assets shows an average value of 
1.158. Finally the number of employees is a variable representing the Size of the parent 
company firm. Our sample has an average value of 61,836 employees, with a maximum of 
536,350 employees.  
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----------------------- 
INSERT TABLE 5 
----------------------- 
 
----------------------- 
INSERT TABLE 6 
----------------------- 
 
In Table 7, we run a correlation test to identify potential sources of multicollinearity, 
this table reports the correlation coefficients between the dependent, independent, and control 
variables. The correlation matrix provides the existence of a positive relationship between the 
CVC activity dichotomic variable and the continuous independent variables: free cash flow, 
R&D expenditure, and NASDAQ index. This table indicates that CVC activity is more 
correlated with the independent variable NASDAQ index (i.e. 0.2098), while the parent 
company independent variables free cash flow and R&D expenditure, show a correlation 
value of 0.0100 and 0.0363 respectively. In contrast CVC activity has a negative relationship 
with sales growth (i.e. -0.0352). 
 
----------------------- 
INSERT TABLE 7 
----------------------- 
 
Due to the fact that our dependent variable CVC activity is constrained and a number 
of observations have a value of zero, we use a Probit regression to estimate the model. In 
Table 8 we report the results of our Probit regression estimating the set of factors that drive 
 
 
55 
 
the decision to engage in CVC activity. As mentioned earlier, to operationalize our model we 
created a binary version of CVC activity where all levels of investment greater than zero are 
assigned the value of one, in this regression we assume that the decision to engage in CVC 
activity is driven by the availability of cash flow, the lack of growth, the R&D expenditure, 
and the level of the NASDAQ index. While not reported, all models include year dummies to 
control for unobserved period effects and a firm-industrial sector fixed effect at a two-digit 
SIC code. 
 
----------------------- 
INSERT TABLE 8 
----------------------- 
 
We analyze the different CVC cyclical, contraction, and expansion periods. In Model 
1 (i.e. 1985 to 2008 cyclical period), the estimated coefficients of our firm-level variables, 
sales growth and R&D expenditure, suggest each has a significant effect on CVC activity, 
although it is negative for sales growth (β=-0.112, p<0.1) and positive for R&D expenditure 
(β=0.763, p<0.01) as hypothesized (Hypotheses 1 and 3, respectively). It is interesting to see 
the negative sign for sales growth which can be interpreted as firms are willing to pursue 
CVC when sales growth decreases. Furthermore, we find support for our hypothesis H4 that 
CVC activity will be higher contingent to financial market conditions (i.e. NASDAQ index 
β=0.000394, p<0.01). We do not find support in this cyclical period for free cash flow having 
an effect on CVC activity (Hypothesis 2).  
In Model 2 and 4 (i.e. CVC contraction periods), the estimated coefficients of our 
firm-level variables free cash flow and R&D expenditure suggest a significant effect on CVC 
activity, free cash flow (β=7.744, p<0.01) for Model 2 (i.e. 1985 to 1993), supporting 
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hypothesis H2. For Model 4 (i.e. 2001 to 2004) free cash flow (β=0.654, p<0.05), supporting 
hypothesis H2, R&D expenditure (β=2.197, p<0.01), supporting hypothesis H3. We find 
support for our hypothesis H4 on CVC activity contingent to financial market conditions (i.e. 
NASDAQ index β=0.000294, p<0.01). We find no support indicating that sales growth has an 
effect on CVC activity (Hypotheses 1).  
In Model 3 (i.e. 1994 to 2000 expansion period), the estimated coefficient of our firm-
level variable R&D expenditure, suggest a significant effect on CVC activity (β=1.008, 
p<0.05) as hypothesized (Hypothesis 3). Furthermore, we find support for our hypothesis H4 
that CVC activity will be higher depending on financial market conditions (i.e. NASDAQ 
index β=0.000525, p<0.01). We do not find support that either sales growth or free cash flow 
have an effect on CVC activity in this expansion period (Hypotheses 1 and 2).  
Regarding Model 5 (i.e. 2005 to 2008 expansion period), the estimated coefficients of 
our firm-level variables, free cash flow and R&D expenditure, suggest each has a significant 
positive effect on CVC activity, (β=0.487, p<0.1) for free cash flow and for R&D expenditure 
(β=1.387, p<0.05) as hypothesized (Hypotheses 2 and 3, respectively). We find no support for 
neither sales growth, nor NASDAQ index in this expansion period.  
By analyzing the results from an independent variables perspective (i.e. sales growth, 
free cash flow, R&D expenditure, and NASDAQ index) rather than the different periods, 
findings remain consistent. Our results in Model 1 present a negative significant coefficient 
for sales growth influencing CVC activity for the whole 1985 to 2008 period. This can be 
explained by taking into account the Burgelman and Valikangas (2005) quadrant model in 
Figure 3, in which a “CVC desperate” situation could have been originated by not having free 
cash flow readily available and a lack of sales growth. When analyzing expansion and 
contraction periods, sales growth didn’t show significance in any of the different expansion 
or contraction models. 
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For our hypothesis arguing that free cash flow positively impacts CVC activity, our 
Models 2, 4, and 5 support H2.  
Similar to Dushnitsky and Lenox (2005a), we found a significant positive coefficient 
of R&D expenditure influencing CVC activity across all models, except Model 2. This 
suggests that since 1994 going forward internal R&D expenditure and external CVC 
investment act as complements. After 1994 this positive coefficient remains significant 
regardless of expansion or contraction CVC trends, supporting our Hypothesis H3. As 
suggested in the complementarity knowledge creation literature, by combining internal R&D 
expenditure and external CVC investment as sources of knowledge, firms benefit from the 
positive effects that both sources offer (Cassiman & Veugelers, 2002; Ennen & Richter, 
2010). Mitchell and Singh (1992) describe the R&D-CVC combination as a way for large 
firms to gain information about the emerging products and markets. Moreover, Sahaym et al. 
(2010) also conclude that R&D expenditure has a positive effect on CVC activity. Essentially, 
CVC seems to provide large firms with a flexible step up investment mechanism providing 
the possibility to further invest should prospects for the novel technology or market appear 
more attractive (McGrath & Nerkar, 2004). 
Although the level of the NASDAQ index influences CVC activity for the whole 1985 
to 2008 period, when analyzed by expansion and contraction periods, it is only in the 1994 to 
2000 and 2001 to 2004 periods that H4 is supported. These periods coincide with the Internet 
bubble, a period characterized by speculative investors. We find that for certain periods, there 
is evidence suggesting that external financial fluctuating conditions influence the behavior of 
managers of CVC units that can increase or reduce investments to minimize or maximize the 
effects of the financial market fluctuations (Bruton & Ahlstrom, 2003). We also find that 
similar to Baker et al., (2003) who found that venture capital investment activity is influenced 
by financial market volatility, we observe that CVC activity is also affected by financial 
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volatility cycles. However, as noted by Chesbrough (2002a) despite the financial market 
volatility several large firms seem to maintain their CVC activity as a window on technology 
regardless of the ups and downs of the financial market. 
 
1.6. Discussion  
Several decades after its initial emergence, it seems that the CVC phenomenon will 
prevail. Our study reflects the relationship between CVC and companies’ internal variables 
and external financial market forces. It is important to be aware of these determinants as CVC 
is a valuable vehicle for innovation, providing established firms with platforms for growth 
and value creation (Allen & Hevert, 2007; Burgelman & Välikangas, 2005; Dushnitsky & 
Lenox, 2006; Hurry et al., 1992; Maula et al., 2005; Roberts & Berry, 1985; Wadhwa & 
Kotha, 2006). 
When analyzing the overall cyclical CVC period from 1985 to 2008 the results of our 
study suggest that established firms’ CVC engagement behavior is influenced by their R&D 
expenditure, lack of growth in sales, and financial market conditions, with R&D expenditure 
and NASDAQ index as the main significant elements explaining CVC activity, followed by 
lack of growth in sales. 
Regarding CVC activity explained by external financial market conditions, we 
observe that during the first contraction period (i.e. 1985 to 1993), the NASDAQ index 
variable shows no significance. Nonetheless the expansion period 1994-2000 and contraction 
period 2001-2004 highlight NASDAQ index as a significant determinant at the 1% level. It is 
interesting to note that these periods coincide with the Internet hype. The other period 2005-
2008 shows no significance for NASDAQ index suggesting that an alternative explanation to 
the lack of significance for these later periods could be a less speculative opportunistic 
 
 
59 
 
behavior from established firms and a commitment to CVC by established firms as a lever on 
technology.  
In terms of firms’ internal determinants and CVC activity, we find the variable R&D 
expenditure significant indicating firm willingness to commit resources to CVC. Particularly 
for R&D expenditure, CVC can represent the capacity to evaluate external technology which 
is important when reviewing emerging technology and potential investment options (Sahaym 
et al., 2010). Moreover, the knowledge gained through R&D expenditure reduces the 
difficulty in evaluating relatively unfamiliar technology (Cohen & Levinthal, 1990; Keil, 
2002). Separately, free cash flow availability was more relevant during the expansion and 
contraction periods 1985 to 1993, 2001 to 2004, and 2005 to 2008. Finally, between 1985 and 
2008 lack of sales growth prove to be influential to generate CVC activity, but not during 
each of the expansion or contraction periods. 
We believe that the evidence obtained could be seen as the first base for further 
research to understand the fluctuating cyclical behavior of firm CVC activity. There is room 
for future research on the analysis of the factors influencing the mortality of specific CVC 
programs. This includes examining in detail the forces of getting the CVC cycle started, the 
length of such cycles, and the causes that would terminate the CVC program. Therefore a 
survival methodology can provide new insights to CVC research. Another interesting study 
could be to further explore the R&D and CVC relationship as our findings supporting 
Hypothesis H3, suggest complementarity between R&D expenditure and CVC investment. 
These heterogeneous resources (i.e. R&D expenditure and CVC investment) can have the 
potential to generate positive returns beyond the effect of each one on its own (Arora & 
Gambardella, 1990; Chesbrough & Tucci, 2004; Ennen & Richter, 2010; Granstrand, Bohlin, 
Oskarsson, & Sjöberg, 1992). 
 
 
60 
 
1.7. Conclusions  
This study was motivated by limitations of existing research in CVC and the effect that 
internal factors and external financial market conditions have on CVC activity in different 
CVC expansion and contraction periods. Although, Keil (2002) indicates that gaining 
external knowledge sources is a way for firms to adapt to changing external conditions, 
research on the influential external factors to pursue CVC as a source of external knowledge 
is still limited. Furthermore, despite the strategy literature notion of fit between firms’ 
internal conditions and their external environment (Andrews, 1971), few studies have 
explored the relationship between CVC investment activity and its external and internal 
determinants. In addressing these limitations, the results of this study make several 
contributions. First, the external financial market fluctuations analyzed in this study reveal 
that CVC activity is highly volatile as demonstrated by fluctuations in the investment activity 
over the past decades. Second, our econometric analysis indicates strong and significant 
positive associations between CVC activity and our independent variables R&D expenditure 
and NASDAQ index, as well as an existing negative significant association between CVC and 
sales growth. By focusing on the characteristics and conditions in which established firms 
operate as CVC investors, we complement the work by Dushnitsky and Lenox (2005a) and 
Basu et al. (2011). 
It is also interesting to see the applicability of the Burgelman and Valikangas (2005) 
quadrant model (see Figure 3), as during the 1985 to 2008 period free cash flow was not 
significant and there was also a lack of sales growth, hence considering a “CVC desperate” 
situation. Such situations can potentially explain why established firms act “desperately” and 
invest in the “first reasonable” looking startup, which considering the substantial 
technological uncertainty in CVC and having CVC influenced by NASDAQ speculative 
investment behavior the likelihood of a failure would be high.  
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In line with Dushnitsky and Lenox (2005a), we also found a significant positive 
coefficient of R&D expenditure influencing CVC, suggesting that internal R&D expenditure 
and external CVC investment are complementary after 1994 regardless of expansion or 
contraction on CVC activity trends. This supports previous literature on complementarity 
between internal R&D expenditure and external CVC investment (Cassiman & Veugelers, 
2002; Ennen & Richter, 2010; Mitchell & Singh, 1992; Sahaym et al., 2010). In essence, 
CVC seems to provide large firms with a flexible way to increase or decrease commitments 
to novel technology depending on market and technological uncertainty and attractiveness 
(McGrath & Nerkar, 2004). 
We also found evidence suggesting that external financial conditions influence CVC 
investment with the aim to maximize the financial and strategic goals (Bruton & Ahlstrom, 
2003). Nonetheless, in line with Chesbrough (2002a), despite financial market volatility 
several large firms seem to maintain their CVC activity as a window on technology. 
Regarding limitations, even though we found empirical support for our hypotheses, the 
results may be limited to the time periods. Historically, CVC investing has been cyclical, 
with three different waves of activity beginning in the mid-1960s (Dushnitsky & Lenox, 
2006). Our sample only covers data after 1985 and the rise in CVC activity in the recent 2005 
to 2008 period. An additional limitation is that we use the data available by Thomson Reuters 
and it is likely that certain firms do not disclose all CVC investment information.  
As for the implications for managerial practice, we suggest that managers need to 
have an understanding of the influential factors that drive CVC activity, and manage CVC 
through the different internal and external determinants to which the established firm will be 
exposed. Additionally, even though the CVC phenomenon has been studied as a way to 
capture benefits for strategic management (Burgelman, 1983a, b; Fast, 1979), in practice it 
still seems that CVC programs are usually terminated before investment pays off. In other 
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words, even if barriers to wind down CVC activity are low, CVC should not be first in line 
for cuts when internal resources tighten up. Despite the advantages enjoyed by large scale 
R&D activity CVC partnerships with startups can play an important role for innovation and 
growth. For instance Acs and Audretsch (1990) highlight that small growing innovative 
startups can serve as innovation and growth platforms for larger established firms. Moreover, 
the speed of recent technological advances and shortening product life cycles in global 
industries has shifted the advantage to CVC units interacting with startups which are flexible 
and can move quicker to develop new products and processes (Zahra, Ireland, & Hitt, 2000). 
Consequently, even though we find that CVC follows the ups and downs of the economy, 
CVC is too important to be treated as an “on-off intermittent switch”. For example if firms 
can manage talented qualified R&D personnel as a scarce valuable resource considering that 
their separation from the firm can disrupt long-run projects. CVC can similarly be managed 
to retain skilled CVC personnel. This can be further justified as CVC is a linking way to 
access a pool of scientists and entrepreneurs who would be difficult to employ in the firm.  
Finally, corporate instruments functioning as vehicles to keep firms abreast of 
emerging opportunities are important as they can provide strategic direction (Hamel, 2002; 
Prahalad & Hamel, 1996). Consequently due to its exploratory and flexible step-up 
commitment nature, CVC requires recognition from top management as a valuable corporate 
instrument. Furthermore, top management attitude towards entrepreneurship and a risk 
adverse mentality does not favor business venturing, discouraging and hindering CVC 
activities. It is important to acknowledge that CVC should be managed as an exploratory 
process, in which technical and market risks and opportunities are gradually assessed and 
better understood as more information and knowledge is generated.  
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Figure 1. Total CVC investment in million USD. 
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Figure 1 presents the actual amount invested in CVC, the sample consists of 1,904 CVC units owned by 938 established firms from 27 countries. Statistics based on annual 
available data for the years between 1968 and 2008. Data derived from Thomson Reuters Venture Expert. The CVC investment in 2000 and 2008 surpassed US$ 16 billion 
and US$ 4 billion respectively. Several studies on VC and CVC have used this database (e.g., Dushnitsky and Lenox, 2005a, b; Gompers, 1995; Wadhwa and Kotha, 2006, 
Basu et al.  2011). Country sample includes: Australia, Austria, Belgium, Canada, China, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Israel, Italy, Japan, 
Malaysia, Mexico, Netherlands, Norway, Singapore, South Korea, Spain, Sweden, Switzerland, Taiwan, United Kingdom, and Unites States of America. 
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Figure 2. Number of actively investing CVC units. 
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Figure 2 Same sample as in Figure 1. The graph represents the number of established firms actively investing in CVC on at least one portfolio company (i.e. startup) per year. 
This means that a CVC unit may still be active transferring or absorbing technology between the startup and parent company despite not reporting actual investments during a 
particular year. In 2000 the CVC activity peaked with more than 450 established firms actively investing in CVC.  
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Figure 3. Quadrant: factors driving Corporate Venture Capital (CVC). 
 
 
Source:  Burgelman, R. A. “Corporate Entrepreneurship and Strategic Management: Insights From a Process 
Study.” Management Science 29, no. 12 (December 1983): 1349-1365 and Burgelman, R. A., & 
Valikangas, L. 2005. Managing Internal Corporate Venturing Cycles. MIT Sloan Management Review, 
46(4): 26-34. 
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Figure 4. Number of CVC units created by established firms. 
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Figure 4 Same sample as in Figure 1. This figure represents the total CVC industry available data for the number of CVC units being created by established firms; note that 
an established firm can have more than one CVC unit or investment fund. In 1999 more than 180 new CVC units were created by established firms. 
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Figure 5. Number of portfolio companies (i.e. startups) financed by CVC. 
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Figure 5 shows the number of portfolio companies (startups) financed through CVC. In 2000, the CVC activity peaked with more than 3,000 startups being financed by CVC. 
Same sample as in Figure 1. 
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Table 1. Countries of sample firms. 
 
Country of established firms              Freq.        Percent 
Australia         10 2.51%
Canada            2 0.50%
United Kingdom                  25 6.27%
United States              223 55.89%
Total Anglo-Saxon 260 65.16%  
     
Austria           1 0.25%
Belgium           2 0.50%
China            1 0.25%
Denmark            4 1.00%
Egypt          2 0.50%
Finland            2 0.50%
France           11 2.76%
Germany           18 4.51%
Hong Kong            4 1.00%
India           12 3.01%
Israel            2 0.50%
Italy            3 0.75%
Japan          33 8.27%
Malaysia            3 0.75%
Mexico            3 0.75%
Netherlands            3 0.75%
Norway            2 0.50%
Singapore            8 2.01%
South Korea                  11 2.76%
Spain            1 0.25%
Sweden            6 1.50%
Switzerland            5 1.25%
Taiwan            2 0.50%
Total Non-Anglo-Saxon          139 34.84%  
     
Total sample 399 100.00%  
____________________________________________________________________________________________________ 
The Table presents 399 sampled parent companies. We studied firms beyond the U.S. to capture a global scope, unlike 
existing studies focused on the U.S. market (e.g. Dushnitsky and Lenox 2005b; Dushnitsky and Lenox 2006).  
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Table 2. Summary of the investment activity of the 20 largest CVC firms (1969-1999). 
 
Firm CVC first 
year  
CVC 
Maximum 
annual 
ventures 
Total dollars 
invested a 
Max. annual 
invested a 
Average 
annual rounds 
Total CVC 
Funds 
Intel 1992 179 1486 771 57 5 
Cisco 1995 55 1056 730 19 1 
Microsoft 1983 29 713 436 7 1 
Comdisco 1992 70 554 334 24 2 
Dell 1995 48 502 395 26 1 
MCI Worldcom 1996 11 495 410 8 1 
AOL 1993 39 333 169 10 2 
Motorola 1963 33 315 177 11 1 
Sony 1984 30 313 169 7 6 
Qualcomm 1999 5 262 207 5 1 
Safeguard 1983 21 231 118 6 3 
Sun Micro 1999 31 204 180 19 1 
J & J 1961 21 196 80 5 2 
Global-Tech 1999 13 188 122 11 1 
Yahoo 1997 5 186 163 3 1 
Xerox 1960 30 184 24 13 6 
Compaq 1992 21 182 113 5 3 
Citigroup 1999 11 156 93 9 1 
Ford Motor 1951 22 146 125 8 4 
Comcast 1996 16 144 84 11 1 
a  In millions of dollars ($ million). 
 
Source: Dushnitsky and Lenox (2005b). When do incumbents learn from entrepreneurial ventures? Corporate    
             venture capital and investing firm innovation rates. Research Policy, 34 (5), 615 – 639. 
__________________________________________________________________________________________ 
This panel represents the total cumulative dollars invested between 1969 and 1999. Intel leads the list with total 
investments approaching $1.5 billion since 1992. The top 20 is dominated by the largest electronics and 
computer ICT related firms such as Microsoft, Sony, Motorola, AOL, and Dell.  
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Table 3. Sectors of sample firms. 
                   Freq.       Percent        
Information Comm. Technology      85         21.30  
Business Engineering Services      83         20.80  
Machinery & Electronics            82         20.55  
Chemicals                           41         10.28  
Devices                             35            8.77  
Pharmaceutical                     28            7.02  
Vehicle                             18            4.51  
Metals                              10            2.51  
Printing and Publishing                9            2.26  
Food Beverage & Tobacco                8            2.01        
Total                 399                    100.00 
This table presents the sectors of the 399 firms of the sample (by 4 digit SIC code). Sample business sectors 
include: information communication and technology ICT (357*, 367*, 48**, 3663), business & engineering 
services (73**, 87**), industrial machinery and electronics (35**, 36** excluding 3663), chemicals (28** 
excluding 2834 and 2836, 29**, 3080), devices (38**), pharmaceuticals (2834, 2836), vehicles (37**), metals 
(33**), printing and publishing (27**), and food beverage and tobacco (20**, 21**). We created a binary 
version of sample sectors where sample firms present in a sector take a value of one, otherwise firms not active 
in such business sector are assigned the value of zero. Note that certain firms participate in more than one sector.  
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Table 4. Variables description. 
Variable      Description      
 
CVC activity Dichotomic variable taking the value of one for each observation where annual CVC 
investment or the number of startups in which an established firm invested in a 
particular year is greater than zero; otherwise the dependent variable equals zero. 
 
Sales growth     Annual change in sales ($ million) over previous year sales ($ million).  
  
Free cash flow  Income after interest and taxes plus depreciation and amortization ($ million) 
normalized by assets. Variable lagged by one year in reference to CVC activity. 
  
R&D expenditure    Annual total Research and Development expenditures ($ million) normalized by 
assets. 
 
NASDAQ index  Annual average NASDAQ. This is an indicator of the performance of stocks for high 
growth technology companies. Variable lagged by one year in reference to CVC 
activity. 
   
Firm size     Log of firm employees. 
 
CVC investment   Annual Corporate Venture Capital invested ($ million) in absolute values. 
 
Startups   Number of startups that were financed through CVC. 
 
Sales   Annual sales in ($ million) normalized by assets. 
 
Employees  Number of employees.  
    
 
Table 5. Descriptive statistics (1985-2008). 
 
Variable       Obs.         Mean      Std. Dev.        Min         Max 
CVC activity                    9576        0.175      0.380                   0                  1 
Sales growth        6403        0.039      0.634                 -0.889    5.886  
Free cash flow     4641        0.064      0.413                 -0.988   2.805 
R&D expenditure 5795        0.080      0.808                   0       7.643 
Firm size   6479        4.150      0.960                   0       5.729 
NASDAQ index        9576       1312     914      249   3197 
___________________________________________________________________________ 
Descriptive statistics of main regression variables. 
This table reports summary statistics of the main regression variables. Sample consists of 399 large established 
firms from 27 countries9 and 10 business sectors10. Statistics based on annual data for the years between 1985 
and 2008, if available. Data derived from Venture Expert and DataStream data sets. We decided to exclude 
financial and real estate institutions from our CVC sample limiting the study to established parent companies 
that invest in new product development.  
 
 
 
 
 
 
                                                 
9 Full country sample includes: Australia, Austria, Belgium, Canada, China, Denmark, Egypt, Finland, France, Germany, 
Hong Kong, India, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Norway,  Singapore, South Korea, Spain, Sweden, 
Switzerland, Taiwan, United Kingdom, and Unites States of America. 
 
10 Sample business sectors include: Information communication and technology, pharmaceuticals, vehicles, food beverage & 
tobacco, industrial machinery & electronics, chemicals, metals, printing & publishing, devices, and business & engineering 
services. 
 
 
73 
 
Table 6. Descriptive statistics (1985-2008)                                                                                                               . 
 
Stats        CVC investment a Startups   Sales       Employees 
Mean     2.668                4    1.158        61,836 
Std. Dev.    24.800      10.287     1.690        92,384 
Median    0.000              0    0.926        26,000 
Max     1,280                       221                42.090      536,350 
Min     0.000                0    0.000                 0 
Obs         9,131         1,956     7,420          7,327         .                           
Descriptive statistics of established firms profile variables. 
This table reports summary statistics of the main profile variables. The sample consists of 399 large established 
firms from 27 countries. Statistics are based on annual data for the years between 1985 and 2008, if available. 
CVC investment is the total corporate venture capital invested in ($ million). Startups are the rounded number of 
startups that were financed through equity by CVC. Both CVC and Startups reflect a zero value for observations 
where there was no CVC activity reported. Sales are actual sales normalized by assets. We normalized Sales by 
assets to negate the absolute variable's effect on the data, and because we had data in different currencies, hence 
allowing underlying characteristics of the data sets to be compared by normalizing them to a common scale. 
Employees as total number of employees provide a variable for firm size. Data are derived from Venture Expert 
and DataStream data sets.  
 
a In millions of dollars ($ million). 
 
 
 
 
 
 
Table 7. Pairwise correlations (1985-2008). 
  
(obs=4029) (1)   (2) (3) (4) (5) (6) 
1. CVC activity    1.0000      
2. Sales growth             -0.0352 1.0000     
3. Free cash flow          0.0100   -0.0425 1.0000    
4. R&D expenditure 0.0363 0.1423 -0.2853   1.0000   
5. NASDAQ index   0.2098 -0.0096 -0.0233 -0.0592   1.0000  
6. Firm size       0.1641   -0.1031   0.1592  -0.2282   0.0107   1.0000 
 
Correlation matrix of main regression variables. 
This table reports the correlations between the main regression variables. Sample consists of 399 large 
established firms from 27 countries and 9 business sectors. Statistics based on annual data for the years between 
1985 and 2008, if available. Unless otherwise indicated CVC activity is a dichotomic variable taking the value 
of one for each observation in which annual CVC investment in millions of dollars and number of startups in 
portfolio, are greater than zero; otherwise CVC activity equals zero, Sales growth is annual change in sales ($ 
million) over previous year sales ($ million), Free cash flow is established firm’s income after interest and taxes 
plus depreciation and amortization ($ million) normalized by assets, R&D expenditure is established firm’s 
annual total Research and Development expenditures ($ million) normalized by assets, NASDAQ index is the 
NASDAQ stock market index of the common stocks used as an indicator of the performance of stocks of 
technology companies, Firm size is the Log of number of employees at the established firm. Data derived from 
Thomson Reuters Venture Expert and DataStream data sets.  
 
 
 
 
 
 
 
 
 
 
 
 
74 
 
Table 8. Internal and external determinants for CVC investment. 
 
 Hypotheses 1985-2008 
CVC Activity  
Cyclical 
1985-1993 
CVC Activity 
Contraction 
1994-2000 
CVC Activity 
Expansion 
2001-2004 
CVC Activity 
Contraction 
2005-2008 
CVC Activity 
Expansion 
 
VARIABLES 
(Predicted 
sign) 
 
Model 1 
 
Model 2 
 
Model 3 
 
Model 4 
 
Model 5 
Sales growth H1 (-) -0.112* 2.340 -0.224 -0.0349 -0.0392 
   (0.0637) (1.686) (0.139) (0.103) (0.117) 
Free cash flow H2 (+) -0.00806 7.744*** -0.462 0.654** 0.487* 
   (0.0547) (2.831) (0.298) (0.298) (0.261) 
R&D  H3 (+) 0.763*** 3.131 1.008** 2.197*** 1.387** 
expenditure   (0.251) (2.709) (0.506) (0.717) (0.585) 
NASDAQ  H4 (+) 0.000394*** 0.000845 0.000525*** 0.000294*** (-0.00003) 
 index  (0.00003) (0.00172) (0.00004) (0.00007) (0.000196) 
Firm size  0.328*** 1.176*** 0.361*** 0.317*** 0.352*** 
   (0.0286) (0.297) (0.0547) (0.0511) (0.0536) 
Year and firm-
sector fixed 
effect  
 
YES YES YES YES YES 
R-squared  0.0955 0.2633 0.1428 0.0899 0.0998 
Constant  -2.559*** -8.192*** -2.409*** -2.012*** -2.892*** 
   (0.473) (1.877) (0.836) (0.733) (0.743) 
Observations  3,849 175 1,257 1,072 1,120 
This table presents probit regression results of CVC Activity measured as a dependent dichotomic variable, and 
internal and external CVC determinants. Sample consists of 399 large established firms from 27 countries and 9 
business sectors. Statistics based on annual data for the years between 1985 and 2008, if available. Unless 
otherwise indicated Sales Growth is annual change in sales ($ million) over previous year sales ($ million), Free 
cash flow is established firm’s income after interest and taxes plus depreciation and amortization ($ million) 
normalized by assets, R&D expenditure is established firm’s annual total Research and Development 
expenditures ($ million) normalized by assets, NASDAQ is the current year NASDAQ stock market index of 
the common stocks used as an indicator of the performance of stocks of technology companies, Firm size is the 
Log of number of employees at the established firm. Data derived from Venture Expert and DataStream data 
sets. Regression variables are computed using annual level data, unless otherwise indicated. Dependent variable 
is CVC Activity a dichotomic variable taking the value of one for each observation where annual CVC 
investment in millions of dollars and number of startups on portfolio, are greater than zero; otherwise the 
dependent variable equals zero. Results are similar if we use the NASDAQ return year-to-year value instead of 
the NASDAQ index. We normalized R&D and free cash flow by assets in order to negate the absolute variable's 
effect on the data, and because we had data in different currencies, hence allowing underlying characteristics of 
the data sets to be compared by normalizing them to a common scale. We consider size measured by number of 
employees (log) as a control variable. Regressions are estimated using a Probit regression including year and 
firm-industrial sector fixed effect at a two-digit main SIC code. *, **, and *** indicate significance at the 10%, 
5%, and 1% levels respectively.  
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Appendix 
 
Appendix Table A1. Chow test comparing coefficients and structural break (1985-2008). 
 
(Contraction. 1985-1993) vs. (Expansion. 1994-2000) 
F(7, 450) = 2.68  
Prob > F = 0.0099 
 
(Contraction. 2001-2004) vs. (Expansion. 2005-2008) 
F(7, 761) = 2.06  
Prob > F = 0.0842 
 
(Contraction. 1985-1993) vs. (Contraction. 2001-2004) 
F(7, 418) = 0.48  
Prob > F = 0.8507 
 
(Expansion. 1994-2000) vs. (Expansion. 2005-2008) 
F(7, 793) = 0.81  
Prob > F = 0.5808 
__________________________________________________________________________________ 
Unlike existing studies [e.g. Zahra (1991) analyzed the CVC contraction period 1986 to 1989, and Dushnitsky 
and Lenox (2005) studied the CVC expansion period 1990 to 1999], this panel data includes expansion and 
contraction periods. The table presents results from our period partition proposal based on the cyclical effects on 
the time series data measuring CVC activity over four sub-periods; 1994 to 2000 and 2005 to 2008 as expansion 
periods as well as 1985 to 1993 and 2001 to 2004 as contraction periods. The proposed partitioned cut-off points 
are based on the structural breaks. The test statistics for Chow breakpoint confirmed a structural change in the 
parameters during these structural break years. The F statistics rejected the null hypothesis of no structural 
change for all models at the 1 and 5 percent level of significance. In this Chow test we determined that the 
independent variables have a change in parameters when comparing expansion and contraction periods; 
contraction period 1985-1993 vs. expansion period 1994-2000 and contraction period 2001-2004 vs. expansion 
period 2005-2008. For both cases the probability was significant at F (7, 450) = 2.68 Prob > F = 0.0099, and F 
(7, 761) = 2.06 Prob > F = 0.0842 respectively, hence rejecting the hypothesis that estimators are equal, 
concluding that there is a structural break between these periods. In contrast, when comparing two CVC 
contraction periods and two expansion periods we cannot reject the null hypotheses as results for contraction 
period 1985-1993 vs. contraction periods 2001-2004 have a value of F(7, 418) = 0.48 Prob > F = 0.8507, and for 
the two expansion periods 1994-2000 and 2005-2008 a value of F(7, 793) = 0.81 Prob > F = 0.5808. After 
confirming the different periods we decided to analyze each period separately. Consequently we identified 
1994-2000, and 2005-2008 as expansion periods and we considered 1985-1993 and 2001-2004 as CVC 
contraction periods. 
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2. CVC Interaction with R&D and its Contribution to Value Creation 
 
2.1. Introduction 
Corporate venture capital (CVC) is defined as external equity investments made by 
established firms in privately held entrepreneurial startups (Gompers & Lerner, 1998b). CVC 
has been an important investment phenomenon in which high-tech companies (e.g., Apple, 
Intel, and Motorola), automotive giants (e.g., BMW, Ford Motor Company, and Honda), food 
and beverage leaders (e.g., Nestlé, Starbucks, and Carlsberg), machinery companies (e.g., 
Caterpillar and Honeywell), pharmaceuticals (e.g., Johnson & Johnson, Roche, and 
GlaxoSmithKline) among others invest billions of dollars in innovative startups. In its highest 
peak in 2000, these firms invested in close to 3,000 startups surpassing US$ 16 billion in 
investments representing approximately 25% of the entire venture capital market (Dushnitsky 
& Lenox, 2005b). By 2008 CVC still remained meaningful with a reported investment of 
approximately US$ 4 billion. 
Interestingly, despite cyclical economic debacles numerous companies have 
maintained their commitment to CVC (Chesbrough & Teece, 2002). This has been reflected 
since the late 1960s and early 1970s when 25% of the Fortune 500 companies had a CVC 
program (Fast, 1978). During the mid-70s these programs where greatly reduced until 1978 
when favorable changes to investment legislation led to an increase in venturing investments 
by independent venture capitalists as well as CVC (Dushnitsky & Lenox, 2005a). By the 
early 1980s established firms renewed their interest in CVC, however by the mid-1980s CVC 
was reduced again accentuated by the financial market downturn of 1986 and 1987. 
Afterwards the “bullish” Internet market period of the 1990s ignited CVC momentum and 
corporations re-introduced CVC (Yost & Devlin, 1993). In 2000, with the burst of the 
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Internet bubble, corporations once again headed-out of CVC (Chesbrough & Teece, 2002). 
More recently between 2005 and 2008 we observed a new CVC expansion cycle.  
Regarding business sectors prone to engage in CVC activity, Dushnitsky and Lenox 
(2005b) presented the total cumulative dollars invested in CVC between 1969 and 1999. 
Firms such as Intel, Microsoft, Cisco, Xerox, Ford Motor Co., Sony, Motorola, AOL, Dell, 
and Johnson & Johnson led the list in total investments. The top 20 companies engaged in 
CVC belong to the electronics, information communication technology (ICT), automotive, 
and pharmaceutical business sectors. Our sample also comprises firms in high technology 
sectors (see Table 1), for example, 88.27% of all CVC investments by companies in our 
sample went into ventures in the following six sectors: ICT, business and engineering 
services, machinery and electronics, chemicals, devices, and pharmaceuticals. Only a 
relatively small portion (i.e. 11.73%) of CVC investment came from business sectors such as 
vehicles, metals, printing, publishing, food, beverage, and tobacco.  
 
----------------------- 
INSERT TABLE 1 
----------------------- 
 
Freeman and Soete (1997) defined innovation as a commercialized invention. Afuah 
(1997) determined that innovation is the use of new knowledge to offer a new product or 
service that customers want. Firms innovate to differentiate themselves and distance 
themselves advantageously from the competition (Schumpeter, 1942). In order to innovate 
successfully firms rely on the development and integration of new knowledge. Nowadays 
even the largest and most technologically advanced firms require knowledge beyond their 
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boundaries seeking to optimally combine internal and external sources of knowledge11 to 
benefit from the positive effects that internal and external sources have to offer (Cassiman & 
Veugelers, 2002). This innovation strategic approach is referred to in the literature as Open 
Innovation12 because it broadens the sources of ideas and new product development (NPD) 
through cooperative agreements between firms and different types of external partners such 
as startups, competitors, suppliers, customers, universities and research centers. 
Research and development (R&D) has traditionally been the main approach to 
generate innovation and it has been widely studied (Aldrich, 1979; Cohen & Klepper, 1996; 
Ericson & Pakes, 1995; Hall, 1992; Henderson & Cockburn, 2000; Jaffe, 1986; Klette & 
Moen, 2000; Levin et al., 1987; Stuart et al., 1999). However R&D is only one innovation 
activity. More and more scholars e.g. (Chesbrough, 2002b; Cohen & Levinthal, 1990; Davila 
et al., 2006; Dushnitsky & Lenox, 2005a; Teece et al., 1997) acknowledge the ability to 
exploit alternative external knowledge as a fundamental element of innovation management 
hence scholar attention has shifted towards understanding external innovation activities. For 
example Cohen et al. (2002a) studied partnerships with universities & research centers while 
Keil (2004) conducted research on mergers & acquisitions, and strategic alliances as a means 
to generate innovation. More importantly for our study, research on CVC is limited and has 
recently attracted scholar interest (Dushnitsky & Lenox, 2006).  
We know that CVC represents an important potential driver for profitable growth 
(Allen & Hevert, 2007; Burgelman & Välikangas, 2005; Hurry et al., 1992) and that it 
positively impacts the creation of value (Dushnitsky & Lenox, 2006). In addition, we know 
that CVC offers several benefits such as increasing firm financial returns (Allen & Hevert, 
2007), boosting innovation output and NPD opportunities (Maula, Autio, & Murray, 2003; 
                                                 
11 For example innovation activities such as research and development can be considered an internal source of knowledge, 
and CVC can be considered an external source of knowledge. 
12 Chesbrough’s 2003 definition of open innovation: “a paradigm that assumes that firms can and should use external ideas 
as well as internal ideas, and internal and external paths to market, as they look to advance their technology. Open 
Innovation processes combine internal and external ideas into architectures and systems.” 
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Roberts & Berry, 1985; Wadhwa & Kotha, 2006), and expanding access to new knowledge 
thereby increasing the rate of corporate learning and technological development (Hamel, 
1991). CVC also provides strategic flexibility relative to R&D as it involves an equity 
investment that can be restructured or exited in case of changing internal or external 
conditions (Folta, 1998) and it also facilitates access to information that reduces market and 
technology uncertainties (Kogut, 1991).  
Interestingly, the interaction between CVC and R&D has generated much debate. 
Some researchers see them as substitutes while others consider them complementary. 
(Hellmann, 2002) suggests that firms have to choose between CVC and R&D. On the other 
hand Chesbrough and Tucci (2004) state that the interaction can be complementary. In other 
words while availability of external CVC technology may substitute internal R&D, there are 
also arguments suggesting complementarity (Arora & Gambardella, 1990; Granstrand et al., 
1992). Several researchers have already provided theoretical frameworks on the existence of 
such interaction (Chesbrough & Socolof, 2000; Gompers & Lerner, 1998b). However there 
are still some open questions about CVC and R&D: Are CVC and R&D substitutes or 
complementary? How do firms organize themselves to perform effective simultaneous CVC 
and R&D innovation activities? For what kind of innovation are CVC and R&D better 
suited? Are CVC and its interaction with R&D effective for creating value contingent to 
certain business sectors or geographic regions? While the decision to commit resources 
towards internal R&D expenditure has been studied (Hall, 1992; Himmelberg & Petersen, 
1994) there remains a need to analyze firms that utilize R&D and CVC simultaneously and to 
assess the impact this strategy can have on value creation. Research falls short to explain the 
CVC and R&D interaction effect on value creation (Dushnitsky & Lenox, 2006; Gompers, 
2002). Consequently these gaps represent research opportunities for us.  
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We measure the impact of CVC and its interaction with R&D, on value creation. We 
construct a robust data set and perform multiple tests studying 324 large established firms 
between 1985 and 2000, and find that CVC and its interaction with R&D are associated with 
value creation however this relationship is contingent upon business sectors and regions. We 
conclude that the contribution of CVC to value creation is greatest within the ICT, machinery 
& electronics, and engineering & business service sectors. Interestingly the complementarity 
between CVC and R&D also presents its value creation influence in the ICT, machinery & 
electronics, and engineering & business service business sectors. Similarly, we conclude that 
the contribution of CVC to value creation is greatest within the USA & Canada, and Asia 
regions.  
In this paper, we extend beyond the existing literature by looking at the market and 
profitability value creation of CVC and its interaction with R&D. We study the business 
sectors and regions under which these create value. Unlike existing studies13 the findings of 
our research arise not only from a panel data that includes both CVC expansion and 
contraction periods between 1985 and 2000, but also considers a global scope as previous 
studies on CVC (Dushnitsky & Lenox, 2005b) have been conducted mainly with a U.S. 
focus, while ours encompasses firms from different countries14.  
The paper has the following structure. In Section 2 we look at the literature relevant to 
our subject and develop hypotheses. In section 3 we describe our data. Our methodology and 
variables are in section 4. In section 5 we discuss the results obtained from our quantitative 
analysis. In section 6 we expand on the discussion, and finally the conclusions and 
managerial implications are presented in section 7. 
                                                 
13 e.g. Zahra (1991) analyzed the CVC contraction period 1986 to 1989, and Dushnitsky and Lenox (2005) studied the CVC 
expansion period 1990 to 1999.  
14 Australia, Austria, Belgium, Canada, China, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Israel, Italy, 
Japan, Malaysia, Mexico, Netherlands, Norway, Singapore, South Korea, Spain, Sweden, Switzerland, Taiwan, USA, UK. 
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2.2. Literature Review and Hypotheses 
2.2.1. Theory Review on Innovation and Value Creation 
Research has linked theories of organization with firms’ CVC practices. For example 
Basu et al. (2011) adopted a resource-based view when explaining why firms make CVC 
investments considering these valuable resources that allow firms to remain competitive. 
Moreover, firms undertake internal and external corporate initiatives15 to build tangible and 
intangible valuable resources (Wernerfelt, 1984). Both R&D and CVC are valuable, rare, 
inimitable, and non-substitutable (Basu et al., 2011). These characteristics are critical to the 
resource-based theory (Ahuja, 2000; Barney, 1991a, b; Eisenhardt & Schoonhoven, 1996; 
Smith, Vasudevan, & Tanniru, 1996). However, alternative explanations can emerge from a 
different theoretical angle. For example when investigating the effects on the value creation 
of a firm’s internal R&D and external CVC innovation activities we can also consider the 
dynamic capabilities theory which offers a framework for understanding a firm’s value 
creation through its ability to integrate, build, and reconfigure innovation activities 
(Eisenhardt & Martin, 2000; Teece et al., 1997). This ability to reconfigure can include 
assembling and combining internal R&D and external CVC competences, hence firms can 
adapt to changes in the competitive landscape.  
To explain the causal chain from R&D and CVC, to innovation, and value creation, 
we take into account the empirical evidence that implies a positive effect of high 
innovativeness on a firm’s competitive advantage (Kleinschmidt & Cooper, 1991; Sorescu, 
Chandy, & Prabhu, 2003). Innovative product development also provides a competitive 
advantage allowing firms to obtain returns on innovation such as higher sales and firm 
growth (Bayus, 1998; Bayus, Erickson, & Jacobson, 2003). This competitive advantage effect 
increases with a higher degree of innovativeness (Gatignon & Xuereb, 1997) meaning that 
                                                 
15 By initiatives we refer to internal and external means to acquire knowledge e.g. R&D as internal and CVC as external. 
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highly innovative new products are likely to better address market needs (Schmidt & 
Calantone, 2002) which then positively influence consumer willingness to pay and adopt new 
products (Rogers, 1995). Consequently, a client’s willingness to pay and adopt new products 
and services influences firm value creation (Zahra et al., 2000). 
 
2.2.2. CVC and Value Creation 
CVC is based on corporate motivations pursuing strategic and financial goals (Block 
& MacMillan, 1995; Henderson, Leleux, & White, 2006). Alter and Buchsbaum (2000) 
reported that 85% of CVC units pursue financial value creation while 71% of the respondents 
claim to use CVC also as a strategic “Window on Technology”. This provides important 
benefits to large established firms interacting with startups’ new technologies that can have a 
positive effect on value creation (Bottazzi, Da Rin, & Hellmann, 2004; Maula et al., 2003). 
Chesbrough (2002b; 2002c) also proposed that CVC can represent an important tool 
not only for financial returns, but also as an important catalyst to boost growth and value 
creation. However, in their research, Lin and Lee (2011) studied future growth opportunity as 
the central strategic benefit of CVC activity, finding that there was no significant relationship 
between CVC and growth.  
There have been other studies on value creation and strategic benefits including 
technology acquisition (Chesbrough, 2003a, b), knowledge accumulation (Wadhwa & Kotha, 
2006), and organizational renewal (Siegel et al., 1988) indicating that these contribute to 
company value creation. It has also been documented that CVC can be an important driver for 
profitable growth (Burgelman & Välikangas, 2005).  And according to Zahra (1991), CVC 
represents a basis for corporate growth, while Tsai and Wang (2008) report that large firms 
eagerly seek to utilize external knowledge (e.g. CVC activity) as a source of growth 
opportunities. 
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Chesbrough (2002c) claimed that firms can justify CVC investment if such firms 
create value for their shareholders in ways shareholders cannot do themselves. The main 
argument for this is that firms can have superior knowledge with regard to technologies and 
commercialization due to their exposure to technology and markets. Moreover, CVC offers 
several benefits such as increasing financial returns (Allen & Hevert, 2007), boosting NPD 
output (Maula et al., 2003; Roberts & Berry, 1985; Wadhwa & Kotha, 2006), raising 
corporate knowledge and technological development (Hamel, 1991), and providing strategic 
organizational flexibility relative to R&D due to investments that can be up or down scale 
depending on evolving technological or market conditions (Folta, 1998; Kogut, 1991).  
Previous work has also found that CVC investment may be an effective way for firms 
to increase their innovative output (Dushnitsky & Lenox, 2005a). There is also evidence 
indicating that CVC is associated with value creation, particularly when firms pursue 
innovative strategic technologies (Dushnitsky & Lenox, 2006).  
Furthermore CVC contributes to the firm by facilitating the formation and expansion 
of the firm’s “ecosystem” consisting of suppliers, customers and other providers, thus 
stimulating demand for their core products (Lin & Lee, 2011). An example of this 
“ecosystem” expansion is developed by Campbell et al. (2003) where Intel Capital invests in 
startups that in turn can increase the demand for Intel microprocessors. Another study 
focusing on a firm is DuPont's CVC initiative. Bhardwaj et al. (2006) reported that DuPont 
invested rapidly but selectively in startups to quickly explore the growth opportunities within 
a specific sector. In other words, when DuPont CVC invests in multiple new startups within a 
narrowly defined industrial sector, the aggregate growth value of those investments creates 
more growth potential (Vassolo et al., 2005; Vassolo et al., 2004). Finally, another recent 
company focus study from McGrath et al. (2006) found that firms such as Nokia consider 
CVC as a source of value creation. For example between 1998 and 2002 although 70% of 
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Nokia’s portfolio company was discontinued and 21% was absorbed by Nokia business units, 
Nokia’s innovation managers responded that in 25% of the cases, startups generated new 
organizational capabilities, 16% led to the introduction of new products, and most generated 
important intellectual property. In other words, despite the high discontinuation ratio of 
startups, Nokia benefited from the value generated by its CVC activities. 
Hence we present the following hypotheses related to CVC and value creation: 
 
H1. The magnitude of CVC investment is positively associated with the value of firms 
investing in CVC. 
 
2.2.3. CVC and R&D Interaction and Value Creation 
Previous work from Cassiman and Veugelers (2002) links transaction costs economics 
(TCE) with internal and external complementary innovation activities. TCE focuses on the 
decision to “make” or “buy”. “Make” represents innovation produced through internal R&D 
and “buy” would be innovation acquired through external CVC. This approach suggests that 
in order to generate innovation, CVC and R&D operate as substitutes (Pisano, 1990; 
Williamson, 1985). Teece, Pisano and Shuen (1997), Roberts and Berry (1985), and 
Chesbrough and Tucci (2004) provide different approaches to generate NPD. For example, 
for technologies and markets that are familiar to the established firm, R&D is a suitable path 
to develop new products. While for unfamiliar technologies and markets CVC can be the 
advisable path to generate innovation. Consequently the established firm’s market and 
technology position and its relation to the new business or NPD that it’s trying to develop can 
determine which mechanism to utilize (i.e. R&D or CVC) making these substitutes for one 
another. 
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While availability of external CVC activity may substitute internal R&D technology 
development, there are also scholars who suggest there is complementarity between CVC and 
R&D (Arora & Gambardella, 1990; Granstrand et al., 1992). Ennen and Richter (2010) 
suggested that complementarities result from the skillful matching of heterogeneous 
resources which generate positive returns above and beyond the effect each resource could 
generate on its own. For example a large firm that has strong R&D competencies can seek 
access to new external technological resources via CVC investment (Ahuja, 2000). Such 
access to R&D resources, infrastructure, and new technology is particularly important for 
firms engaged in CVC as this can represent a mechanism for value creation (Hee-Jae & 
Pucik, 2005; Mitchell & Singh, 1992). Furthermore firms that combine internal and external 
sources of knowledge are more capable of identifying ways in which value can be captured 
from partnering with startups (Gans & Stern, 2003b). A large firm’s CVC unit with access to 
its parent’s technological and commercial resources can create value by interacting with new 
resources of a startup to create NPD (Hill & Birkinshaw, 2006). Such established firms can 
have the technological R&D competence to create value as internal R&D provides the 
infrastructure foundation upon which firms can learn from external CVC activities (McGrath, 
1997). This can be exemplified by an established firm’s R&D staff interacting with startups 
at the pre-investment technological due diligence (Dushnitsky & Lenox, 2005a). The benefits 
of these interactions between large firms and startups outweigh the potential hazards of 
intellectual property leaks between them (Cassiman & Veugelers, 2006). This notion is 
particularly problematic because CVC investors are often viewed suspiciously by startups 
due to the perception that a CVC investor's goal can be to expropriate a startup’s technology 
(Dushnitsky & Shaver, 2009; Katila et al., 2008). 
CVC activity can also strengthen a firm's ability to create new business opportunities 
as large firms gain access to proprietary technologies of startups that can then be combined 
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with existing internal R&D technologies to create new products (Gompers & Lerner, 2001a; 
Gompers & Lerner, 2001b). The interaction between R&D and CVC influencing value 
creation has not been fully attended by scholars. There is a dearth of research to explain the 
effect of such interaction (Chesbrough & Tucci, 2004; Dushnitsky & Lenox, 2006; Gompers, 
2002). Nonetheless, researchers have provided theoretical frameworks on the existence of 
such interaction (Chesbrough & Tucci, 2004; Chesbrough & Socolof, 2000; Gompers & 
Lerner, 1998b). However these frameworks have different views with no common 
conclusion. Some suggest that large firms can achieve synergies by working with startups, 
but can also face conflicts of interest if the interaction between the investing firms and the 
startup is a substitute “cannibalizing” the investing firm’s current product offering. 
Additionally in most cases the CVC investor often pays a higher valuation than an 
independent venture capitalist. In these situations established firms are faced with the 
decision to invest resources either via CVC or R&D suggesting that CVC and R&D compete 
for corporate resources implying a substitution effect (Cassiman & Veugelers, 2002; 
Hellmann, 2002).  
There is another school of thought suggesting that access to external know-how may 
leverage the productivity of the internal R&D activities (Veugelers, 1997) and that such 
interaction can be complementary to value creation (Chesbrough & Tucci, 2004). Moreover, 
Afuah and Tucci (2001) and Chesbrough and Rosenbloom (2001) stressed on the need for 
firms to look beyond their boundaries and seek for external mechanisms to harness new 
technology. There are also “goodwill” intangible assets (e.g. brand and company reputation) 
that can leverage and complement the new technology provided by the startup. This 
complementarity is the rationale behind Intel Capital CVC investments (Taptich, 1998). 
In a resource constrained world firms can allocate resources between internal R&D 
and external CVC opportunities. However a profit-seeking firm can choose to invest 
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simultaneously in CVC and R&D for an expected higher value creation output. Hence we 
present the following hypothesis related to the CVC and R&D interaction influencing value 
creation: 
 
H2. The simultaneous investment in CVC and R&D, has a positive effect on the value 
of the firms investing in CVC. 
 
2.3. Data 
To test our hypotheses, we explore the relationship between value creation and the 
elements of CVC investment and CVC x R&D interaction. We build a large panel data and 
because CVC investments are typically made by established firms (Dushnitsky & Lenox, 
2006) we focus our study on publicly listed firms investing in CVC. Due to lack of reliable 
data prior to 1985, our period study ranges from 1985 to 2000. To the best of our knowledge, 
our database is unique in that it provides detailed information on financial and corporate 
venturing activities made by international publicly listed established firms. The database 
contains financial information on firms drawn from Thomson Reuters DataStream and we 
combine these data with CVC data collected from Venture Economics VentureExpert 
database which includes a comprehensive coverage of CVC investment, exit, and 
performance activity in the private equity industry. Several studies on VC and CVC have 
used this database (Basu et al., 2011; Dushnitsky & Lenox, 2005a, b; Gompers, 1995; 
Wadhwa & Kotha, 2006).  
In order to combine DataStream and VentureExpert, we utilize an automated matching 
algorithm and a hand-checking. For our study we dropped the established firms when 
financial accounting data were missing. Furthermore, we decided to exclude real estate and 
financial institutions from our sample, hence limiting the study to establish firms that invest 
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in NPD. After these adjustments our sample had 324 publicly listed established firms 
investing in R&D and CVC. 
Previous studies on CVC have been conducted mainly with a U.S. focus (Dushnitsky 
& Lenox, 2005b, 2006), while research on Europe, Asia, and the rest of the world (ROW) has 
been scarce. An exception is the Lin and Lee (2011) study focusing on Taiwanese based 
firms. Our research encompasses a global scope with firms from different countries. For 
sample description purposes we group them by Anglo-Saxon vs. non Anglo-Saxon countries. 
In Table 2 we observe that between 1985 and 2000, the established firms in our sample were 
predominantly from Anglo-Saxon countries (i.e. 64.51%) while 35.49% pertain to Non 
Anglo-Saxon countries. This difference can depict country characteristics such as judicial 
system including the kind of law (i.e. common law or code law), language, as well as other 
varying characteristics such as technology transfer policy, and tax incentives (Armour & 
Cumming, 2006; Klette & Moen, 2000; Lerner, 2010; Poterba, 1989). 
 
----------------------- 
INSERT TABLE 2 
----------------------- 
 
2.4. Methodology and Variables 
2.4.1. Dependent Variables 
We utilize a widely used measure of firm performance: Tobin’s q is a measure of 
market valuation. Capital market performance data provide a metric and allow bridging the 
potential time lag (Lee & Grewal, 2004; Sorescu et al., 2003). Tobin’s q was chosen as an 
adequate capital market metric as it measures investors’ expectations concerning a firm’s 
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potential to generate future profit (Brealey, 2007). Tobin’s q has recently been applied in 
several studies in NPD and marketing research (Firth & Narayanan, 1996; Lee & Grewal, 
2004). Furthermore Tobin’s q is a good proxy for a firm’s competitive advantage 
(Montgomery & Wernerfelt, 1988; Wernerfelt & Montgomery, 1988). A Tobin’s q greater 
than 1.0 indicates that investors have a positive outlook for the firm’s growth opportunities. 
The higher the Tobin’s q, the greater the perceived growth opportunities for such a firm, 
Tobin’s q is defined as the ratio of a firm’s market value to the replacement cost of its assets 
(Brainard & Tobin, 1968). We calculate Tobin’s q by dividing the sum of firm equity value, 
book value of long-term debt, and net current liabilities by total assets (Chung & Pruitt, 
1994).  
For research exploration purposes we decided to include other profitability 
performance metrics such as return on sales (ROS), return on assets (ROA) and return on 
equity (ROE) (see Table 3 for variables description). Regarding profitability, we used return 
on sales (ROS) as an accounting-based measure (Hart & Ahuja, 1994). ROS represents a 
measure of firm value and is calculated by dividing net earnings by net sales. Innovations that 
are developed will only be launched in the medium or long term, hence assessing 
performance effects of innovation strategy needs to account for a potential time lag between 
the time the CVC investment was executed and the time it can take to have an impact on value 
creation. Consequently, to account for a time lag between the impact that R&D and CVC 
have on performance we consider a period of five years, i.e. (time t+5 years). The entire 
analysis presented in this study was replicated using Return on Equity (ROE) as an 
alternative measure of profitability. However Palepu (1985) mentions that ROE could create 
distortions depending on the focus of the research. For example, if we were to analyze 
innovation and value creation through acquisitions – these could be financed by cash or debt. 
The equity base of a company may grow very little while the absolute size of the profits 
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increases due to the acquisition consolidation of financial statements. The use of ROE 
measures may introduce a bias as a consequence of factors such as the debt-equity mix used 
in financing such acquisitions. In contrast ROS measures avoid this problem, thus, in the 
context of the present study, the use of the ROS measures is probably superior to ROE 
measures. More importantly for a competitive advantage such as a continuous flow of new 
commercialization, meaning sales of new products, ROS distinguishes itself from other 
managerial accounting metrics. Furthermore CVC can also be considered an instrument 
contributing to NPD allowing firms to offer new products to market distancing themselves 
advantageously from competitors by being able to price products and services at higher 
margins, consequently influencing ROS.  
 
----------------------- 
INSERT TABLE 3 
----------------------- 
 
2.4.2. Independent Variables 
One of our primary independent variables is annual CVC investment in millions of 
dollars normalized by assets. This measure is calculated as the sum of all dollars invested via 
corporate venturing funds of a firm in a year. This variable has the characteristic of being 
continuous and observable over time. The main independent variable is the interaction term 
between CVC and R&D for which we create the variable CVC investment x R&D 
expenditure (CVC x R&D). This identifies year observations in which firms pursue CVC 
investments and R&D expenditure simultaneously.  
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2.4.3. Control Variables 
We include a number of measure controls commonly used in the analysis of financial 
performance (Berger & Ofek, 1995). A company’s size (firm size) is calculated as the log of 
the company’s assets. The amount by which a firm grows (growth) is calculated as the annual 
percent change in sales. The degree to which the firm is leveraged (leverage) is expressed as 
the ratio of its debt to assets. Capital expenditure represents the funds used to acquire fixed 
assets other than those associated with acquisitions, including, but not restricted to, additions 
to property, plant and equipment, and investments in machinery. Additionally we include 
measures of average industry Tobin’s q for the whole industry and sector Tobin’s q for the 
whole sector both to control for time-variant and industry or sector specific variation. At any 
point in time, differences in industry profitability may have to do with any number of factors 
including industry structure, technological innovation, or government regulation. Industry 
and sector Tobin’s q is calculated as the average q of all firms within a firm’s four-digit SIC 
code in a given year. We also control for risk represented by stock price volatility as a 
measure of a stock's average annual price movement to a high and low from a mean price for 
each year. For example a stock's price volatility of 20% indicates that the stock's annual high 
and low price has shown a historical variation of +20% to -20% from its annual average 
price. Finally, we include R&D as a control variable that we interacted with our main 
independent variable CVC. R&D is the traditional activity conducted by firms to generate 
internal knowledge and create value (Griliches, 1979; Hall, 1992; Himmelberg & Petersen, 
1994). Kuratko and Audretsch (2009) consider R&D as an important factor for corporate 
growth, since R&D encompasses identification and exploitation of new innovative 
opportunities within firm boundaries fostering organizational renewal. Levin et al. (1987) 
studied the incentives to invest in R&D explaining that firms need to appropriate sufficient 
returns to make R&D expenditure worthwhile. Jaffe (1986) also conducted research on R&D 
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and value creation measured by profits and market value and found that firms with lower 
R&D activity suffer from lower profits and lower market value than firms with higher R&D 
activity. R&D signals a parent company’s commitment to technology, which in turn generates 
valuable resources and outputs such as patents, laboratory facilities, and specialized 
technology staff that can influence value creation (Stuart et al., 1999). Furthermore, there 
have been studies unveiling the relationship between R&D expenditures and innovation 
competencies (Henderson & Cockburn, 2000). Expanding on the positive significant 
relationship between R&D and value creation, Klette and Griliches (2000), Ericson and Pakes 
(1995), and Cohen and Klepper (1996) determined that R&D expenditure is an engine for 
firm growth. They extended their research to incorporate other performance metrics such as 
productivity, patenting, profitability, and sales growth, all of which are influenced by R&D 
and innovations within the firm. Thompson (1996) also developed a complete model of R&D 
expenditure. On the basis of his model he presents an empirical analysis of the positive 
significant relationship between R&D and the stock market value of the firm.  
 
2.4.4. Selection Variables 
By adopting a two-stage specification, in line with Maddala (1983) and Heckman 
(1979), we control for the fact that firms self-select to invest in CVC, we expand on this 
matter on the methodology section. In brief, the first stage of this model is used to predict the 
likelihood that a firm will invest in CVC through a Probit regression utilizing CVC activity as 
a dependent dichotomic variable, where all levels of CVC investments greater than zero, 
were assigned the value of one. Otherwise, the variable was assigned a value of zero if there 
was no CVC investment.  
For the first stage Probit regression, we used the following independent variables: free 
cash flow calculated as income after interest and taxes plus depreciation and amortization 
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normalized by assets and the NASDAQ index representing a stock market index indicating the 
performance of stocks of technology companies. 
 
2.4.5. Methodology 
Similar to Dushnitsky and Lenox (2006), to test the research hypotheses we selected 
Ordinary Least Square (OLS) regressions. Following Mitchell and James (2001) we gathered 
public market environmental data that corresponded directly to the point in time at which the 
VentureExpert data was collected.  
Considering the time series nature of our data, to decide whether to utilize a fixed-effect 
or random-effect, we performed a Hausman test based on the difference between the random-
effect estimator and the fixed effect estimator in which observationally equivalent firms may 
differ on some unobservable or unmeasured characteristic (Hausman, 1978; Maddala, 1983). 
It is possible to correct for unobserved heterogeneity using random and fixed effects 
estimations. Our results met the asymptotic assumptions converging for our data showing to 
be highly significant (Prob>chi2 = 0.0001). Therefore we use the consistent estimator for the 
fixed effect, and not the efficient estimator for the random effect. We implemented a firm and 
year fixed effect.  
Our sample includes only firms that have engaged in CVC and R&D. As mentioned 
earlier the CVC investment decision can be the result of self-selection such that only 
investing firms with available financial resources and access to innovative startups can 
engage in CVC. This could create an endogeneity problem in which regular OLS regressions 
could overestimate the effects of CVC (Shaver, 1998). To confront this estimation bias which 
could threaten the generalizability of our results to the larger population of firms, we 
conducted, similarly to Lin and Lee (2011) and Dushnitsky and Lenox (2006), a Heckman 
model (Heckman, 1979) as a robustness test before running the OLS regressions previously 
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described. A Heckman model includes two equations: the first selection model estimates the 
likelihood of a company to engage in CVC. The hazard rate from that model is included in 
the second stage regression model to predict Tobin’s q. This analytical approach has been 
widely used in the empirical literatures on strategy and performance (Geletkanycz & 
Hambrick, 1997; Zajac & Westphal, 1994). Similar to the OLS regressions, due to the 
Hausman test results, we use the consistent estimator for the fixed effect, and not the efficient 
estimator for the random effect. We implement a firm-industrial sector fixed effect at a two-
digit SIC code. 
Unlike existing studies16 our study includes an expansion and a contraction period. A 
Chow test was conducted to verify whether estimates were different between the periods 
presenting CVC expansion (i.e. 1994 to 2000) and CVC contraction (i.e. 1985 to 1993). The 
test for Chow breakpoint confirmed a structural break in the parameters in 1993. The F 
statistics rejected the null hypothesis of no structural change at 1% level of significance (see 
Appendix Table A1). After confirming the structural break we decided to analyze the whole 
1985 to 2000 period to observe if value creation holds regardless of the contraction-
expansion structural break. 
 
2.5. Analysis and Results 
In Table 4 we present descriptive statistics for our dependent and independent 
variables used for the continuous regressions for the total selected cyclical period between 
1985 and 2000. The sample consists of 324 large established firms from 27 countries17 and 
                                                 
16 e.g. Zahra (1991) analyzed the CVC contraction period 1986 to 1989, and Dushnitsky and Lenox (2005) studied the CVC 
expansion period 1990 to 1999.  
17 Full country sample includes: Australia, Austria, Belgium, Canada, China, Denmark, Egypt, Finland, France, Germany, 
Hong Kong, India, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Norway,  Singapore, South Korea, Spain, Sweden, 
Switzerland, Taiwan, United Kingdom, and Unites States of America. 
 
 
 
100 
 
similar to (Dushnitsky & Lenox, 2006) we focus on 6 business sectors18 excluding other 
sectors for parsimony sake. We observe that the average Tobin’s q for the firms in our sample 
is 2.114. CVC investment represents the total corporate venture capital invested ($ million) 
normalized by assets. CVC x R&D is computed as the interaction term between CVC 
investment and R&D expenditure. Capital expenditures ($ million) is normalized by assets. 
Growth is represented as the annual change in sales ($ million) over previous year sales ($ 
million) presenting in our sample a minimum of 71% sales reduction, while maximum firm 
growth was over 588% year-to-year on sales growth. Leverage is calculated as the ratio of 
debt ($ million) to firm assets ($ million). Industry Tobin’s q equals the average industry 
Tobin’s q (by 4 digit SIC code). Risk is represented by the stock price volatility measure of 
stock's average annual price movement to a high and low from a mean price for each year. 
Finally, Firm size is the Log of firm assets ($ million) at the established firm. 
For a more comprehensive description of the firms in our sample, in Table 5 we 
include descriptive statistics on the profile of the established firms. Tobin’s q is showing an 
average of 2.114, Sales is based in millions USD ($ million) with an average of USD 10.2 ($ 
billion). CVC investment as total corporate venture capital invested in millions USD ($ 
million) ranging from USD 0 to 931 ($ million). R&D expenditure equals an average of USD 
831 ($ million). Assets in our sample represent an average of USD 16 ($ billion) and for 
Employees we have a mean value of 62,319, with a maximum of 446,800 employees.  
 
----------------------- 
INSERT TABLE 4 
----------------------- 
                                                 
18 Sample business sectors include: information communication and technology ICT (357*, 367*, 48**, 3663), 
pharmaceuticals (2834, 2836),  vehicles (37**), food beverage and tobacco (20**, 21**), industrial machinery and 
electronics (35**, 36** excluding 3663), and business & engineering services (73**, 87**). 
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----------------------- 
INSERT TABLE 5 
----------------------- 
 
In Table 6, we run a correlation test to identify potential sources of multicollinearity, 
this table reports the correlation coefficients between the dependent, independent, and control 
variables. The correlation matrix presents correlations for the parent company independent 
variables CVC investment and CVC x R&D, and the control variables R&D expenditure, 
Capital expenditure, Growth, Leverage, Industry Tobin’s q, Risk, and Size. This table 
presents our dependent variable Tobin’s q which is correlated with the independent variables 
(i.e. 0.3896 for CVC investment) and (i.e. 0.5108 for CVC x R&D). Regarding the correlation 
between the independent variables CVC x R&D interaction term and CVC investment there 
is the existence of a 0.2618 correlation between them.  
  
----------------------- 
INSERT TABLE 6 
----------------------- 
 
In Model 1 (Table 7) we regress Tobin’s q including CVC investment, R&D 
expenditures, capital expenditure, growth, leverage, risk, firm size, and industry Tobin’s q. 
Due to Tobin’s q, reflection on public market expectations of future discounted cash flow, we 
use contemporaneous values for each of our independent variables. We adopt a fixed-effect 
specification that includes both firm industrial sector and year dummies to address stable 
unobserved heterogeneity across firms as well as macroeconomic trends. Model 1 in Table 7 
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shows that CVC investment is significant and positively related at the 1% level to Tobin’s q 
hence supporting hypothesis H1.  
For Model 2 (i.e. the interaction CVC x R&D term model). Following Cohen et al. 
(2003) we mean-centered the variables for the interaction regressions. The results in this CVC 
x R&D interaction subsection indicate that, consistent with hypothesis H2, firms that pursue 
CVC investment and R&D expenditure simultaneously are associated with value creation. 
This positive relationship is attributable to the combination of CVC investment and R&D 
expenditure significant at the 1% level. This is particularly interesting, as in the literature we 
found that Dushnitsky and Lenox (2006) also reported a significant positive coefficient 
between R&D expenditure and CVC investment. This would suggest that internal R&D 
expenditure and CVC investment are in fact complements and not substitutes. 
For Models 3 to 6, the Heckman first stage regressions indicated that for our 
independent variable CVC activity, there was censorship causing a concentration of 
observations at zero values. By executing this Probit regression for the whole period 1985 to 
2000 we found significant support at the 1%-level that both NASDAQ and free cash flow 
influence CVC engagement (see bottom section Table 7 Models 3, 4, 5, and 6. As for the 
second stage regression model to predict Tobin’s q, these are presented on Models 3, 4, 5, and 
6 in which we report results with no firm-sector fixed effect (i.e. Models 3 and 5) and then we 
introduce the year and firm-sector fixed effect (i.e. Models 4 and 6). After implementing the 
fixed effects the results remain significant at the 1% level for both CVC investment and CVC 
x R&D interaction.  
 
----------------------- 
INSERT TABLE 7 
----------------------- 
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For research exploration purposes we decided to include other accounting 
performance measures as dependent variables i.e. ROA, ROE, and ROS (see Table 8). Model 
8 suggests there is a relationship at the 5% level between CVC investment and ROA 10 years 
after CVC investment has been executed. However, we found no evidence suggesting a 
significant relationship between CVC investment and ROE. Regarding Model 11 (i.e. Table 8 
ROS 5 years) CVC investment is significant at the 10% level supporting H1. One possible 
explanation for this finding is that for our sampled firms, CVC may be a valuable tool to 
influence future sales margins. 
 
----------------------- 
INSERT TABLE 8 
----------------------- 
 
Considering the benefits and limits that CVC provide to firms it is likely that the 
utilitarian advantages of CVC are contingent on the business sector where established firms 
operate (Dushnitsky & Lenox, 2006). Business sectors differ significantly in their level of 
technological opportunity and Cohen et al. (2002a) proposed that the marginal benefit of 
external CVC relative to internal R&D should be greater in business sectors with more 
technological opportunities. This is because in business sectors with greater technological 
opportunities, startups are more likely to identify valuable innovations which can represent 
attractive CVC investment opportunities for established firms that can be exploited and 
scaled up to create value (Shane, 2001). Dushnitsky and Lenox (2005a) and Levin et al. 
(1987) proposed that established firms will most likely invest in business sectors with rich 
technological opportunities where the level of technological opportunity is influenced by 
 
 
104 
 
advancements in technology. Prior research also suggests that ICT and business service firms 
typically engage in CVC as a window on technology and are able to leverage innovation to 
reach superior financial and strategic returns (Chesbrough, 2000). For instance the ICT 
business sector is characterized by greater technological opportunity and is the most fertile 
ground for scanning and sourcing external technologies (Cohen et al., 2002a).  
Our firm fixed effects capture business sector differences. However a pool sample 
could create an underlying heterogeneity in the coefficients. To address whether inter 
industrial variability influenced the results, similar to Dushnitsky and Lenox (2006), we 
partitioned the database sample in six business sectors: Food beverage & tobacco, 
Engineering & business services, Machinery & Electronics, ICT, Pharmaceuticals, and 
Vehicles.19 Replicating Model 1 at the business sector level, we found that the benefits of 
CVC investment apply to firms in certain sectors (see Table 9). In particular, CVC investment 
has a positive significant impact on Tobin’s q for ICT (Model 14), machinery & electronics 
(Model 15), and engineering & business services (Model 17), supporting hypothesis H1, at 
the 1% level.  
 
----------------------- 
INSERT TABLE 9 
----------------------- 
 
Following the approach replicating Model 11 at the business sector level for ROS 5 
years after CVC investment has been executed, we found that the benefits of CVC investment 
also apply to firms in certain sectors (see Table 10). Similar to Tobin’s q, CVC investment has 
                                                 
19 Sectors are defined by SIC code: information communication and technology ICT (357*, 367*, 48**, 3663), 
pharmaceuticals (2834, 2836), vehicles (37**), food beverage and tobacco (20**, 21**), industrial machinery and 
electronics (35**, 36** excluding 3663), and business & engineering services (73**, 87**). We exclude other business 
sectors for parsimony sake. 
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a positive significant impact on ROS 5 years for ICT (Model 20), and machinery & 
electronics (Model 21) supporting hypothesis H1 at the 5% level. However it did not prove 
positively significant for engineering & business services.  
 
----------------------- 
INSERT TABLE 10 
----------------------- 
 
Our sample covers several countries and regions20: USA & Canada, Europe, Asia, and 
the rest of the world (ROW). We also group countries by Anglo-Saxon vs. non Anglo-Saxon 
groups characterized by differences such as the kind of law (i.e. code law or common law) 
practices and language. By considering the benefits that CVC provide to firms it is likely that 
the utilitarian advantages of CVC investment are contingent on the development of a country 
or region due to their legal system, technology transfer policy, and tax incentives (Armour & 
Cumming, 2006; Lerner, 2010; Poterba, 1989).  
To address whether inter regional variability influenced the results, we partitioned the 
database sample in a set of comparable regressions: USA vs. Non USA, Anglo-Saxon vs. Non 
Anglo-Saxon; and finally continental regions. Replicating Model 25 on the different regions, 
we found that the benefits of CVC investment are applicable to firms in certain regions (see 
Table 11). In particular, CVC investment has an impact on Tobin’s q for USA (Model 26), 
USA & Canada (Model 30). Model 32 for Asia also presents a positive significant 
relationship at the 5% level. Models 28 and 29 for Anglo-Saxon and Non Anglo-Saxon show 
                                                 
20 Full country sample includes: Australia, Austria, Belgium, Canada, China, Denmark, Egypt, Finland, France, Germany, 
Hong Kong, India, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Norway, Singapore, South Korea, Spain, Sweden, 
Switzerland, Taiwan, United Kingdom, and Unites States of America. 
Anglo-Saxon sample includes: Australia, Canada, United Kingdom, and Unites States of America. 
Europe sample includes: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Spain, 
Sweden, Switzerland, and United Kingdom. 
Asia sample includes: China, Hong Kong, India, Israel, Japan, Malaysia, Singapore, South Korea, and Taiwan. 
Rest of the World (ROW) country sample includes: Australia, Egypt, and Mexico. 
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that CVC investment has an impact on Tobin’s q. All Models in which CVC investment was 
significant reported significance at the 1% level.  
Regarding regressions for Non USA, and Europe (i.e. Models 27 and 31) we observe 
that our control variable R&D expenditure has a significant and positive impact at the 5% 
level. The coefficients for the ROW regression (i.e. Model 33) proved non-significant.  
 
----------------------- 
INSERT TABLE 11 
----------------------- 
 
For Tables 12 and 13, following Cohen et al. (2003) we mean-centered the variables 
for the interaction regressions. The results in this CVC x R&D interaction subsection indicate 
that, consistent with hypothesis H2, firms that pursue CVC investment and R&D expenditure 
simultaneously are associated with value creation. We have also documented that this 
positive relationship is attributable to the combination of CVC investment and R&D 
expenditure significant at the 1% level (see Tables 12 and 13 Models 35 and 42). This is 
particularly interesting, as in the literature we found that Dushnitsky and Lenox (2006) also 
reported a significant positive coefficient between R&D expenditure and CVC investment. 
This would suggest that internal R&D expenditure and CVC investment are in fact 
complements and not substitutes. Our firm fixed effects capture business sector differences. 
However a pool sample could create an underlying heterogeneity in the coefficients. To 
assess whether inter industrial variability influenced the results, we first partitioned the 
database sample in six business sectors21 see Table 12, and secondly partitioned the database 
                                                 
21 Sectors are defined by SIC code: information communication and technology ICT (357*, 367*, 48**, 3663), 
pharmaceuticals (2834, 2836), vehicles (37**), food beverage and tobacco (20**, 21**), industrial machinery and 
electronics (35**, 36** excluding 3663), and business & engineering services (73**, 87**). We exclude other business 
sectors for parsimony sake. 
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sample in the different regions see Table 13. Considering the benefits of pursuing CVC 
investment and R&D expenditure simultaneously, it is likely that the utilitarian advantages of 
such interaction are contingent on the business sector or region where the established firm 
operates. As mentioned earlier, the literature suggests that ICT and business service firms 
typically engage in CVC as a window on technology and are able to leverage innovation to 
create value (Chesbrough, 2000). The ICT business sector is characterized by greater 
technological opportunity and is the most fertile ground for scanning and sourcing of external 
technologies (Cohen et al., 2002a). Thus, the results presented in Table 12 are consistent with 
our expected results where the CVC x R&D interaction has an influence on value creation in 
sectors such as ICT (Model 37), machinery and electronics (Model 38) and engineering and 
business services (Model 40) significant at the 1% level supporting hypothesis H2. Even after 
running OLS with the interaction term, we found that the benefits of CVC investment have an 
impact on Tobin’s q for ICT (Model 37) and engineering & business services (Model 40), 
while for machinery & electronics (Model 38) the CVC investment sign changed. One 
potential explanation for this is the sample data of the 994 observations adjusted by the 
multicollinearity introduced by the interaction factor (Laeven & Levine, 2009). Regarding 
business sectors such as food, beverage & tobacco, pharmaceuticals, and vehicles (i.e. 
Models 36, 39, and 41) we observe that the CVC x R&D interaction is not significant. By 
considering the benefits that the CVC x R&D interaction can provide to firms in different 
regions, we observe that such benefits vary contingent to the region where the firms operate. 
A potential explanation can be the differences in these regions as a source of influence to the 
simultaneous CVC and R&D innovation strategy. These differences can be  the development 
of a country or region’s judicial-court system, technology transfer policy, and tax incentives 
(Armour & Cumming, 2006; Lerner, 2010; Poterba, 1989). Similar to the approach explained 
earlier on Table 11, we now introduce the CVC x R&D interaction term on Table 13 where we 
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found that the benefits of simultaneously investing in CVC and R&D are applicable to firms 
in certain regions. In particular, CVC x R&D has a positive impact at the 1% level on Tobin’s 
q in the USA (Model 43), USA & Canada (Model 47), Europe (Model 48) as well as in 
Models 45 and 46 for Anglo-Saxon and Non Anglo-Saxon countries. This suggests that 
internal R&D and external CVC in these regions are in fact complements not substitutes. As 
mentioned before the CVC x R&D interaction benefits are expected to be greater in regions 
with developed legal systems, technology transfer policy, and tax incentives, while it will be 
more limited for regions with less developed judicial systems, technology transfer policy, and 
less attractive tax incentives. Thus, regions like Asia (Model 49) and ROW (Model 50) 
presenting less mature legal systems and less tax capital gain incentives present a negative 
and significant relationship between the CVC x R&D interaction and Tobin’s q.  
By conducting the study on different business sectors and regions we shed some light 
on  the technological innovation strategy of simultaneously investing in CVC and R&D and 
the value that can be created contingent to the business sector and region in which the 
established firm operates.  
 
----------------------- 
INSERT TABLE 12 
----------------------- 
 
----------------------- 
INSERT TABLE 13 
----------------------- 
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2.6. Discussion 
Our study examines the relationship between value creation represented by Tobin’s q 
and our independent variables CVC investment and CVC x R&D interaction term. We observe 
that firms in various business sectors create value through internal and external innovation 
activities (Chesbrough, 2002a; Chesbrough & Rosenbloom, 2002; Chesbrough & Tachau, 
2002; Covin & Miles, 2007; Dushnitsky & Lenox, 2006; Gompers & Lerner, 2001a; 
Gompers & Lerner, 2001b) and that CVC investments can provide an important foundation 
of knowledge for firms in different business sectors to identify, acquire and exploit new 
knowledge that in turn influences value creation (Cohen & Levinthal, 1990; Tsai & Wang, 
2008).  
We present evidence that CVC investment and the CVC x R&D interaction are 
associated with the creation of firm value. We find that this relationship is stronger in the 
machinery & electronics, engineering & business services, and ICT sectors. Previous research 
found that a number of firms in the R&D intensive telecommunication industry attributed 
their success in understanding and evaluating the value proposition of emerging technologies 
to CVC investments’ evaluative capacity, which is cultivated by R&D investments over the 
years (Covin & Miles, 2007). We are aware that the soundness of Tobin’s q, as a measure of 
firm value, depends on the premise that the financial market investor rationale is receptive to 
upcoming financial appreciation of stock based on CVC investment by the firm. To secure 
that the association between a firm’s CVC investment and its Tobin’s q is not caused by an 
unobserved factor, similar to Dushnitsky and Lenox (2006) and Lin and Lee (2011), we apply 
fixed effects to address the potential heterogeneity across firms within a sector. We also 
undertook the CVC investment self-selection decision to engage in CVC investment by 
following a Heckman selection model that required us to identify variables that explain CVC 
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investment (i.e. free cash flow and NASDAQ index). After running these models and 
regressions, our results remain robust. 
Despite these studies we need to be cautious about the results interpretation as there 
are limitation concerns. For instance, the generalization of the findings may be limited to the 
time periods studied or the sampled firms. Historically CVC investing has been cyclical with 
different waves of activity beginning in the mid-1960s (Dushnitsky & Lenox, 2006). Our 
sample period covers only data between 1985 and 2000. An additional limitation is that we 
used the data available by Thomson Reuters and VentureExpert reporting and it is likely that 
certain firms do not disclose all information concerning their CVC programs. Nevertheless 
we believe that the evidence obtained could be seen as the first base for future research in the 
domain of CVC and its interaction with R&D influencing value creation. 
We also observed that CVC is positive and significant for both Anglo-Saxon and non-
Anglo-Saxon countries. While, in terms of geography, there is a significant effect of CVC in 
USA & Canada, and Asia. When introducing the CVC x R&D interaction term, evidence 
suggest that the interaction is also associated with the creation of firm value contingent to 
regions where established firms operate, presenting for all regions a positive significant 
relationship with value creation, except in the case of Asia and ROW. This could be 
explained due to different characteristics between countries and regions, such as management 
practices, language, kind of law (i.e. code law or common law) which makes in certain 
countries risk and control on the CVC investment more controllable and predictable for CVC 
investors (e.g. minority shareholder rights). Alternative explanations can also be the 
development of the country judicial-court system, technology transfer policies, and tax 
incentives for CVC investors (Armour & Cumming, 2006; Klette & Moen, 2000; Lerner, 
2010; Poterba, 1989).  
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Our CVC x R&D interaction results also provide initial evidence of the CVC and 
R&D complementarity effect to value creation, supporting the notion that CVC complements 
internal R&D activities by tapping external CVC knowledge sources leveraged by internal 
R&D knowledge generation (Cassiman & Veugelers, 2002; Keil, 2002; Keil, Maula, Schildt, 
& Zahra, 2008; Sahaym et al., 2010). However alternative methodological approaches may 
provide robustness to this interaction and value creation. For example, we suggest 
considering alternative approaches such as the ones utilized by Cassiman and Veugelers 
(2006) i.e. productivity (direct) approach with dummy variables for Making of Buying 
innovation, and the adoption (indirect) approach testing the existence of complementarity 
through an exclusion restriction on a bivariate probit model. Additional future questions may 
change from whether or not a firm ought to establish a CVC program to: How much funds 
should be dedicated to CVC? What is the optimum mix between R&D and CVC? How many 
startups should be included in the portfolio? What types of startups should be supported 
depending on the sectors and regions in which firms operate? We also assume there may be a 
threshold beyond which CVC becomes detrimental to value creation, mainly depending on 
capital and asset intensity, which differs across business sectors. Therefore, for certain firms 
establishing a CVC program, at certain levels of investment CVC could pose a threat rather 
than an opportunity. Another future research initiative is to follow Hart and Ahuja’s (1994) 
approach to perform regression runs lagging the dependent variables on incremental periods, 
i.e. (time t + l), (time t + 2), (time t+3) and so on, to determine in which year the performance 
dependent variable peaks, and by introducing polynomial models to see if performance 
curves could be derived. The same could be done for other accounting metrics such as ROS, 
ROE, and ROA. 
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2.7. Conclusions 
This study examines the impact of CVC and its interaction with R&D on value 
creation across six business sectors and different regions between 1985 and 2000. Our 
findings suggest that the effect of CVC and its interaction with R&D on value creation is 
positive and significant. However, this relationship is contingent upon business sectors and 
regions. 
Some business sectors are more active in their use of CVC than others. CVC variance 
across business sectors suggests that the value of CVC depends on the sector context and its 
environment. Sahaym et al., (2010) found that business sectors with greater absorptive 
capacity developed by prior R&D investment display greater efforts towards pursuing 
innovations using CVC. Moreover when analyzing our sampled firms by business sectors, 
certain sector estimates support the notion that CVC can be more potent in creating market 
value (i.e. Tobin’s q) than our control variable R&D. Such sectors are engineering & business 
services and ICT. While in other sectors only R&D presents a significant positive relationship 
with market value creation, such as food, beverage & tobacco, pharmaceuticals, and vehicles. 
Hence, we support, along with Qualls et al. (1981) and Eisenhardt and Martin (2000) that 
firms operating in business sectors characterized with rapid technological change, are 
motivated to develop new alternative external sources of innovation that can influence value 
creation. Our results also suggest that for certain business sectors, entrepreneurial external 
ventures harness via CVC can be an important source of innovation and value creation.  
Our results also support previous research (Griliches & Lichtenberg, 1984; Kortum, 
1997; Thornhill, 2006) on the rate of technological change for firms operating in business 
sectors with larger R&D resources exhibiting greater technological change, making firms 
prone to explore new external venues to capture innovation.  
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In terms of geography, we observe a significant effect of CVC in USA & Canada, and 
Asia. However in Europe only our innovation control variable R&D shows a significant 
positive effect.  
We notice that regarding the CVC x R&D interaction, when analyzing the whole 
sample the regression estimates convey that R&D and CVC are complementary to value 
creation. Although when partitioning the sample in different business sectors the results 
suggest that corporations operating in ICT, machinery & electronics, and engineering & 
business services are better off engaging in R&D and CVC simultaneously. Hence, firms can 
combine CVC and R&D aiming to increase the probability to generate value creation.  
Finally, for managerial practice considerations we highlight the importance of an 
innovation strategy that can benefit from internal and external sources of knowledge. In other 
words our findings support the notion that an innovation strategy that combines CVC and 
R&D can create value. The results of this research can be used as a reference to encourage 
technology and innovation managers to further explore combining CVC and R&D as 
complementary mechanisms for innovation and value creation. 
 
 
 
 
 
 
 
 
 
 
 
 
114 
 
Tables and Figures 
 
Table 1. Sectors of sample firms. 
 Freq.  Percent  
Information Comm. Technology     69 21.30%
Business Engineering Services     67 20.68%
Machinery & Electronics           65 20.06%
Chemicals                         33 10.19%
Devices                           29 8.95%
Pharmaceutical                    23 7.10%
Vehicle                           15 4.63%
Metals                             8 2.47%
Food Beverage & Tobacco            8 2.47%
Printing and Publishing            7 2.16%
    
Total 324 100.00%  
_____________________________________________________________________________________ 
This table presents the analyzed sectors for the 324 parent companies (by 4 digit SIC code). Sample business 
sectors include: information communication and technology ICT (357*, 367*, 48**, 3663), business & 
engineering services (73**, 87**), industrial machinery and electronics (35**, 36** excluding 3663), chemicals 
(28** excluding 2834 and 2836, 29**, 3080), devices (38**), pharmaceuticals (2834, 2836), vehicles (37**), 
metals (33**), printing and publishing (27**), and food beverage and tobacco (20**, 21**). We created a 
binary version of sample sectors where sample firms present in a sector take a value of one, otherwise firms not 
active in such business sector are assigned the value of zero. Note that certain firms participate in more than one 
sector. The percentages in this table represent the main activity by each of firms based on its SIC codes. In other 
words a firm like General Electric (GE) has SIC codes in Machinery & Electronics and Devices. However in 
order to avoid duplication for this table GE is only considered under Machinery and Electronics. 
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Table 2. Countries of sample firms. 
Country of established firm             Freq.       Percent 
Australia 8 2.47%
Canada 2 0.62%
United Kingdom 23 7.10%
United States 176 54.32%
Total Anglo-Saxon 209 64.51%
   
Austria 1 0.31%
Belgium 1 0.31%
China 1 0.31%
Denmark 3 0.93%
Egypt 1 0.31%
Finland 2 0.62%
France 7 2.16%
Germany 15 4.63%
Hong Kong 3 0.93%
India 10 3.09%
Israel 2 0.62%
Italy 3 0.93%
Japan 30 9.26%
Malaysia 2 0.62%
Mexico 2 0.62%
Netherlands 3 0.93%
Norway 2 0.62%
Singapore 5 1.54%
South Korea 9 2.78%
Spain 1 0.31%
Sweden 6 1.85%
Switzerland 5 1.54%
Taiwan 1 0.31%
Total Non-Anglo-Saxon 115 35.49%  
      
Total sample 324 100.00%  
 _____________________________________________________________________________________ 
This table represents our sample of 324 established companies. Listed countries consider the location of 
headquarters. Unlike existing studies focused on the U.S. market (e.g. Dushnitsky and Lenox 2005a; Dushnitsky 
and Lenox 2006).    
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Table 3. Variables description. 
Variable      Description      
 
Tobin’s q     Sum of firm equity, long term debt, and liabilities over firm assets. 
 
Return on Sales     Earnings / Sales x 100. Five and ten years after R&D expenditure and CVC  
(ROS 5yr, 10yr)  investment. 
 
Return on Assets     (Net Income – Bottom Line + ((Interest Expense on Debt- Interest Capitalized) 
(ROA 5yr, 10yr)    x (1-Tax Rate))) / Average of Last Year's and Current Year’s Total Assets x 100. 
   Five and ten years after actual R&D expenditure and CVC investment. 
 
Return on Equity   (Net Income before Preferred Dividends - Preferred Dividend Requirement) /  
(ROE 5yr, 10yr)    Average of Last Year's and Current Year’s Common Equity * 100. 
 
CVC investment         Total Corporate Venture Capital invested ($ million) normalized by assets.  
 
R&D expenditure Total Research and Development expenditures ($ million) normalized by assets. 
 
CVC x R&D  Interaction term between CVC investment and R&D expenditure. 
 
Capital expenditure    Capital expenditures ($ million) normalized by assets.    
   
Growth     Annual change in sales ($ million) over previous year sales ($ million) .  
 
Leverage    Ratio of debt ($ million) to firm assets ($ million).    
 
Firm size     Log of firm assets ($ million).      
 
Industry Tobin’s q  Average industry Tobin’s q (by 4 digit SIC code). 
 
Sector Tobin’s q  Average specific business sector Tobin’s q (by 4 digits SIC code): information  
communication and technology ICT (357*, 367*, 48**, 3663), pharmaceuticals 
(2834, 2836), vehicles (37**), food beverage and tobacco (20**, 21**), industrial 
machinery and electronics (35**, 36** excluding 3663), and business & engineering 
services (73**, 87**).  
 
Risk Stock price volatility measure of stock's average annual price movement to a high  
and low from a mean price for each year. 
 
CVC activity Dichotomic variable taking the value of one for each observation where annual CVC 
investment and number of startups on portfolio are greater than zero; otherwise the 
dependent variable equals zero. 
 
Free cash flow  Income after interest and taxes plus depreciation and amortization ($ million) 
normalized by assets. 
 
NASDAQ index Stock market annual average index of the common stocks, it is an indicator of the 
performance of stocks of technology companies. 
 
CVC  Annual Corporate Venture Capital invested ($ million) in absolute values. 
 
R&D Total Research and Development expenditures ($ million) in absolute values.  
 
Sales Annual sales in ($ million) in absolute values. 
 
Assets  Assets in ($ million) in absolute values.  
 
Employees Number of employees.  
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Table 4. Descriptive statistics (1985-2000). 
 
Variable       Obs.         Mean      Std. Dev.        Min         Max 
Tobin’s q  2891      2.114      3.277     0.004     99.135    
ROS 5yr     3669      4.041      19.029    -318.296    107.406 
CVC investment     3136      0.001  0.015    0     0.452 
R&D expenditure    3137      0.057      0.078           0     2.210 
CVC x R&D   3136      0.001      0.002           0     0.073 
Capital expenditure    3046      0.071      0.044           0     0.499 
Growth     3003      0.219      1.678   -0.710          5.886   
Leverage     3061       0.171      0.192           0     3.138 
Industry Tobin’s q    5184      3.688      0.577     2.161     4.760 
Risk stock volatility   3172      0.357      0.207        0.016        3.410 
Firm size (assets)  3140      9.514      0.910     5.575     11.607 
Descriptive statistics of main regression variables. 
This table reports summary statistics of the main regression variables. Sample consists of 324 large established 
firms from 27 countries and 6 business sectors. Statistics based on annual data for the years between 1985 and 
2000, if available.  
 
 
 
 
 
Table 5. Summary statistics (1985-2000) 
Statistic        Tobin’s q   CVC a        R&D a         Sales a             Assets a  Employees 
 
Mean            2.114      2.732                831           10,200               16,000      62,319 
Std.Dev.          3.277           26           1,210           17,400               37,000      90,698 
Median            1.493             0                250              3,110                  4,320      26,770 
Min.           0.004             0                    0                         0                      0.376                               9 
Max.          99.135         931         6,830        161,000            405,000     446,800 
Observations   2,891      5,180              3,283                3,587                    3,140          3,069                
This table reports summary statistics of the main firms’ profile variables. Sample consists of 324 large 
established firms from 27 countries and 6 business sectors. Statistics based on annual data for the years between 
1985 and 2000, if available. CVC is the total corporate venture capital invested in rounded absolute values (not 
normalized). R&D, Sales, and Assets are also represented in rounded absolute values (not normalized).    
a In millions of dollars ($ million). 
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Table 6. Pairwise correlations (1985-2000) including the CVC x R&D interaction factor. 
 
 (1)   (2)    (3)          (4)           (5)          (6)           (7)         (8)           (9)          (10) 
    1. Tobin’s q              1.0000 
    2. CVC investment         0.3896   1.0000 
    3. R&D expenditure      0.2461    0.0731    1.0000 
    4. CVC x R&D    0.5108    0.2618    0.1186    1.0000 
    5. Capital expenditure   0.0508   -0.0234    0.0975    0.0116    1.0000 
    6. Growth    0.4836    0.2299    0.1457    0.2816    0.1139    1.0000 
    7. Leverage    0.0663    0.1104   -0.2762    0.1319    0.0450    0.0246    1.0000 
    8. Industry Tobin’s q       -0.0828  -0.0276    -0.0139    0.0121    0.0740    0.0035    0.0064    1.0000 
    9. Risk stock volatility   0.3482    0.1838    0.2755     0.1386    0.0128    0.3054    0.0209   -0.1030    1.0000 
   10. Firm size (assets)  -0.1747  -0.1192    -0.2202   -0.0274   -0.1132   -0.2125    0.0205   -0.0129   -0.3848    1.0000 
 
n =2668 
_________________________________________________________________________________________________________________________________ 
Correlation matrix of main regression variables including the CVC x R&D interaction factor. 
This table reports the correlations between the main regression variables. Sample consists of 324 large established firms from 27 countries and 6 business sectors. Statistics 
based on annual data for the years between 1985 and 2000, if available.  
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Table 7. CVC investment and R&D expenditure impact on Tobin’s q and Heckman (1985-2000)     
1985-2000 All 
Business Sectors 
(1) 
OLS 
(2) 
OLS 
(3) 
Heckman 
(4) 
Heckman 
(5) 
Heckman 
(6) 
Heckman 
VARIABLES Tobin’s q Tobin’s q Tobin’s q Tobin’s q Tobin’s q Tobin’s q 
CVC investment 42.99*** 31.73*** 138.6*** 129.2*** -5.100 -18.41 
 (3.813) (3.601) (23.92) (19.48) (55.75) (45.87) 
R&D expenditure 13.92*** 10.60*** 15.55** 21.85*** -2.999 0.214 
 (1.473) (1.384) (7.137) (6.598) (10.56) (9.888) 
CVC inv. x R&D exp.  572.4***   798.5*** 834.0*** 
  (29.75)   (253.5) (212.7) 
Capital expenditure 0.893 2.323* -17.39* -25.86*** -16.57 -23.62** 
 (1.271) (1.187) (9.758) (8.888) (12.55) (11.25) 
Growth 1.182*** 0.772*** 2.889*** 2.636*** 2.614*** 2.393*** 
 (0.132) (0.125) (0.475) (0.377) (0.615) (0.483) 
Leverage 2.400*** 1.967*** -1.264 -2.166 -3.604 -4.272** 
 (0.289) (0.270) (1.922) (1.579) (2.566) (2.076) 
Industry Tobin’s q -0.0479 1.703*** -1.663 -1.400 -2.988 -2.799 
 (0.0694) (0.360) (1.727) (1.317) (2.261) (1.751) 
Risk stock volatility 2.212*** 1.283*** 5.451** 5.897*** 6.460* 7.051** 
 (0.386) (0.182) (2.573) (2.182) (3.323) (2.817) 
Firm size (assets) 1.205*** -0.0493 0.741 1.225** 0.156 0.558 
 (0.196) (0.0647) (0.613) (0.600) (0.806) (0.783) 
Year fixed effect (FE)  YES YES YES YES YES YES 
Firm-sector FE YES YES NO YES NO YES 
Constant -10.93*** -11.17*** 8.111 -0.556 22.72 14.07 
 (2.614) (2.429) (11.22) (11.70) (15.06) (15.56) 
Observations 2,668 2,668 1,355 1,355     1,355         1,355 
R-squared 
Wald χ2 
0.723 0.760  
200.56*** 
 
379.51*** 
 
    129.44*** 
 
        242.24*** 
The estimates for the first Probit stage of models 3, 4, 5, and 6 are as follows:  
Free cash flow                             1.284***             1.284***        1.284***                 1.284*** 
                   (0.423)            (0.423)              (0.423)        (0.423) 
                                       NASDAQ index                0.00055***         0.00055***             0.00055***        0.00055*** 
                   (0.00004)            (0.00004)        (0.00004)        (0.00004) 
This table presents regression results for indicators of CVC investment and CVC investment x R&D expenditure impacting Tobin’s q. Sample consists of 324 large established firms from 27 countries and 6 business 
sectors. For Regression 1 and 2 we utilized ordinary least squares. In order to address firms’ self-selection to invest in CVC (Maddala, 1983) we created a binary version of CVC investment where all levels of 
investment greater than zero are assigned the value of one. In the first stage, we assume that the decision to invest in CVC is driven by the availability of free cash flow and the NASDAQ index. Through a Probit 
regression we found significant support at the 1%-level that both NASDAQ and free cash flow influence the CVC engagement. As for the second stage regression model to predict Tobin’s q, models 3, 4, 5, and 6 
present the Heckman regressions representing that for our dependent variable there was censorship causing a concentration of observations of zero values, the results prove significant for CVC investment on models 3 
and 4. Results prove significant for CVC investment x R&D expenditure on models 5 and 6. Standard errors are reported in parentheses. *, **, and *** indicate significance at the 10%, 5%, and 1% levels, respectively.
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Table 8. CVC investment and R&D expenditure impact on Tobin’s q, and ROA, ROE, and ROS five and ten years after actual investment (1985-2000). 
All business sectors (7) (8) (9) (10) (11) (12) 
Variables ROA 5yr ROA 10yr ROE 5yr ROE 10yr ROS 5yr ROS 10yr 
CVC investment 9.845 79.60** 129.9 -20.77 42.58* 18.62 
(13.11) (33.72) (120.0) (257.7) (23.00) (50.52) 
R&D expenditure -1.268 -3.496 -22.43 -24.26 9.132 13.13 
(4.852) (6.122) (40.39) (46.54) (8.527) (9.064) 
Capital expenditure 8.213* -2.629 -34.81 20.44 -12.72* 10.67 
(4.396) (5.059) (36.62) (38.93) (7.711) (7.587) 
Growth -0.538 1.297** 3.945 1.141 1.709** 1.632* 
(0.415) (0.586) (3.421) (4.426) (0.727) (0.863) 
Leverage 2.334** 1.968* -3.467 7.093 -0.158 3.888** 
(1.011) (1.169) (8.482) (8.945) (1.774) (1.743) 
Industry Tobin’s q -0.112 0.594** 5.127** 0.0374 3.864*** 0.442 
(0.242) (0.266) (2.009) (2.049) (0.424) (0.398) 
Risk stock volatility 2.239* 0.00510 9.249 13.26 -9.030*** -2.412 
(1.336) (1.671) (11.11) (12.86) (2.342) (2.502) 
Firm size (assets) -4.207*** -3.638*** -1.563 -9.483 2.305** 1.754 
(0.663) (0.820) (5.581) (6.453) (1.166) (1.225) 
Year fixed effect YES YES YES YES YES YES 
Firm fixed effect YES YES YES YES YES YES 
Constant 33.51*** 18.34 -5.109 128.8 -45.76** -22.48 
(8.696) (12.05) (72.52) (82.63) (17.86) (17.87) 
Observations 2,722 2,480 2,708 2,470 2,729 2,493 
R-squared 0.507 0.457 0.163 0.152 0.476 0.457 
This table presents regression results of indicators of CVC investment and R&D expenditure impact on Tobin’s q, ROA 5yr and 10 yr., ROE 5yr and 10 yr., ROS 5yr and 10yr. 
Sample consists of 324 large established firms from 27 countries and 6 business sectors. Statistics based on annual data for the years between 1985 and 2000, if available. These 
regressions were computed through ordinary least squares. We performed the regressions controlling for firm and year fixed effect. As anticipated we found that firms which are 
growing have higher ROS 5yr, ROS 10 yr, and ROA 10yr. Model 8 suggests there is a relationship between CVC and ROA 10 years after CVC investment has been done. Standard 
errors are reported in parentheses. *, **, and *** indicate significance at the 10%, 5%, and 1% levels, respectively. 
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Table 9. CVC investment and R&D expenditure impact on Tobin’s q by sector (1985-2000)        
1985-2000 (13) (14) (15) (16) (17) (18) 
VARIABLES Food  
Tobin’s q 
ICT  
Tobin’s q 
Machinery and 
Electronics  
Tobin’s q 
Pharma 
Tobin’s q 
Engineering and 
Business Services 
Tobin’s q 
Vehicles 
Tobin’s q 
CVC investment -12.63 269.8*** 76.93*** -154.1 116.6*** -11.59 
 (12.92) (8.054) (10.24) (122.8) (9.501) (7.602) 
R&D expenditure 31.65*** 18.00*** 16.86*** 9.394*** 7.608*** 2.653* 
 (3.358) (1.932) (1.423) (1.939) (2.747) (1.537) 
Capital expenditure -1.997 1.824 1.440 3.417 2.873 1.066 
 (2.301) (1.856) (1.238) (2.566) (3.083) (0.677) 
Growth -0.0286 0.808*** 0.316*** 0.379 1.007*** 0.720*** 
 (0.461) (0.158) (0.117) (0.251) (0.246) (0.142) 
Leverage 2.805*** 2.544*** 1.863*** 2.627*** 2.005*** 2.500*** 
 (0.674) (0.381) (0.261) (0.469) (0.516) (0.230) 
Sector Tobin’s q 0.358** 0.0237 -0.0200 -0.233*** -0.0501 -0.0830*** 
 (0.175) (0.116) (0.0851) (0.0413) (0.109) (0.0142) 
Risk stock volatility 0.659 0.834* 0.197 -0.299 3.275*** -0.0863 
 (0.848) (0.481) (0.374) (1.005) (0.790) (0.173) 
Firm size (assets) -0.257 0.749*** 1.560*** -0.340 1.508*** -0.606*** 
 (0.470) (0.251) (0.196) (0.382) (0.394) (0.120) 
Year fixed effect YES YES YES YES YES YES 
Firm fixed effect YES YES YES YES YES YES 
Constant 0.476 -5.726* -14.39*** 6.512 -10.54*** 7.266*** 
 (3.603) (3.227) (2.172) (4.160) (3.586) (1.288) 
Observations 238 1,075 994 341 960 259 
R-squared 0.789 0.858 0.647 0.723 0.752 0.797 
This table presents regression results of indicators of CVC investment and R&D expenditure impact on Tobin’s q. 
Sample consists of 324 large established firms from 27 countries and 6 business sectors. Statistics based on annual data 
for the years between 1985 and 2000, if available.  
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Table 10. CVC investment and R&D expenditure impact on ROS 5 years by sector (1985-2000). 
1985-2000 (19) (20) (21) (22) (23) (24) 
VARIABLES Food  
ROS 5yr 
ICT  
ROS 5yr 
Machinery and 
Electronics  
ROS 5yr 
Pharma 
ROS 5yr 
Engineering and 
Business Services 
ROS 5yr 
Vehicles 
ROS 5yr 
CVC investment 140.0 122.9** 212.6** 95.90 48.84 169.2 
 (92.25) (57.26) (105.4) (1,104) (43.24) (156.6) 
R&D expenditure 65.51*** 9.328 12.89 30.19* 5.866 -45.39 
 (23.98) (13.62) (14.59) (17.46) (12.46) (31.43) 
Capital expenditure 5.899 13.47 20.41 7.014 -35.96** -20.54 
 (16.43) (14.02) (12.45) (23.11) (14.92) (13.97) 
Growth 0.777 2.093** 2.640** 0.237 1.313 1.617 
 (3.289) (1.020) (1.165) (2.260) (1.030) (2.916) 
Leverage -9.059* -3.398 2.491 2.624 -3.505 5.586 
 (4.811) (3.012) (2.687) (4.222) (2.534) (4.658) 
Sector Tobin’s q 9.925*** 4.496*** -1.318 0.478 3.323*** -1.261*** 
 (1.251) (0.908) (0.858) (0.367) (0.528) (0.292) 
Risk stock volatility 4.331 -5.151 -11.35*** -37.17*** -11.69*** -1.590 
 (6.054) (3.557) (3.802) (9.049) (3.811) (3.568) 
Firm size (assets) -8.977*** 1.736 0.597 -4.999 -0.808 12.21*** 
 (3.359) (1.900) (1.962) (3.424) (1.860) (2.480) 
Year fixed effect YES YES YES YES YES YES 
Firm fixed effect YES YES YES YES YES YES 
Constant 39.65 -23.83 14.48 81.17** 4.760 -0.00511 
 (25.73) (23.23) (22.66) (37.46) (20.00) (19.98) 
Observations 238 1,129 1,035 343 979 261 
R-squared 0.751 0.414 0.383 0.603 0.513 0.811 
 
This table presents regression results of indicators of CVC investment and R&D expenditure impact on ROS 5yr. 
Sample consists of 324 large established firms from 27 countries and 6 business sectors. Statistics based on annual data 
for the years between 1985 and 2000, if available. Data derived from VentureExpert and DataStream data sets. 
Regressions are estimated using ordinary least squares. We performed the regression controlling for firm and year fixed 
effect. Our sample covers several business sectors, that when considering the benefits and limits that CVC provide to 
firms it is likely that the utilitarian advantages of CVC are contingent on the dynamism of the business sector or the 
industrial maturity context where established firms operate. CVC benefits are expected to be greater in growing 
business sectors with rich technological opportunities, while it will be more limited for mature business sectors where 
R&D may prove more effective in impacting the value creation. CVC has a stronger impact than R&D on ROS 5 years 
for ICT, and machinery & electronics significant at the 5% level. However it did not prove positively significant for 
engineering & business services. Although we consider these three sectors characterized by a dynamic and high 
technology operating framework it was only for models 20 and 21 that CVC seem to explain an increase on the earnings 
by actual sales five years after an entrepreneurial CVC investment has been structured. Regarding mature R&D 
intensive business sectors such as: Food beverage & tobacco, and pharmaceuticals we observe that R&D has a stronger 
significant and positive impact than CVC. For models 19 and 22 significant at the 1% and 10% level respectively. 
Standard errors are reported in parentheses. *, **, and *** indicate significance at the 10%, 5%, and 1% levels, 
respectively. 
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Table 11. CVC investment and R&D expenditure impact in different regions (1985-2000). 
 (25) (26) (27) (28) (29) (30) (31) (32) (33) 
All business sectors Tobin’s q Tobin’s q Tobin’s q Tobin’s q Tobin’s q Tobin’s q Tobin’s q Tobin’s q Tobin’s q 
Variables Full sample USA Non USA Anglo-Saxon Non Anglo-
Saxon 
USA & Canada Europe Asia ROW 
 
CVC investment 42.99*** 102.1*** 0.996 40.67*** 58.16*** 102.1*** 0.779 38.45*** 8.025 
(3.813) (7.026) (2.477) (4.367) (13.78) (7.026) (2.835) (12.78) (37.70) 
R&D expenditure 13.92*** 14.40*** 4.038** 15.65*** 4.737*** 14.40*** 4.252** -4.310 153.2 
(1.473) (1.847) (1.734) (1.813) (1.798) (1.847) (2.131) (3.656) (134.2) 
Capital expenditure 0.893 0.159 3.955*** 0.306 1.794 0.159 4.696** 2.275 -0.443 
(1.271) (1.671) (1.325) (1.605) (1.438) (1.671) (1.979) (2.381) (2.103) 
Growth 1.182*** 1.636*** 0.00969 1.826*** -0.154 1.636*** 0.0349 -0.0144 0.313 
(0.132) (0.194) (0.116) (0.186) (0.114) (0.194) (0.136) (0.458) (0.502) 
Leverage 2.400*** 2.009*** 2.263*** 2.521*** 2.050*** 2.009*** 2.214*** 0.854 3.313** 
(0.289) (0.437) (0.226) (0.425) (0.224) (0.437) (0.272) (0.751) (1.280) 
Industry Tobin’s q -0.0479 -0.0904 0.0112 -0.117 0.0792 -0.0904 -0.118 0.184** 0.0584 
(0.0694) (0.0962) (0.0602) (0.0926) (0.0626) (0.0962) (0.0885) (0.0781) (0.253) 
Risk stock volatility 2.212*** 2.103*** 1.762*** 2.383*** 1.877*** 2.103*** 0.834* 2.744*** 1.231 
(0.386) (0.561) (0.312) (0.544) (0.313) (0.561) (0.481) (0.400) (1.410) 
Firm size (assets) 1.205*** 1.349*** 1.099*** 1.244*** 1.936*** 1.349*** 0.776** 1.985*** 0.425 
(0.196) (0.251) (0.239) (0.241) (0.283) (0.251) (0.309) (0.592) (1.174) 
Year fixed effect YES YES YES YES YES YES YES YES YES 
    Firm fixed effect YES YES YES YES YES YES YES YES YES 
Constant -10.93*** -12.22*** 6.231*** -21.14*** -13.94*** -12.05*** -7.357** -22.57*** -4.631 
(2.614) (2.933) (2.215) (3.833) (2.246) (3.153) (3.236) (6.498) (12.69) 
Observations 2,668 1,739 929 1,907 761 1,741 545 343 39 
R-squared 0.723 0.742 0.759 0.722 0.745 0.745 0.693 0.842 0.930 
This table presents regression results of indicators of CVC investment impact on Tobin’s q. Sample consists of 324 large established firms from 27 countries and 6 business 
sectors. Regressions are estimated using ordinary least squares. By considering the benefits that CVC provide to firms it is likely that the utilitarian advantages of CVC are 
contingent on the development of a country or region: judicial system, technology transfer policy, and tax incentives in terms of taxing capital gains. CVC benefits are 
expected to be greater in regions with developed legal systems, technology transfer policy, and tax incentives, while it will be more limited for less developed judicial 
systems, technology transfer policy, and less attractive tax incentives. Thus, the results present the view that CVC is most influential in countries such as the US characterized 
by a developed legal system, technology transfer policy, and capital gains tax incentives. Full country sample includes: Australia, Austria, Belgium, Canada, China, Denmark, 
Egypt, Finland, France, Germany, Hong Kong, India, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Norway, Singapore, South Korea, Spain, Sweden, Switzerland, 
Taiwan, United Kingdom, and Unites States of America. Anglo-Saxon sample includes: Australia, Canada, United Kingdom, and Unites States of America. Europe sample 
includes: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, and United Kingdom. Asia sample includes: 
China, Hong Kong, India, Israel, Japan, Malaysia, Singapore, South Korea, and Taiwan. Rest of the World (ROW) country sample includes: Australia, Egypt, and Mexico. 
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Table 12. CVC x R&D interaction factor impact on Tobin’s q by business sector (1985-2000). 
 (34) (35)  (36) (37) (38) (39) (40) (41) 
Variables All business 
sectors 
Tobin’s q 
All business 
sectors 
Tobin’s q 
Food  
Tobin’s q 
ICT  
Tobin’s q 
Machinery and 
Electronics  
Tobin’s q 
Pharma 
Tobin’s q 
Engineering and 
Business Serv. 
Tobin’s q 
Vehicles 
Tobin’s q 
CVC investment 42.99*** 31.73*** -386.9* 75.64*** -20.78** -159.7 53.89*** -20.26 
 (3.813) (3.601) (230.0) (11.02) (8.532) (134.0) (16.05) (41.30) 
R&D expenditure 13.92*** 10.60*** 20.97*** 9.580*** 6.743*** 8.997** 7.517*** 1.965 
 (1.473) (1.384) (7.354) (1.626) (1.136) (4.261) (2.711) (3.570) 
CVC inv. x R&D exp.  572.4*** -6,488 1,370*** 1,323*** -254.8 429.0*** -463.6 
  (29.75) (3,981) (62.37) (49.99) (2,436) (89.00) (2,171) 
Capital expenditure 0.893 2.323* -1.729 4.040*** 2.026** 3.424 3.893 1.048 
 (1.271) (1.187) (2.297) (1.521) (0.931) (2.571) (3.051) (0.684) 
Growth 1.182*** 0.772*** -0.0418 0.308** 0.242*** 0.378 0.820*** 0.719*** 
 (0.132) (0.125) (0.459) (0.131) (0.0877) (0.251) (0.246) (0.142) 
Leverage 2.400*** 1.967*** 2.779*** 2.342*** 1.802*** 2.625*** 1.887*** 2.501*** 
 (0.289) (0.270) (0.671) (0.312) (0.196) (0.470) (0.510) (0.230) 
Risk stock volatility 2.212*** 1.703*** 0.638 0.509 -0.116 -0.301 3.007*** -0.0866 
 (0.386) (0.360) (0.844) (0.394) (0.281) (1.007) (0.782) (0.173) 
Firm size (assets) 1.205*** 1.283*** -0.260 0.937*** 1.067*** -0.341 1.705*** -0.605*** 
 (0.196) (0.182) (0.468) (0.205) (0.149) (0.383) (0.391) (0.121) 
Industry Tobin’s q -0.0479 -0.0493       
 (0.0694) (0.0647)       
Sector Tobin’s q   0.388** 0.344*** 0.0121 -0.233*** -0.0856 -0.0826*** 
   (0.175) (0.0962) (0.0639) (0.0416) (0.108) (0.0144) 
Year fixed effect YES YES YES YES YES YES YES YES 
Firm fixed effect YES YES YES YES YES YES YES YES 
Constant -10.06*** -11.17*** 1.601 1.414 -8.079*** 6.830 -11.52*** 7.369*** 
 (2.606) (2.429) (3.612) (2.637) (1.633) (4.162) (3.540) (1.266) 
Observations 2,668 2,668 238 1,075 994 341 960 259 
R-squared 0.723 0.760 0.792 0.905 0.801 0.723 0.758 0.797 
This table presents regression results of indicators of CVC investment and R&D expenditure impact on Tobin’s q. Sample consists of 324 large established firms from 27 countries 
and 6 business sectors. Firms that pursue CVC and R&D simultaneously are associated with value creation. We have also documented that this positive relationship (see Table 12 
Model 35) is attributable to the combination of CVC and R&D significant at the 1% level. This is particularly interesting, as we found on our literature review that Dushnitsky (2003) 
also reports a significant, positive coefficient on R&D and CVC. This would suggest that internal R&D and CVC investment are in fact complements not substitutes. The CVC x R&D 
interaction benefits are expected to be greater in growing business sectors with rich technological opportunities, while it will be more limited for mature business sectors where R&D 
may prove more effective in impacting the value creation. The results presented are consistent with our expected results where the CVC x R&D interaction has a stronger influence on 
value creation on sectors such as ICT, machinery and electronics and engineering and business services as these represent business sectors characterized by dynamic technological and 
market conditions. Results on models 37, 38, and 40 show the CVC x R&D interaction term significant at the 1% level.  
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Table 13. CVC x R&D interaction factor impact on Tobin’s q in different regions (1985-2000). 
 (42) (43) (44) (45) (46) (47) (48) (49) (50) 
All business sectors Tobin’s q Tobin’s q Tobin’s q Tobin’s q Tobin’s q Tobin’s q Tobin’s q Tobin’s q Tobin’s q 
Variables Full sample 
All Regions 
USA Non USA Anglo-Saxon Non Anglo-
Saxon 
USA & 
Canada 
Europe Asia ROW 
 
CVC investment 31.73*** 25.80** 48.30*** 33.48*** 46.19*** 25.75** 79.33*** 56.31*** -7,168*** 
 (3.601) (10.11) (7.044) (4.103) (13.84) (10.12) (10.17) (12.48) (2,065) 
R&D expenditure 10.60*** 12.28*** 7.349*** 11.76*** 7.506*** 12.35*** 8.109*** -11.82*** -2,483*** 
 (1.384) (1.802) (1.746) (1.711) (1.875) (1.801) (2.061) (3.691) (764.8) 
CVC inv. x R&D exp. 572.4*** 595.3*** 1,181*** 548.4*** 997.4*** 595.3*** 1,665*** -2,911*** -0.000005*** 
 (29.75) (58.36) (165.3) (34.37) (220.7) (58.36) (208.1) (495.9) (0.0000016) 
Capital expenditure 2.323* 0.805 4.330*** 2.010 2.264 0.805 5.296*** 0.673 -0.0379 
 (1.187) (1.620) (1.288) (1.502) (1.422) (1.620) (1.863) (2.271) (1.521) 
Growth 0.772*** 1.358*** 0.0496 1.245*** -0.129 1.358*** 0.117 0.149 0.0281 
 (0.125) (0.189) (0.112) (0.178) (0.113) (0.189) (0.129) (0.435) (0.371) 
Leverage 1.967*** 1.682*** 2.299*** 1.834*** 2.087*** 1.682*** 2.311*** -0.136 3.244*** 
 (0.270) (0.425) (0.219) (0.399) (0.221) (0.425) (0.256) (0.731) (0.923) 
Industry Tobin’s q -0.0493 -0.108 0.00747 -0.116 0.0808 -0.108 -0.130 0.165** 0.0891 
 (0.0647) (0.0932) (0.0584) (0.0865) (0.0617) (0.0932) (0.0832) (0.0740) (0.182) 
Risk stock volatility 1.703*** 1.558*** 1.715*** 1.580*** 1.955*** 1.558*** 0.463 1.883*** 1.692 
 (0.360) (0.547) (0.303) (0.511) (0.309) (0.547) (0.455) (0.406) (1.025) 
Firm size (assets) 1.283*** 1.492*** 0.913*** 1.274*** 1.824*** 1.492*** 0.478 1.623*** 0.881 
 (0.182) (0.243) (0.234) (0.225) (0.280) (0.243) (0.293) (0.564) (0.857) 
Year fixed effect YES YES YES YES YES YES YES YES YES 
Firm fixed effect YES YES YES YES YES YES YES YES YES 
Constant -11.17*** -12.63*** 8.101*** -12.69*** -12.78*** -12.70*** -3.882 -18.12*** -12.33 
 (2.429) (2.834) (2.154) (3.602) (2.218) (3.048) (3.061) (6.181) (9.450) 
Observations 2,668 1,739 929 1,907 761 1,741 545 343 39 
R-squared 0.760 0.758 0.773 0.758 0.753 0.761 0.729 0.859 0.967 
This table presents regression results for firms that pursue CVC and R&D simultaneously. We document the positive relationship (see Table 13 Model 42) attributable to the 
combination of CVC and R&D significant at the 1% level. This suggests that internal R&D and external CVC are in fact complements not substitutes. The CVC x R&D 
interaction benefits are expected to be greater in regions with developed legal systems, technology transfer policy, and tax incentives, while it will be more limited for less 
developed judicial systems, technology transfer policy, and less attractive tax incentives. Thus, the results present the view that the interaction is most influential in countries 
such as the USA (see Table 13 Model 43) characterized by a developed legal system, technology transfer policy, and capital gains tax incentives. The regions with less 
mature legal systems and less tax capital gain incentives such as Asia and ROW (i.e. Models 49 and 50) present a negative and significant relationship between the CVC x 
R&D interaction and Tobin’s q. Anglo-Saxon sample includes: Australia, Canada, United Kingdom, and Unites States of America. Europe sample includes: Austria, 
Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, and United Kingdom. Asia sample includes: China, Hong Kong, 
India, Israel, Japan, Malaysia, Singapore, South Korea, and Taiwan. Rest of the World (ROW) country sample includes: Australia, Egypt, and Mexico. Standard errors are 
reported in parentheses. *, **, and *** indicate significance at the 10%, 5%, and 1% levels, respectively. 
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Appendix 
 
Table A1. Chow test comparing coefficients and structural break (1985-2000) 
(Contraction. 1985-1993) vs. (Expansion. 1994-2000) 
F(7, 450) = 2.68  
Prob > F = 0.0099 
 
Unlike existing studies [e.g. Zahra (1991) analyzed the CVC contraction period 1986 to 1989, and Dushnitsky 
and Lenox (2005a) studied the CVC expansion period 1990 to 1999]. The table presents confirmation results of 
our period considering the cyclical effects on the time series data considering CVC activity over two sub-
periods; 1994 to 2000 as expansion period and 1985 to 1993 as contraction period. The test statistics for Chow 
breakpoint confirmed a structural change in the parameters during this structural break year. The F statistics 
rejected the null hypothesis of no structural change at the 1 percent level of significance, with this Chow test we 
determined that the independent variables have a change in parameters when comparing expansion and 
contraction periods. After confirming the structural break we decided to analyze the complete 1985 to 2000 
period to observe if value creation holds regardless of the expansion-contraction phenomenon. 
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3. Management Systems and Organizational Structures to Generate 
Radical Innovation: A Case Study 
 
3.1. Introduction 
Schumpeter (1934) defined innovation as ideas applied successfully in practice. Later 
Freeman and Soete (1997) defined innovation as a commercialized invention, and Afuah 
(1997) determined that innovation is the use of new knowledge to offer a new product or 
service that customers want. Davila et al. (2009) argue that innovation is the pursuit of 
significant new value creation opportunities through a process managed by established firms, 
and that innovation is associated with taking advantage of unexpected opportunities, new 
relationships, uncertain outputs, and the possibility of failure. These definitions and 
arguments provide a delineation of the meaning of innovation. However, they do not 
distinguish on the degree of novelty present in innovations. The literature makes the 
distinction between incremental and radical innovation. Incremental innovation is represented 
by minor changes to existing technology, merely an extent of the current proposition 
introducing relatively minor improvements to the product, process or service, providing 
short-term market advantage (Christensen, 1997a; Davila et al., 2006; Markides & Geroski, 
2005; Munson & Pelz, 1979; Utterback, 1994). In contrast, radical innovation depicts higher 
market and technological uncertainties22 leading to revolutionary changes. It results to 
considerable improvements from existing products disrupting consumer habits and providing 
firms with competitive advantages and high margin economic rents (Duchesneau et al., 1979; 
Ettlie, 1983; Markides & Geroski, 2005; O'Connor & DeMartino, 2006; Utterback, 1994).  
                                                 
22 Galbraith’s 1973 uncertainty definition: “the difference between the amount of information required to perform a task and 
the amount of information already possessed by the organization”. 
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Radical innovation is important because firms that rely on purely continuous 
improvement and incremental innovations could aspire to maintain their market position 
while firms that pursue radical innovation can position themselves advantageously apart from 
competition and become market leaders (Leifer et al., 2000). Day (2007) reported that 
incremental innovation represents 85% to 90% of new product development (NPD) 
portfolios. However these rarely generate the growth leading companies seek. This emphasis 
on incremental innovations can also affect the firm’s innovative capacity by delaying 
projects, stressing the organization, and failing to achieve high growth revenue goals. These 
incremental innovation projects are necessary for continuous improvement, but they don’t 
provide companies with a competitive edge or contribute much to profitability (Cooper, 
2003).  
Denning (2011) conducted a case study to describe the management systems and 
processes at Salesforce.com, one of the most successful examples of a company developing 
radical innovation impacting value creation. Between 2006 and 2011 Salesforce.com 
delivered a 41% annual return to shareholders. This extraordinary performance is due to their 
radical innovation that occurred after the firm instituted a radical set of agile, customer-
driven, outcome-oriented, iterative management processes. According to a study by Kim and 
Mauborgne (1999) only 14% of NPD are radical innovations, but these account for 61% of all 
profit from innovation.  
Porter (1985) described how firms gain market positions over rivals through 
competitive advantages. Usually a competitive advantage comes from a full range of firm 
processes distinguishable from competitors (Ghemawat et al., 1998). Davila et al. (2005; 
2006) mentioned that firms seek competitive advantages, by improving the effectiveness of 
their innovation process from ideation to commercialization. However, they recognized that 
incremental and radical innovations are different and suggested that if firms manage 
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incremental and radical innovation projects through the same one-size-fits-all innovation 
process and through a sole set of Management Control Systems (MCS23), those firms can 
almost guarantee a sub-optimization of certain systems and resources.  
Chandy and Tellis (1998) studied the reasons why some firms are more successful at 
generating radical innovation, finding that organizational structure24 is an important element 
for radical innovation output. Teece (1986) suggested that firms need to organize to 
appropriate the returns of their innovation strategy through internal and external 
complementary25 assets. There have also been organizational developments that foster the 
need for firms to improve their innovation process. For example, cross-functional cooperation 
among individuals in the firm needs to be improved at the different organizational units i.e. 
headquarters, corporate innovation centers, central corporate research and development 
departments (R&D), external partners and business units (BU) to offer short delivery times, 
and a cost effective NPD (Anderson, 1997).  
More importantly, radical innovation is not purely the result of luck. It can be 
generated in a systematic way through enablers such as processes, MCS, and organizational 
structures. Jelinek and Schoonhoven (1993) and Davila et al. (2007; 2006) found that 
innovative firms have institutionalized mechanisms for innovation, arguing that innovation 
cannot occur in an organic environment where flexibility and consensus are the main 
managerial mechanisms. They rather argue that radical innovation requires a clear 
organizational structure and MCS, ensuring that when developing radical innovation both 
discipline and creativity are present.  
Davila et al. (2009) identify research opportunities for innovation management and 
provide a list of pending issues such as: How do companies manage the process for radical 
                                                 
23 Simons’ (1995) definition of Management Control Systems: “formal, information based routines and procedures managers 
use to maintain or alter patterns in organizational activities”. 
24 Child’s (1972) organizational structure is defined as the formal allocation of work roles and the administrative 
mechanisms to control and integrate work activities including those which cross formal organizational boundaries. 
25 Cassiman and Veuglers’ (2006) complementarity implication to performance is “adding an activity while the other activity 
is already being performed and has a higher incremental effect on performance than adding the activity in isolation”.  
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and incremental innovation? What are the performance measures companies use to manage 
radical ideas and how do they select them? The fundamental objective of this paper is to 
address the following research question: What are the processes, MCS, and organizational 
structures for generating radical innovation? Research on innovation management focuses 
mainly on either the firm level (Birkinshaw et al., 2008a) or at the project level examining 
appropriate management techniques associated with high levels of uncertainty (Burgelman & 
Sayles, 1988; Dougherty & Heller, 1994; Jelinek & Schoonhoven, 1993; Kanter et al., 1990; 
Leifer et al., 2000). Therefore, we embark on a novel process-related research framework to 
observe the process stages, MCS, and organizational structures that can generate radical 
innovation. Through abductive reasoning we obtained an understanding of what a firm does 
and the reasons for acting in specific ways. Consequently, we present some insights and 
findings on the processes, MCS, and organizational structures firms can implement to 
generate radical innovation.  
The paper has the following structure. In section 2 we look at the literature relevant to 
our subject. In section 3 we describe our method and provide reasons for selecting an in depth 
field research approach and Alcan Engineered Products (Alcan EP) as our unit of analysis. In 
section 4 we provide the background of our case study with a description of the company, its 
MCS, its innovation process, and its organizational structure for radical innovation. The key 
findings are in section 5 where we discuss the results obtained from our observations and 
interviews. The conclusions are in section 6. Our exploratory research found evolutionary 
advanced MCS, processes and organizational structures to generate radical innovation.  
 
3.2. Literature Review 
The dynamic capabilities framework studies the resources and processes that create 
and capture value by firms operating in environments of rapid technological change (Teece et 
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al., 1997). Eisenhardt and Martin (2000) describe dynamic capabilities as organizational and 
strategic processes that transform knowledge into value for the firm. Kelley et al. (2011) 
recognize that firms need to periodically renew their business processes as the advantages of 
their current ones diminish over time. More broadly dynamic capabilities are repeatable and 
comprise sets of business processes that allow firms to explore new ideas (Stalk, Evans, & 
Shulman, 1992; Zollo & Winter, 2002). As a result, dynamic capabilities enable firms to 
engage in radical exploration projects into the unknown (Schreyögg & Kliesch-Eberl, 2007).  
It is in the context of dynamic capabilities that we set the theoretical framework of this 
paper as we elaborate and distinguish between incremental and radical innovation and present 
the state of research through our literature review on MCS, processes, and organizational 
structures.  
 
3.2.1. Incremental and Radical Innovation  
Innovation has been defined as an idea, practice, or product that is perceived to be 
new (Zaltman, Duncan, & Holbek, 1973). Jolly and Vijay (1997) refer to innovation as a 
process of going from mind to market. However these definitions do not distinguish the 
degree of novelty. This could be further clarified by the notion of radicalness. Radical 
innovation depicts changes that represent revolutionary change in technology and 
considerable improvements from existing products (Duchesneau et al., 1979; Ettlie, 1983; 
Markides & Geroski, 2005; O'Connor & DeMartino, 2006; Utterback, 1994). In contrast, 
incremental innovations are represented by minor changes or adjustments to existing 
technology (Davila et al., 2006; Markides & Geroski, 2005; Munson & Pelz, 1979). Meyer et 
al. (1986) and Gatignon et al. (2002) also contributed with proposals to differentiate 
incremental and radical innovations based on technological newness and innovative business 
models. These kinds of innovations have different competitive effects. Incremental 
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innovation is an extension of the current proposition facing consumers with minor changes to 
the product or service, while radical innovation introduces major new value propositions that 
disrupt existing consumer habits and behaviors (Markides & Geroski, 2005). Furthermore, 
radical innovation encompasses disruptive technologies with lower cost and additional 
performance features (Christensen, 1997a). Utterback (1994) explained the importance of 
radical innovations by highlighting the powerful means for enlarging markets and providing 
new valuable functionalities.  
Although the literature on innovation usually focuses on technology (Henderson & 
Clark, 1990), innovation is not only about changing technologies, but also about meeting 
customer needs through new processes, services, and business models. More important to our 
research focusing on the causality derived from the crossroads of MCS, processes, and 
organizational structures to generate radical innovation, Davila et al., (2009) argue that 
incremental and radical innovation require different systems to manage project initiatives 
from top management vs. creativity “bubbling up” from the rest of the organization. 
Furthermore, they suggest that incremental and radical innovation require MCS that can 
provide a structure for the innovation process without becoming rigid mechanisms, hence 
being flexible enough to take advantage of unexpected opportunities but strong enough to 
continue in one direction. Brown and Eisenhardt (1997) describe this balance as the ability to 
blend flexible-structured MCS which can enable change but can also prevent chaos when 
generating radical innovation. 
 
3.2.2. MCS and the Innovation Process  
MCS are generally known as procedures, policies, and information mechanisms 
across the organization enabling processes to operate. In this paper MCS are interpreted as 
‘formal, information-based routines and procedures managers use to maintain or alter patterns 
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in organizational activities’ (Simons, 1995). MCS range from basic controls such as budget 
and pricing, to additional controls such as cost and risk control (Sandino, 2007).  
MCS are grounded on firm strategy. Their goal is to assist implement and monitor 
strategic initiatives and reduce uncertainty (Simons, 1999). Ansoff (1965), O’Connor (1998), 
Veryzer (1998), and Christensen (1997a, b) argue that developing radical innovation involves 
considerable risk and requires insight and foresight mainly due to the high technology and 
market uncertainty present in radical innovation. Jorgensen and Messner (2010) studied the 
kind of MCS and the type of innovation strategy, observing a contingency route for MCS 
adoption based on market and technology uncertainties. Argyres and Silverman (2004) and 
Zwerink et al. (2007) found that by implementing MCS over R&D budgets and NPD, there 
was a positive effect on innovation output. Nonetheless, Hayes (1977) and Brownell’s (1985) 
research on MCS and innovation established that R&D organizations utilize accounting 
measures. However, the outcome of such research concludes that accounting measures have 
little impact on generating innovation. Furthermore, Kaplan and Norton (1992) studied 
performance measures related to innovation, and found that traditional financial accounting 
measures like return on investment (ROI) can mislead organizations when measuring 
innovation. For example, managers can be induced to delay investment in facilities or 
equipment necessary for innovation, because of the negative effects it might have on ROI in 
the short run. Moreover, they identified that leading innovative companies use non-financial 
performance indicators such as the percent of sales from new products, time to develop NPD, 
and new product introduction, as performance indicators for innovation.  
Davila et al. (2009) developed arguments on the relevance of MCS to foster 
innovation. These arguments are contrary to the traditional MCS paradigm in which due to 
MCS’s explicit contracts, hierarchical organizations and extrinsic motivations designed to 
eliminate variation. The common understanding is that MCS are detrimental to innovation, 
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particularly radical innovation, due to the likelihood of failure and high uncertainty outcomes. 
For example, in his research on determinants of innovation, Damanpour (1991) offers 
empirical evidence that MCS are adverse to innovation. Quinn (1993) also argues that MCS 
limit firm innovation, suggesting that MCS are unfavorable to innovation. Innovation relies 
on intrinsic motivation, freedom, experimentation, and flexibility (Amabile, 1998; Davila et 
al., 2009). However, Simons’ (1987; 1991, 1994, 1995) empirical work led to the 
development of the levers of control model creating a paradigm shift by identifying 
interactive flexible systems as tools to engage the organization in the exploration of strategic 
uncertainties. This led to the development of a concept in MCS literature aimed at creating 
the variation required to generate innovation. Later, Andrew and Sirkin (2007) conducted 
research on managing innovation, MCS and measurement of resources such as cash flow and 
development time which impact the innovation development cost. This cumulative invested 
cash and development time from ideation to commercialization has been determined as an 
important performance metric for innovation management. The cash curve represented in 
Figure 1 considers pre-launch investment, speed (time to market), scale (time to production 
volume), and post launch innovation expenditures. 
 
----------------------- 
INSERT FIGURE 1 
----------------------- 
 
Organizational processes are composed of inputs such as information, a 
transformation process that utilizes inputs to convert them into something of value, and 
outputs such as products or services (Simons, 1999). Innovation processes are organizational 
processes. Davila et al. (2009; 2006) explained that innovation is not a monolithic 
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phenomenon but various processes that coexist, each one requiring different types of MCS 
and that the main goal of the innovation process is to move promising ideas from concept to 
commercialization with speed and minimum use of resources.  
The most innovative organizations excel not just at generating ideas, but in the set of 
capabilities necessary to transform their ideas into profits. For example, Markides (1997) 
studied the case of Canon which in the 1960s was a camera manufacturer that decided to 
enter the photocopier market, at the time dominated by Xerox. However, by the 1980s, 
despite strong attacks by rivals such as IBM and Kodak trying to penetrate this market 
without much success, Canon with its innovative capabilities emerged as a market leader. A 
more recent example by Dedrick et al. (2007) is the introduction of the iPod, which in 2001 
was not the first integrated portable music player. The market had a combination of new 
technologies such as MP3, small hard drives, and flash memories which made it possible to 
store music rather than carry CDs or tapes. Nonetheless, Apple innovative technology 
combining capability allowed them to put together existing technologies so as to capture 
consumer interest and to become a commercial success. These sorts of companies are 
successful in implementing the innovation process. Figure 2 illustrates the complete process 
defined by its stages: idea generation, idea selection, project execution, and 
commercialization (Davila et al., 2006). In the literature, there is a general agreement on the 
stage nature of the innovation process with variations on the number of stages  (Dougherty & 
Heller, 1994). However, the literature addresses the innovation process as linear, although in 
reality the ideas and projects move in non-linear cycles referred to as a set of concentric 
circles that flow through the process (Kaufmann & Tödtling, 2001). Each of the stages 
requires active MCS to execute and transform the distinct inputs into the output on its way to 
the next stage, the process could be seen as a funnel flow from many ideas to a few that reach 
market commercialization (Davila et al., 2009; Davila et al., 2006).  
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----------------------- 
INSERT FIGURE 2 
----------------------- 
 
3.2.3. Organizational Structures for Radical Innovation 
Simons (1987; 1999) stated that, in order to perform, firms need to define a strategy 
(e.g. to generate incremental or radical innovation), and once a strategy is defined firms must 
decide how to organize individuals and resources to execute such a strategy. Organizations 
are comprised of individuals who work together to perform specific functions that are 
monitored and controlled by MCS. MCS are important for organizations because MCS must 
be aligned with the underlying organizational structure to monitor and control organizational 
performance (Simons, 1999). We recognize from previous literature that individuals at 
organizational structures can have multiple roles and that it is unlikely that one individual 
will be the sole contributor to a project’s outcome, but rather a cross-functional organization 
(Day, 1994; Leifer et al., 2000). Abernethy and Brownell (1997) studied a broader approach 
attempting to measure the performance of organizations by studying organizational goals 
contingent to organizational structures. Their findings suggest that organizational goals can 
be reached if there is an appropriate functional organization.  
Scholars such as Benner and Tushman (2003), Campbell et al. (2003) and Kanter 
(1985), have identified aspects of organizational structures based on the goal to generate 
innovation. They argue that the organizational unit responsible for radical innovation must be 
physically separate from the mainstream organization that is under stress to deliver 
immediate results. Heller (1999) makes references to case studies that have presented 
evidence that physical separation at the project level may work for a time but that complete 
isolation may be counterproductive since the purpose of a radical innovation process is to 
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leverage current organizational competences. Consequently, the interface between innovation 
centers and the rest of the organization is important and isolation of the innovation center 
from the rest of the organization can hinder the generation of radical innovation. 
Ettlie et al. (1984) conducted research on firms’ organizational structures for 
generating radical and incremental innovation. Their findings suggest that when generating 
radical innovation firms require a specifically defined project organizational structure on a 
case-by-case basis, while a more traditional-standard organizational structure tends to support 
incremental innovations. Furthermore they propose that incremental innovation projects tend 
to be promoted in large, decentralized organizations with low top management involvement. 
While for radical innovation a central organization and greater support of top managers is 
necessary. Argyres and Silverman (2004) went further to unveil the organizational 
competency to acquire technological knowledge, by analyzing centralized vs. decentralized 
R&D structures and the type of innovation they produce. These scholars suggest that, 
centralized R&D organizations will generate innovations that have a larger and broader 
impact on subsequent technological evolution than will a decentralized R&D organization. 
O’Connor and DeMartino (2006) conducted research on organizational structures at 
large established firms seeking growth through radical innovation. They found that in order to 
generate radical innovation firms need to evolve their innovation capabilities, and for this to 
happen firms need to make their organizational structures adjustable mechanisms that can 
adapt depending on specific project requirements. This dynamic capability exposed to the 
high-uncertainty of radical innovation requires processes that need to be constantly attended 
by individuals within the organization. If this is not done the innovation competence of the 
firm will be diminished (Eisenhardt & Martin, 2000). Therefore, a clear set of roles and 
responsibilities is required for individuals to effectively sustain the organizational effort of 
generating radical innovation (Amabile, 1998; Jørgensen & Messner, 2010; O'Connor & 
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DeMartino, 2006). Organizational capabilities also play a key role in developing radical 
innovation. Based on Eisenhardt and Martin (2000), organizational capabilities allow firms to 
transform knowledge into value for the firm. Organizational capabilities involve a complex 
combination of organizational roles (O'Connor, 2008). The direct role in managing 
individuals for radical innovation projects was studied by Kelley et al. (2011) suggesting that 
managers use performance-based metrics to select and interact with innovation project 
individuals. 
From a sociology perspective, Mouritsen (1999) develops the concept of the “Flexible 
Firm” as a firm committed to lateral relations, customer orientation, new technology and 
innovation. Brown and Eisenhardt (1997) describe a flexible firm, as one with the ability to 
enable change and undertake emergent opportunities but that can also prevent chaos. 
 
3.3. Research Design and Methodology 
The literature on management of innovation has been developed mainly either at the 
firm level (Birkinshaw et al., 2008a) or at the project level (Burgelman & Sayles, 1988; 
Dougherty & Heller, 1994; Jelinek & Schoonhoven, 1993; Kanter et al., 1990; Leifer et al., 
2000). Davila et al. (2009) argue that deeper case studies at the project level can unveil 
insights on new topic areas such as the emergence of MCS, processes, and organizational 
structures as enablers of radical innovation. Consequently, we chose a case study focusing on 
the process level to study the MCS, and organizational structures that can generate radical 
innovation. We are aware of the limitations on lack of generalization and non-universal 
validity of case studies. However, this approach is especially appropriate in new topic areas 
(Eisenhardt, 1989). As suggested by Ahrens and Chapman (2006) and performed by 
McCutcheon and Meredith (1993) through a descriptive exploratory case study, we analyze 
and try to understand the process, MCS, and organizational structure to generate radical 
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innovation. We obtained an understanding of what the organization does and the reasons for 
acting in particular ways. Our findings follow a narrative approach. Critics of narratives often 
consider this method purely “storytelling”. However, a scientific narrative serves as a 
reference framework that potentially can be reinterpreted and which can become relevant to 
other settings (Llewellyn, 1999). To conduct our research we also took into account a practice 
theory perspective applied by Ahrens and Chapman (2007) and Jorgensen and Messner 
(2010) to study the linkages between NPD and MCS.  
We chose Alcan EP, a division of Rio Tinto Alcan Group, as our unit of analysis due 
to their systemic Open Innovation26 approach delivering radical innovations to the market. In 
2007, Alcan EP was recognized as an innovative firm by the University of St. Gallen’s 
Technology Management Transfer Center (TECTEM) in Switzerland. Alcan EP was selected 
as one of the top five companies to demonstrate its status as a successful enterprise for 
practicing innovation management. The benchmarking survey of 63 European companies 
ranked Alcan EP as one of the leaders. The other companies that ranked in the top five were 
IBM Research, Lufthansa Technik GmbH, F. Hoffmann-La Roche Ltd. and Volkswagen AG. 
The award recognizes the progress Alcan EP made to meet its goals for profitable growth 
through innovation. Furthermore, in 2008 Alcan EP decided to adapt its organizational 
structure and set up an innovation support unit dedicated to radical innovation referred to as 
Alcan Innovation Cells (IC), which assists the different BUs to develop their radical ideas 
into projects that could evolve into actual products to be commercialized. We were 
particularly interested in this dedicated radical innovation unit as studies have shown that 
specific dedicated units can be advantageous to foster radical innovation, because they are not 
subject to the short term result orientation that BUs have (O'Connor & DeMartino, 2006).  
                                                 
26 Chesbrough’s 2003 definition of open innovation: “a paradigm that assumes that firms can and should use external ideas 
as well as internal ideas, and internal and external paths to market, as they look to advance their technology. Open 
Innovation processes combine internal and external ideas into architectures and systems”. 
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To exemplify the radical innovation outcome of Alcan EP, we present some examples 
of the latest radical projects. The “Aluminum Foam” project involves a food process external 
partner to produce dough with a mix of salt, flour, water and aluminum. The final application 
is to produce high efficient heat exchangers offering superior heat transfer capacity with less 
volume and weight. Another example of radical innovation is “Smart Material” with the 
vision to revolutionize the aerospace industry by providing materials that could be used for 
airplane wings allowing these to change shape adapting to flight conditions, thanks to an 
electromechanical interaction between the mechanical and the electrical state in crystalline 
material state. These materials can also “heal” themselves after they crack, thanks to 
integrated capsules able to sense their environment and adapt their mechanical properties 
accordingly.  
We were involved in a project carried out as part of a university program to develop 
new markets, technology, services, business models and applications. The research was 
conducted through active interaction with Alcan EP for six months, and two follow up rounds 
of interviews over a two-year period. We used four research methods: interviews, analysis of 
internal documents, observation of processes, and study of public records. We first researched 
the antecedents of Alcan EP, studying documents and formal reports used to manage radical 
innovation. We also examined external public available documents, including annual reports, 
stock analyst reports, press releases, public statements, and public presentations by top 
management. The case study exploration research methodology requires proximity to the 
field (Garfinkel, 1994). Therefore we visited operational units and innovation support units to 
get better access to the organization. There were meetings and frequent informal discussions 
with company managers. Eleven key participants were selected to be interviewed from 
corporate offices, central R&D, BUs, innovation center, and external partners (see Table 1). 
The interviewees were chosen to meet the objectives of the research to gain a comprehensive 
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understanding of the organizational structures, managerial roles, MCS, and processes 
involved in generating radical innovation. In all, a total of 18 interviews were completed. We 
employed a methodology where qualitative semi structured interviews were conducted 
utilizing a questionnaire (see Appendix). All interviews began with open-ended questions 
addressing the strategic reasons for Alcan EP to generate radical innovation, and the process, 
MCS and organizational structure utilized to manage radical innovation.  
  
----------------------- 
INSERT TABLE 1 
----------------------- 
 
3.4. The Case Study 
3.4.1. The Company 
Rio Tinto is one of the world's leading mining conglomerates with aluminum, gold, 
copper, diamonds, energy products, minerals and iron ore extraction and transformation 
activities. Rio Tinto Alcan Group is responsible for managing the aluminum business, and it 
is a leading global materials company with 68,000 employees operating in 61 countries. It 
provides innovative materials and technology worldwide through four divisions: Bauxite and 
Alumina, Primary Metal, Engineered Products and Packaging. Figure 3 illustrates the 
corporate organizational structure and our unit of analysis. Alcan Engineered Products (Alcan 
EP) manufactures engineered materials and solutions for a wide range of industrial sectors, 
including aerospace, automotive, mass transportation, building and energy. It has 15,000 
employees located in 34 countries. Alcan EP is an innovative global leader in most of the 
markets it serves (see Figure 4), offering a variety of category leading brands for the display 
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and graphic arts, construction, wind energy, marine and other transportation markets. Alcan 
EP is composed of operational business units (BU) dedicated to produce materials such as 
aluminum rolled products, aluminum extrusions, aluminum cable, composite products, and 
automotive and aerospace components. Alcan EP is headquartered in Paris, France and has 
two innovation support units, a corporate central R&D organization referred to as Technology 
& Innovation (T&I), responsible for R&D and technology development for long term future 
business growth employing over 300 researchers in two facilities in Neuhausen, Switzerland, 
and Voreppe, France. The second innovation support unit is Innovation Cells (IC) which was 
created in 2008. At that time Alcan EP identified that in order to grow and create more value 
they needed to organize differently, especially to generate radical innovation. T&I has 
traditionally delivered innovations related mainly to alloy development and surface finish. 
Alcan EP management realized that to embark on radical innovation new links and 
partnerships would have to be developed with research institutes, consultants, and companies 
from unrelated business sectors and it was conscious that T&I didn’t have the capacity to 
develop such strategic partnerships. Furthermore, Alcan EP was advised by consultants that 
to generate radical innovation, the company must have a dedicated unit to produce radical 
innovation and that such a unit must be physically separate from the mainstream organization 
to avoid a short term vision. Consequently, Alcan EP established its radical innovation unit 
(i.e. IC) at the Science Park “Parc Scientifique” (PSE) of the École Polytechnique Fédérale de 
Lausanne (EPFL). IC facilitates complementarity between Alcan EP units and EPFL through 
an open innovation approach. IC is composed of a multidisciplinary team where commercial, 
business development, technical, and scientific experts work together to deliver market-ready 
prototypes and innovative business plans in small timeframes. IC main services comprise 
materials engineering, innovation management, and NPD. Figure 5 represents the scope of 
Alcan IC services.  
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Two operational BUs participated in this research, Alcan Composites (Composites) 
and Alcan Specialty Sheet (SSH). Composites develops advanced technologies and combines 
lightweight materials such as aluminum, paper, plastics and balsa wood into a unique and 
broad range of aluminum composite materials. On the other hand SSH is a leader in the 
aluminum rolling industry, serving markets such as beverage cans and closures, automotive, 
customized industrial sheet solutions including high quality functional surface products. An 
example of their innovative products is Alcan SSH solar surface products underlying Alcan's 
concern for the environment. These products are designed for a variety of solar applications, 
such as parabolic mirrors that capture solar energy and portable solar cookers. These products 
are produced at the rolling mill at Alcan Singen, Germany, which has established a solid 
reputation in many product areas most notably in the area of high-gloss surfaces for the 
lighting and cosmetic industries. 
Throughout 2010 Rio Tinto decided to restructure Alcan EP as of early 2011. This 
initiative resulted in merging Engineered & Automotive Solutions with Extruded Products. 
The new unit, along with Global Aerospace, Transportation and Industry and Specialty Sheet 
reports to Alcan EP, which, in mid-2011, became Constellium with a stronger vision towards 
radical innovation. The Cable unit is for sale under Rio Tinto Alcan Group, and Composites 
was sold and became 3A Composites, a division of the Swiss Schweiter Technologies Group.  
 
----------------------- 
INSERT FIGURE 3 
----------------------- 
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----------------------- 
INSERT FIGURE 4 
----------------------- 
 
----------------------- 
INSERT FIGURE 5 
----------------------- 
 
3.4.2. Alcan Management Systems and Performance Measurement 
In 2004 Rio Tinto Alcan Group introduced the Alcan Integrated Management System 
(AIMS), comprised of three key corporate building blocks: Value-Based Management, 
Environment Health and Safety (EHS FIRST), and Continuous Improvement. These blocks 
are aligned into an integrated business management system with the objective of maximizing 
value. Value-Based Management is the basis for all strategic investment decisions and value-
generating initiatives worldwide. It enforces rigorous financial discipline, allowing BUs to 
fully identify and capitalize upon opportunities and make the best use of all available 
resources. EHS FIRST incorporates the common standards, procedures and a mindset for 
achieving excellence in environment, health and safety performance for the benefit of their 
employees and for the communities in which they operate. Continuous Improvement aims at 
maximizing opportunities by improving the company’s competitiveness and efficiency. 
Incremental innovation initiatives run through the Continuous Improvement program 
combining two complementary approaches – Lean Manufacturing and Six Sigma – providing 
a full range of tools for their businesses to choose the most appropriate techniques for each 
incremental innovation project. We observed that AIMS is the management system platform 
from which strategic planning, innovation funding, performance measurement, and incentives 
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and reward systems are deployed through the organization. However, according to our 
interviews AIMS induced mainly incremental innovation opportunities represented by minor 
changes to existing aluminum alloys or merely an extent of the current metal surface 
finishing. Consequently BUs such as Composites developed their own management system 
for radical innovation. 
At Composites, an example of a management system to support both incremental and 
radical innovations is the Innovation Management at Composites (im@c), which gets 
executed over a collaborative online tool that allows real-time sharing of incremental and 
radical project information. The im@c establishes secure access through an encrypted virtual 
private network, this secure access allows to control the rights to view or edit a specific 
project by the different members collaborating in the team. Composites also utilize electronic 
Internet tools to facilitate global dispersed teams to work simultaneously and to document, 
and reuse the output from team sessions. In addition they provide telephone conferencing for 
verbal communication, and public or private chat. These electronic tools ultimately assist 
individuals to review team calendars, team member capabilities, access databases, and review 
project status displays.  
In terms of planning management systems, Composites utilizes an Innovation 
Roadmap showing innovation market fields, technologies and organizational competences. 
The roadmap also captures market insights, allowing Composites to better understand current 
and future customer needs. Composites maps out innovation projects to define the next 
multiple years of new initiatives and keep track of budgets and development timelines. 
Through Innovation Roadmaps Composites match short-term and long-term goals with 
specific technology and market solutions. Roadmaps also facilitate decision making about 
resources required to reach specific milestones, provide a mechanism to help forecast 
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technology developments, and render a framework to help plan and coordinate technology 
developments. 
 
“For each of our business units there is a specific Innovation Roadmap that functions 
as the basis for future planning regarding products, markets, technology and competences. 
The innovation roadmaps are reviewed every year and adjusted according to external market 
conditions and internal organization circumstances, allowing the flexibility to capture viable 
opportunities”.  
Director Technology & Innovation, Alcan Composites. 
 
Through our observations we consider performance measurement as a key element for 
radical innovation. IC utilizes two comprehensive sets of measures to indicate their radical 
innovation progress. These are linked to the input and output of the innovation process. For 
the input it is the number of “good ideas27” that are being generated and for the output the 
profitability of radical innovations being commercialized. At IC they also acknowledge that 
each project is different and they adjust the development stages on a case-by-case basis. 
However their goal is not to exceed six months between the project setup and handing over 
the project to the BU (see Figure 6). 
At Composites they indicated that a significant portion of their organic growth was 
derived from new products introduced within the last five years and that regarding 
performance metrics for the innovation process, development cost and cycle time are the 
most commonly tracked measures. However, there are other metrics that apply more 
specifically to radical innovation such as percentage of revenue from radical innovation, sales 
                                                 
27 Good ideas need to present initial production feasibility through a simulation, a trial, or a prototype and have an important 
market potential. Should these criteria not be met, then the idea is considered “not a good idea”. 
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margins, time to market, R&D expenditure as a percentage of sales, and number of radical 
ideas.  
SSH innovation performance measures indicate increased productivity that will result 
in improved profitability. Innovation performance metrics enable SSH to make timely and 
educated financial decisions. They track gross margin, total portfolio value, and the number 
of patents filed annually.  
 
“Alcan Specialty Sheet is looking to develop a broader innovation program to 
facilitate radical innovation without requiring the degree of business case and ROI rigor 
required for larger investments. An important consideration for us is to ensure not to be 
overly dependent on processes to the point that the process becomes the end itself. Instead, 
the concrete commercial success of a new product launch should always be the ultimate 
performance metric”.  
Director Strategy & Innovation, Alcan Specialty Sheet 
 
----------------------- 
INSERT FIGURE 6 
----------------------- 
 
3.4.3. Incentives and Rewards 
In its effort to achieve organizational alignment, Alcan EP employs performance 
measurements linking strategic goals with innovation objectives to drive their personnel 
towards innovation. Alcan EP does not consider innovation as a separate function but rather 
part of its overall strategy. The company states that alignment to the business goals is a key 
success factor in meeting innovation objectives. Additionally, Alcan EP recognizes teams as 
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well as individuals by offering a performance based compensation. Each employee has an 
individual performance management plan that defines goals and deliverables that must be 
accomplished during the year. There are competencies to be developed such as acting upon 
opportunities for change and innovation with scales from one to five where managers can 
assess the employee’s contribution to innovation. Each employee then has performance 
reviews that are quantifiable and depending on this evaluation employees are eligible to earn 
a financial bonus compensation.  
In terms of intrinsic non-financial stimulus, Alcan EP promotes the Alcan “Thank 
You” Award. This award represents the highest tribute to individual employees or teams of 
employees in three categories: Environment Health and Safety (EHS First), Customers-
Innovation-Growth, and Operational Excellence. Employees nominate candidates and a 
committee composed of cross-functional members assigns the gold, silver and bronze awards. 
Alcan EP believes that through the Alcan “Thank You” Award, the company can further align 
the organization to its innovation goals. 
 
3.4.4. Process for Radical Innovation 
To manage both incremental and radical innovation, Composites’ im@c management 
system distinguishes between incremental and radical ideas and it processes them differently. 
For an incremental innovation (i.e. SMARTinno) and for a radical innovation (i.e. RADinno) 
(see Figure 7). im@c explicitly recognizes that it needs to follow a different approach when 
processing incremental and radical innovation, hence avoiding a “one-size-fits-all” process 
that can almost guarantee a sub-optimization of resources. We observe that through MCS 
based on market and technology uncertainties Composites assess the idea to identify if an 
innovation is incremental, which means that it needs to have low complexity, existing market 
accessibility, and minor adaptation of existing products and processes. In contrast a radical 
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innovation has high technical challenges, undefined market access, and challenging 
development of new radical processes, products, and services. Composites developed an 
adaptation of its incremental stage-gate process SMARTinno for processing RADinno radical 
innovations. The first quality gate (QG1) is the same for all ideas. At this gate it is determined 
if the idea should follow the incremental path, the radical route, or whether it is a non-
innovative non-viable idea. From that point forward the quality gates for SMARTinno (QGS) 
and RADinno (QGR) are different. In QG1 the criteria includes the maturity of the idea being 
developed. It may be a quick short-term win, or it may a future attractiveness in terms of 
market size and growth. As the focus of this research is radical innovation we now describe 
the next gates applied exclusively to the radical innovation quality gates (QGR). At QGR2 
the factors that influence whether a project obtains the go-ahead are long-term profitable 
market growth, and compatibility with the product portfolio strategy. The next gate is QGR3 
where feasibility, technical specification, and customer benefits are verified. At QGR4 the 
technical specifications are determined, there is a feasibility market and product introduction 
plan, and an attractive strategic position is confirmed. The last quality gate is QGR5 where 
the customer feedback needs to be positive, cost calculations are verified, the documentation 
for industrial production is defined and the market introduction plan is finally completed. 
 
----------------------- 
INSERT FIGURE 7 
----------------------- 
 
Taking the theoretical innovation process framework from Davila et al. (2006) as a 
reference we describe in the following sections the four stages of the innovation process (i.e. 
idea generation, selection, execution, and commercialization). By adapting the four stages to 
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our observations at Alcan EP radical innovation generation, we document insights and 
observe similarities to literature on technology and innovation management. 
 
3.4.4.1. Idea Generation 
T&I has a management system for innovation called “Step Change Program”. It is 
within this management system that a program for the idea generation stage resides, defined 
as Ideation. T&I captures ideas from two venues: firstly, via employee innovation scouts from 
the BUs who are individuals with formal training within the organization and have a 
technology and product application background; secondly, through “Kaffe Kreativ” sessions, 
in which individuals meet in a relaxed atmosphere to brainstorm ideas with the philosophy of 
not discarding any idea at this stage. Participation in these sessions is not only reserved for 
Alcan EP employees, but also external partners are invited to participate. These two 
approaches, a formal rigid one (i.e. innovation scouts) and a more relaxed creative 
brainstorming one (i.e. “Kaffe Kreativ”) represent a balance between rigidity and creativity 
for idea generation. 
 
“Alcan identifies that being too strict on the idea generation stage of the radical 
innovation process, can be the exact wrong approach when trying to foster and create radical 
innovation. That’s why we try to balance rigidity with creativity”.  
Director Corporate Technology & Innovation 
 
The idea generation stage utilizes several enablers. The process begins when an idea is 
submitted to the administrator of T&I. Then the idea is stored electronically on the online 
database tool for IDEATION, specifying what the idea is, what the target market is, and how 
it works. Once an idea is entered into IDEATION, T&I processes it further to assess 
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feasibility for market and technology proof of viability. T&I develops an initial budget and 
defines objectives and its organizational structure such as a cross-functional team formation. 
T&I also develops a project plan defining resources such as time, cost, headcount and 
strategic decisions including marketing, regulatory framework, operations, and project risk. 
The idea is approved in the system by changing its designation from idea to project. All 
project information is available online for individual team members to access and so that it 
can be further refined. T&I can also transfer the project to the BU directly in case the project 
is incremental, or to IC if the project is considered a radical innovation.  
T&I encourages its technical personnel to get a closer view of existing and new 
customers and end-users. T&I is increasingly involved in meeting customer needs, and in 
some projects technical personnel attend sales meetings. The value of collaboration and 
interaction with existing customers has been recognized for idea generation. However, this 
interaction has been more productive for incremental ideas than for radical ones. 
Consequently, for radical idea generation the organization goes beyond existing customers to 
establish partnerships with external collaborators. This matter will be explained further on in 
section 3.4.4. i.e. Organizational structure for radical innovation. 
 
3.4.4.2. Selection of Radical Projects 
As part of the selection stage for radical projects the more important items considered 
are strategic alignment, market size, growth potential, and unique fit to the organization. This 
last item means that Alcan EP has to identify its unique competitive advantage against its 
competitors before deciding to select a particular radical innovation project. The uniqueness 
can be in terms of manufacturing capabilities, markets where the firm operates, or intellectual 
property protection. To select projects Alcan EP utilizes both quantitative and qualitative 
metrics (see Tables 2 and 3). The qualitative selection criteria for radical ideas include a set of 
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principles. One such principle is that for an idea to fit Alcan EP’s strategy that idea should not 
be a new market for an existing product, and there should be proof of concept at least at 
laboratory scale. On the other hand the quantitative selection criteria for radical ideas include: 
market attractiveness (size and growth), required investment, time-to-market, and, 
commercial and technological feasibility risk assessments. Interestingly, it is in the selection 
stage that the CEO of Alcan EP participates more actively providing input and direction.  
When selecting radical innovations SSH assesses projects with additional qualitative 
and quantitative criteria. In addition to the corporate Alcan EP criteria, SSH qualitative 
metrics include the strategic significance in terms of the balance of power against its 
customers, meaning that for certain radical innovations such as specialty sheets for solar 
collectors, the entry barriers for customers to manufacture aluminum sheets is prohibitive due 
to the high investment required to setup an aluminum rolling mill. The presence of entry 
barriers helps a radical project to get selected and move into the next stage. On the other 
hand, SSH quantitative criteria rank radical project opportunities according to net present 
value. 
 
“MCS are important because in our innovation efforts, we usually start with an 
abundant number of ideas, more than can be executed, and Alcan needs MCS to select which 
ideas to pursue. Without MCS, innovation efforts become ineffective demoralizing the 
organization”.  
Director Corporate Technology & Innovation. 
 
----------------------- 
INSERT TABLE 2 
----------------------- 
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----------------------- 
INSERT TABLE 3 
----------------------- 
 
3.4.4.3. Execution 
Once a project passes the selection stage, a project team is assigned to develop the 
project into a market-technical tested product offering. To execute radical innovation IC 
involves several project stakeholders including individuals from T&I, BUs and external 
partners on a fully dedicated or part-time basis. Functional areas include sales, R&D, finance, 
marketing, purchasing, and manufacturing. The project team is responsible for working on 
marketing and technical details of the radical project to reduce project uncertainties. 
There are formal monthly assessments to evaluate marketing and technical progress. 
At IC there is a rigorous assessment of every project to be on-time and on-budget. Any 
project that creates a new business platform, replaces a major existing product, involves an 
acquisition, license, alliance, or partnership, must apply the Innovation Cells Project 
Guidelines, in which project progress is milestone-based. Funding continues upon 
performance and deliverables of market and technical feedback.  
The market and technical project tasks include evaluation of existing intellectual 
property such as patents, publications, and trademarks. The project team also determines the 
target market and considering that Alcan EP products are mainly business to business, the 
team identifies who are the decision makers and influencers in the purchasing process. To do 
this the individuals in the project team are required to interact with target customers and 
competitors by attending conferences and tradeshows that can provide information to 
estimate the selling price and generate preliminary knowledge for the commercialization 
strategy. There are other considerations related to the high volume manufacturing scale up 
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production, such as defining the process in which the product can be manufactured in a cost 
effective way, proving technical feasibility through simulation or prototypes, and specifying 
engineering operations planning, department scheduling, and supplier value chain. Once the 
radical project team has this information the project team can calculate profitability and 
breakeven point scenarios more accurately. 
In case core metallurgic competences are required to minimize the technology 
uncertainty, T&I is engaged early in the execution stage. In these situations T&I will lead the 
project execution, and be responsible for executing the technical challenge, project definition, 
prototyping, project timeline, and product development. In case the BU and T&I require 
support from corporate resources to further address the market uncertainty IC can assist with 
commercial and business development capabilities.  
 
“Alcan Innovation Cells can help BUs execute radical projects by defining risk 
management plans, and conducting formal design reviews including demonstration of 
technical feasibility and commercial-financial viability”.  
Managing Director, Innovation Cells 
 
3.4.4.4. Commercialization  
Kelm et al. (1995) conducted research on commercialization of innovation and 
determined that during the commercialization stage the cash flow resulting from NPD is less 
dependent on a firm's technological capability, but rather on whether the firm is commercially 
appropriately positioned to take advantage of the new product or service. At this stage firms 
determine the right time to launch the product to market (Leifer et al., 2000). Moreover, when 
commercializing radical innovation firms tend to initiate sales within niche markets before 
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the innovation can be successfully commercialized in broader markets (Christensen, 1997a, 
b).  
At Alcan EP, during the commercialization stage the marketing department prepares 
marketing and communication materials (e.g. brochures and website), the sales team gets 
trained and if applicable training is extended to distributors and subcontractors. Meetings are 
held at major potential clients to validate sales forecast and pricing.  
IC participates as part of the team to develop the commercial implementation plan, 
scale-up, and launch preparation. It goes as far as identifying the marketing and sales human 
resources gaps that the BU has and proposes potential candidates for sales functions. IC is 
also responsible for identifying and testing the primary target costumer group along with 
specifying the breakdown of the early adopters and heavy users. IC in a case-by-case basis 
engages with market opinion leaders to increase the probability of new product adoption by 
influenced buyers. A key aspect during this stage is that the company has to decide on an 
action plan for introducing the product and IC assists the BU to develop a viable marketing-
sales plan and to create a respective marketing budget. Its objective is to build value for 
customers and deliver it through differentiated branded offerings. 
At the commercialization stage BUs and IC identify the right time to introduce the 
new product or process, BUs have to manage internal conflicts with existing product lines as 
there is danger of cannibalizing existing sales. Furthermore, timing is also influenced by the 
state of the economy or the financial condition of target customers. Another key aspect of this 
stage is the location where the product will be launched. Alcan EP BUs cater market 
segments with concentrated few large industrial customers operating globally. However BUs 
also serve a disperse smaller size clientele. The target customer and location decision is also 
influenced by the BU operational and distribution capabilities, as well as financial resources 
and competitive position on the target market. In cases in which Alcan EP developed the 
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radical innovation with a key client, they follow a “leading-client” strategy, introducing the 
new product only to a single customer while both learn to process and commercialize the new 
product.  
 
3.4.5. Organizational Structure for Radical Innovation 
Our observations of the Alcan EP organizational structure presented differences for 
radical and incremental innovation. When generating radical innovation projects a centralized 
organization including T&I and IC is required, as well as support from top managers, while 
incremental innovation projects tend to be processed at the BU level (i.e. decentralized 
organization) with low involvement from top management. Moreover, Alcan EP has learned 
through past experience that it needs to have a mix of centralized and decentralized 
organization focusing on innovation around the company’s competences. In the early 1990s, 
T&I employees were in a corporate technology organization located in R&D headquarters. 
By the mid-1990s the company decided to decentralize their technology competence to a 
certain degree and placed engineers and scientists at the BUs. Nevertheless Alcan EP was still 
concerned about long term opportunities and decided to keep some T&I personnel as a 
centralized unit to avoid neglecting projects that would require a long term commitment.  
In order to determine the organizational structure and the unit that will lead an 
innovation project, Alcan EP takes into account two characteristics of the project: firstly the 
stage of development, and secondly the level of radicalness which determines whether the 
project remains within the decentralized BU or requires centralized support from T&I and IC. 
It is important to note that unless there is a recipient BU willing to adopt the innovation 
project, the project is considered to have a sponsor within the organization. If no BU 
undertakes a project, then the project gets registered as abandoned and no further resources 
are spent on it. This is different from other companies such as Nestlé when they developed 
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Nespresso. Markides and Oyon (2000) studied the Nestlé’s radical innovative idea to make 
coffee out of a capsule cartridge based on the work of a group of external engineers. At that 
time Nestlé decided to acquire the rights for that new technology, probably to prohibit any 
competitor from acquiring such innovation. The most relevant differentiation between Nestlé 
and Alcan EP in this case is that Nestlé decided to establish a separate BU (i.e. Nespresso) 
with full support from top management to tackle organizational resistance as Nespresso was 
seen as cannibalizing Nestle’s main products. They did this despite being challenged by 
entering a hardware market (i.e. Nespresso machines) and not having a well-established 
organization to generate radical innovate internally, or a BU willing to adopt the Nespresso 
project. 
In the case of Alcan EP, the company expressed that there is an important distinction 
between R&D (i.e. T&I) and innovation (i.e. IC). R&D aims at developing core material 
science and long term research, while innovation pursues radical innovation and 
commercialization of new products and services. Figure 8 represents our observations of the 
units involved. The horizontal axis in Figure 8 refers to stage of development, ranging from 
“Exploratory” to “Industrialization & Market Launch”. Exploratory means that R&D is 
exploring at the laboratory scale and the technology has not yet been demonstrated, while 
industrialization & market launch is a developed stage of industrialization, for instance 
prototypes are available and there is a viable commercial business case. The vertical axis (i.e. 
level of radicalness) refers to incremental projects such as a product extension or minor 
process improvement. Semi-radical innovations can be projects of major cost reduction or 
quality improvement, and in radical innovations new product categories are created. The 
important finding was that T&I and BUs were able to develop and launch products to market 
for incremental projects. However, for projects with a higher level of radicalness IC 
participates more actively to bridge core material science with market applications from BUs. 
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It is important to mention that during our interviews we were told that the central radical 
innovation unit (i.e. IC) needs to report to Alcan EP headquarters and not to an R&D support 
unit (i.e. T&I), because T&I tends to be risk adverse and lacks commercial capabilities and 
experience. 
In case of developing radical innovation, both corporate central innovation support 
units (i.e. T&I and IC) participate to address the technical and commercial challenge 
respectively. Specific individuals are assigned to teams and organized on the basis of the 
competences required for each radical project. The team then specifies the technical 
challenges, prototyping, project timeline, and product development. 
Brown and Eisenhardt (1995) studied the innovation process performance and its 
relationship to organizational structures including internal and external project collaborators 
such as project leaders, senior management, R&D, customers, suppliers, and external 
consultants. Similarly, Alcan EP employs a cross functional organization (see Figure 9). 
Alcan EP looks beyond their walls to find ideas and develop radical innovation, by fostering 
Open Innovation to broaden the sources of ideas, and to increase cooperation with academic 
and industrial partners. Alcan EP mainly utilizes external partners for the stages of idea 
generation and project execution, leaving selection and product commercialization to be 
executed within the company units. In Figure 9 the dark color indicates a high interaction by 
the corporate unit or external partner executing and leading a particular radical innovation 
process stage. A lighter color indicates a lower intensity, and the color white represents a low 
relationship. This organizational approach is referred to as the holistic sequential model 
(O'Connor & DeMartino, 2006) in which the scope of the organizational structure for radical 
innovation encompasses incubating radical innovation opportunities, and coaching these 
opportunities to evolve into commercially self-sufficient radical projects at the BUs. The term 
holistic sequential organizational model comes from the fact that the organization is 
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structured so that a project will pass from one unit leading the project to another one in a 
sequential way as the project develops through the process. 
External partnerships were observed during our study. For example, In 2008 Alcan EP 
signed a multi-year cooperation agreement with the EPFL in Switzerland, to help identify 
new ideas for growth and benefit from complementary competences for the development of 
new lightweight materials and solutions. Alcan has direct formal contact and access to 
researchers and their scientific knowledge. It also benefits from informal social access made 
possible only through the proximity of being on campus and having hired some EPFL 
graduates who are well connected to the EPFL. Furthermore, Alcan EP has access to 
laboratory equipment to perform trials or project simulations. An example of these external 
partnership interactions is the development of a unique process to produce aluminum foam, 
using salt dough by the mechanical metallurgy laboratory at EPFL. Alcan EP believed in the 
EPFL concept, and asked IC to lead the scale-up of the process from the laboratory low 
volumes to the factory full scale production. This project required participation of 
“unfamiliar” external partnerships from the world of food processing. For instance, IC 
entered into collaboration with a world leading manufacturer of pasta extruders to produce 
salt dough molds at an industrial scale. In this project IC designed the industrial process, 
identified partners, set up multiple collaborations, identified applications, and assessed 
market potential.  
 
“By being located at the EPFL we live in Open Innovation. Our connection to EPFL 
helps us stay informed of the latest scientific discoveries. And by working alongside other 
leading technology companies we’ve been exposed to many opportunities to explore radical 
projects through external collaborations”. 
Project Manager Innovation Cells 
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----------------------- 
INSERT FIGURE 8 
----------------------- 
 
----------------------- 
INSERT FIGURE 9 
----------------------- 
 
3.5. Discussion 
Davila et al., (2009) highlighted that the crossroad of MCS, organizational structures 
and innovation offered an important field of research opportunities to be explored, in 
particular at the process level. This research examined how an established firm develops the 
innovation process, MCS and organizational structure to generate radical innovation. The 
findings include employing a well-defined, disciplined and systematic process for radical 
innovation at Alcan EP. More importantly we found that radical innovation can be generated 
through enablers such as MCS, processes, and flexible organizational structures. We also 
found that incremental and radical innovation need to be managed through different processes 
(Davila et al., 2006) and by organizational flexible structures (O'Connor & DeMartino, 2006) 
that can adapt and activate contingent to the type of innovation that is being pursued (i.e. 
incremental or radical). In Figure 10, we present a new process architecture of an innovation 
process capable of managing both incremental and radical innovations. The model illustrates 
that within the process at the ideation stage a decision whether an idea is incremental or 
radical is taken, and that determines the incremental or radical path the idea takes as it 
matures into a project. By utilizing this process, a firm manages its innovation projects 
systematically, avoiding diluted resources in several unrelated projects and a one-size-fits-all 
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process that can almost guarantee a sub-optimization of certain resources (Davila et al., 
2006).  
Regarding blending qualitative and quantitative metrics we consider the literature by 
Werner and Souder (1997) in which they report integrating metrics combining quantitative 
and qualitative measures through an extensive search of the literature between 1956 and 1995 
finding this approach not only effective, but also complex and costly to develop and use. 
Integrated qualitative and quantitative methods of innovation evaluation enhance the 
advantages of both types of measurement. These provide information that can improve 
innovation effectiveness (Blau, 1995; Bosomworth & Sage Jr, 1995; Schumann Jr, Ransley, 
& Prestwood, 1995). Alcan EP blends qualitative and quantitative metrics. Particularly in the 
project selection stage these two types of metrics allow decision makers to utilize quantitative 
hard data results and qualitative business intuition inputs into the variables that will 
determine the radical projects that will be selected. This is consistent with literature on 
qualitative and quantitative evaluation criteria for formal portfolio project selection (Cooper, 
Edgett, & Kleinschmidt, 2001). 
We also noticed at Alcan EP that radical innovation requires more time to develop as 
both technology and market uncertainties increase with the degree of radicalness, influencing 
development time (Abetti, 2002). Furthermore, Laurie (2006) argued that the planning 
horizon for radical NPD is significantly longer as there are more hurdles to come across 
before the product gets commercialized.  
During our study at Alcan EP we detected conflicts and tensions among individuals in 
the project team. Similar to Takeuchi and Nonaka (1986), we observed these conflicts and 
tensions tend to arise when radical projects “changed hands”, in other words when T&I 
handed over a project to IC, or IC to a BU. The project individuals or units did not always 
agree on the level of development of the deliverables. There were also other tension and 
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conflict considerations such as budget constraints, cost allocation, and discrepancies on 
delimiting the scope or goal of a project. We also perceived conflicts and tensions when the 
organizational structure tried to integrate units, defined the division of labor, and determined 
project ownership and accountability. Under these circumstances Alcan EP top management 
played a major role to reduce and mitigate these organizational conflicts and tensions through 
making a final determination in case the participating project units could not reach an 
agreement or reconcile different interests or points of view.  
Quintana-García and Benavides-Velasco (2011) analyzed configurations of innovation 
partnerships influencing product innovation. Their evidence highlights the importance of 
collaborating with key partners through R&D partnerships to develop innovative 
competences. Similarly, Alcan EP develops partnerships with academic institutions and 
innovative companies that have the technology or market competences that are needed for a 
particular radical project. One example is 3M which works with Alcan EP to develop 
advanced surface finishing for lightweight materials. Alcan EP is aware that entering into 
external partnerships can create additional challenges and risks in terms of loss of control or 
intellectual property ownership. Therefore, it will only enter into partnerships if there is a 
clear lack of competences within their organization to develop a specific radical project.  
We also found that to generate radical innovation the role of a corporate innovation 
unit (i.e. IC) is different from that of an R&D unit (i.e. T&I). Their participation and 
involvement as leading radical innovation support unit is contingent to the degree of 
radicalness and the technology development stage. We also observed that Alcan EP leans on 
R&D for exploratory science, while Alcan EP depends on BUs development capabilities for 
technology proven prototypes. Only when a project is considered to have a high level of 
radicalness does IC initiate their involvement. This organizational structure framework 
supports Ettlie et al.’s (1984) research on organizational structures for radical innovation as 
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they proposed that when generating incremental innovation and development stage is 
advanced, organizations utilize decentralized organizations (i.e. BUs). For radical innovation, 
a more central R&D and innovation corporate support units are required. 
In terms of future research, we identified that the role of project leadership and 
organizational structures can be an important factor to generate radical innovation. This line 
of research was recently developed by Lin and McDonough (2011), and Kelley et al. (2011). 
Consequently, investigating the role of leadership and organizational structures at the process 
level can provide further insights on enablers of radical innovation.  
 
----------------------- 
INSERT FIGURE 10 
----------------------- 
 
3.6. Conclusions 
Our research leans on the perspective that management of radical innovation 
constitutes a dynamic capability which fundamentally represents a firm’s ability to exploit 
and develop resources and processes that create and capture value, while operating in rapidly 
changing technological environments (Eisenhardt & Martin, 2000; Teece et al., 1997; Zahra, 
Sapienza, & Davidsson, 2006). Moreover, our study on Alcan EP focuses on the development 
and utilization of processes, MCS and organizational structures as a source of dynamic 
capabilities to generate radical innovation via internal knowledge exploitation or external 
knowledge exploration through an open innovation approach. The observed interaction 
between Alcan EP and external partners such as EPFL, consultants, and other companies in 
the value chain reinforces the complementarity that can be found on external partnerships 
described by Cockburn and Henderson (1998), and Cassiman and Veugelers (2002), 
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advocating for external partnerships complementing internal innovation capabilities, which 
allows established firms to get better access to new technologies and markets. 
We found that when generating radical innovation, the organizational structure at 
Alcan EP is flexible depending on the kind of innovation project (i.e. incremental or radical) 
as suggested by Chandler (1962) who stated that organizational structures evolve to fit 
company strategies. Similar to O'Reilly and Tushman (2011), Chandy and Tellis (1998), and 
Teece (1986), we observed that in order for Alcan EP to generate radical innovation, an 
organizational structure adaptation is required to cope with technology and market 
uncertainties. Furthermore, supporting Benner and Tushman (2003), Campbell et al. (2003) 
and Kanter (1985) we observed that at Alcan EP, the organizational unit responsible for 
radical innovation (i.e. Alcan Innovation Cells) was physically separate from the mainstream 
organization. However, in line with Heller (1999) IC maintains strong links and an active 
interface between them and the rest of the organization. 
This research is also in line with innovation management that has been defined as the 
implementation of management processes, structures, or techniques intended to generate 
innovation and reach organizational goals (Birkinshaw et al., 2008a). Our findings allow us to 
explain the different approaches of the innovation process, in which in order to optimize 
resource allocation and outputs, incremental and radical innovations need to be managed 
through different processes, MCS, and organizational structures. Otherwise as described by 
Davila et al. (2006) by processing incremental and radical innovation projects through the 
same “one-size-fits-all” innovation process, firms can almost guarantee a sub-optimization of 
certain resources.  
Cabello-Medina et al. (2011) also performed research on organizations generating 
innovation. Their study focused on the prevailing “simplistic” belief that MCS hinders 
innovation. However, their results show that the relationship between MCS and innovation 
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performance is positive when innovation radicalness is high. Our observation at Alcan EP 
supports these results as both MCS and processes are needed to generate radical innovation. 
Moreover, Alcan EP has an institutionalized process for radical innovation making an 
argument in line with Jelinek and Schoonhoven (1993) that radical innovation cannot occur in 
an organic environment where flexibility and consensus are the main managerial mechanisms 
to generate radical innovation. This suggests that radical innovation requires structure and 
organizational relationships to ensure that both discipline and creativity are present. In this 
regard we add to Pisano (1996a, b) and Markides’ (1997) research on the areas of innovation 
management, organization for innovation, and strategic innovation. 
We are aware of the limitations of this case study (i.e. lack of generalization and non-
universal validity). However, this approach is especially appropriate in new topic areas 
(Eisenhardt, 1989). We obtained an understanding of what the organization does and the 
reasons for acting in such a fashion. Consequently we present some insights and qualitative 
findings on the processes, MCS, and organizational structures firms can implement to 
generate and manage radical innovation. 
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Tables and Figures 
 
      Figure 1. The cash curve (Andrew and Sirkin, 2007). 
 
 
Source: Andrew, J. P., and Sirkin, H. L. 2007. Using the cash curve to discuss and      
             discipline innovation investments. Strategy & Leadership, 35(4): 11-17. 
 
 
 
 
      Figure 2. Innovation process adapted from (Davila, 2006). 
 
    Source: Davila, T., Epstein, M., and Shelton, R., 2006. Making Innovation Work: How to      
                 Manage It, Measure It, and Profit from It. Wharton School Publishing. 
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Figure 3. Rio Tinto organizational structure & Alcan Engineered Products unit of analysis. 
 
 
 
 
 Figure 4. Alcan EP a market and innovator leader. 
 
  Source: Alcan Engineered Products 2009. Corporate brochure. 
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    Figure 5. Scope of Innovation Cells services. 
 
 
    Source: Alcan Innovation Cells 2010. Brochure succeed with materials. 
     
 
 
  
        Figure 6. Project plan for new product development at Innovation Cells. 
 
 
       Source: Alcan Innovation Cells 2009. 
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       Figure 7. Process for incremental & radical innovation  
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       Source: Alcan Composites 2008, Innovation Management at Composites (im@c). 
 
 
Figure 8. Leading organizational unit contingent to “radicalness” and development stage. 
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Figure 9. Internal and external collaboration to develop radical. 
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Figure 10. Process for incremental and radical innovation. 
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Table 1. Interviews, meetings, and conferences 
 
 Round one Round two Round three 
Time March-September 2009 September 2010 May 2011 
Interviewees 1 CEO Alcan EP 
Lausanne, Switzerland 
 
1 Managing Director 
   Innovation Cells 
Lausanne, Switzerland 
 
1 Director Corporate 
   Technology &  Innovation 
Neuhausen, Switzerland 
 
1 Director Corporate 
   Technology &  Innovation 
Voreppe, France 
 
1 Director Composites 
   Technology & Innovation 
Neuhausen, Switzerland 
 
1 Director Strategy &    
   Innovation Specialty Sheet 
Zurich, Switzerland 
 
1 Director Innovation &  
   Commercialization  
   Specialty Sheet 
Singen, Germany 
 
1 Project Manager 
   Innovation Cells 
Lausanne, Switzerland 
 
1 Sales Manager 
   Innovation Cells 
Lausanne, Switzerland 
 
1 Sales Manager  
   Specialty Sheet 
Singen, Germany 
 
10 interviews in total 
1 Managing Director 
   Innovation Cells 
Lausanne, Switzerland 
 
1 Project Manager 
   Innovation Cells 
Lausanne, Switzerland 
 
1 Sales Manager 
   Innovation Cells 
Lausanne, Switzerland 
 
1 Sales Manager  
   Specialty Sheet 
Singen, Germany 
 
1 Senior Technology  
   Transfer Officer EPFL 
Lausanne, Switzerland 
 
5 interviews in total 
1 Managing Director 
   Innovation Cells 
Lausanne, Switzerland 
 
1 Project Manager 
   Innovation Cells 
Lausanne, Switzerland 
 
1 Sales Manager 
   Innovation Cells 
Lausanne, Switzerland 
 
3 interviews in total 
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Table 2. Qualitative selection criteria for radical ideas 
 
1. Idea is not an Environmental Health and Safety, social, and 
economic threat   
2. Idea fits Alcan EP’s strategy      
3. Regulatory or legal issues manageable    
4. Not purely a new market for existing product     
5. Not incremental to existing product or process   
6. Building on core competences   
7. Proven technology at least at lab scale   
8. Identified commercial application   
9. Length of stay at Innovation Center not to exceed 6 months 
 
Source: Alcan Innovation Cells 2009. 
 
 
 
 
 
Table 3. Quantitative selection criteria for radical ideas 
 
1. Market attractiveness (size, growth) 
2. Investment 
3. Time-to-market 
4. Customer benefit / unmet need satisfaction 
5. Commercial feasibility & risk 
6. Technical feasibility & risk 
7. Competitive intensity & entry barriers 
 
Source: Alcan Innovation Cells 2009. 
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Appendix 
 
Questionnaire – Management Systems and Organizational Structures for Radical Innovation28 
Interview - Management Systems for Radical Innovation   
Company   _____ Interviewer  _____ 
Person __________  Date   _____ 
Title   _____ 
 
In this interview we want to better understand for each stage of the innovation 
process: idea generation (IG), idea selection (IS), project execution (PE) and 
commercialization (CO). The challenges that your company faces when developing 
incremental and radical innovation, we are interested in management systems and 
how these help to manage the innovation process.  
 
Innovation Strategy  
1. What are some examples of strategic objectives for radical innovation? And 
how would you rank them? E.g. window on technology, window on market, 
etc. 
 
2. Do you have an innovation project portfolio, and if so how do you balance 
financially promising vs. strategic relevant projects? Has your organization 
specified an optimal balance? 
 
 
 
 
 
 
 
                                                 
28 Questionnaire adapted from Working Council for Chief Financial Officers. Corporate Venture Capital 
Managing for Strategic and Financial Returns. 2000 Corporate Executive Board. 
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3. Is there a minimum score that the project must meet on all three dimensions 
(Strategy, Execution, and Market potential)? 
 
4. Is management tolerant to “failure” (innovation efforts that did not lead to 
value creation)? Is it different for incremental and radical projects? 
 
5. Does management have tolerance for market and technological uncertainty? 
Is it different for incremental and radical projects? 
 
Management Systems and Innovation Process 
6. Do you have different organizational, technology and market risk control for 
radical and incremental innovation? 
 
7. Do you have different budgets for radical and incremental innovation?  
 
8. Are project failures systematically reviewed and analyzed for lessons, or 
buried and nobody talks about it? If so how often and who participates in the 
evaluation? 
 
9. Is there a measurement that tracks the quality of ideas and the conversion 
rate into projects and value? -is it formalized and documented? 
 
10. Is there a project execution system tracking the evolution of projects in 
dimensions such as time, and cost -is it formalized and documented? 
 
11. Do you measure the number of ideas generated by R&D, sales, 
manufacturing, customers, and external partners? 
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12. Please indicate if your Innovation Center (IC) and/ or Business Unit (BU) 
review the following monitoring systems and how often - Is there a difference 
on these when developing incremental or radical innovation:  
 Incr.|Month/Year|(IC/BU) Rad.|Month/Year | (IC/BU)
Product profitability reports   
Customer profitability reports   
Reports comparing budget to actual 
performance 
  
Product quality monitoring systems   
Product development monitoring systems   
Sales force effectiveness (pipeline 
management) 
  
Partnership development reports   
External benchmarking reports   
Operational expenditure approval process   
Capital expenditure approval process   
 
13. What would you describe as the major differences between the management 
systems for incremental and radical innovation at your company?  Why? 
 
14. When transferring ownership “due diligence” of the project to the Business 
Unit, is there a management system to assure proper market and tech 
transfer? Is it specific to certain stages in the innovation process? 
 
15. For each system below, please indicate for what type of innovation it is used 
and at what stage of the innovation process idea generation (IG), idea 
selection (IS), project execution (PE) and commercialization (CO) are 
evaluated.  
 Incremental Radical 
 IG IS PE CO IG IS PE CO
Product profitability analysis         
Customer profitability analysis          
Customer acquisition costs         
Financial performance against budget         
Capital investment approval procedure         
Operational expense approval procedure         
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16. What actors participate at each stage of the Innovation Process, and who has 
the most influential power “rank” to allocate resources, continue or discontinue 
a project. We are interested in their influence when developing incremental 
and radical innovation. Actors are: Innovation Center (IC), Business Unit (BU), 
Corporate (CR), Research & Development (RD), and Outsiders e.g. external 
experts, customers, suppliers, etc. (OS)?  
Ranking Incremental       
(Idea Generation) 
Who participates in the 
decision e.g. Finance, 
Sales, Manufacturing, 
R&D, BU General 
Manager, etc. 
Radical                 
(Idea Generation) 
Who participates in the 
decision e.g. Finance, 
Sales, Manufacturing, 
R&D, BU General 
Manager, etc. 
1         
2         
3         
4         
5         
Ranking Incremental       
(Idea Selection) 
Who participates in the 
decision e.g. Finance, 
Sales, Manufacturing, 
R&D, BU General 
Manager, etc. 
Radical                  
(Idea Selection) 
Who participates in the 
decision e.g. Finance, 
Sales, Manufacturing, 
R&D, BU General 
Manager, etc. 
1         
2         
3         
4         
5         
Ranking Incremental       
(Project Execution) 
Who participates in the 
decision e.g. Finance, 
Sales, Manufacturing, 
R&D, BU General 
Manager, etc. 
Radical                  
(Project Execution) 
Who participates in the 
decision e.g. Finance, 
Sales, Manufacturing, 
R&D, BU General 
Manager, etc. 
1         
2         
3         
4         
5         
Ranking Incremental 
(Commercialization) 
Who participates in the 
decision e.g. Finance, 
Sales, Manufacturing, 
R&D, BU General 
Manager, etc. 
Radical 
(Commercialization) 
Who participates in the 
decision e.g. Finance, 
Sales, Manufacturing, 
R&D, BU General 
Manager, etc. 
1         
2         
3         
4         
5         
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17. What are the three most important financial measures that you use to 
evaluate progress at each of the stages of the Innovation Process, and where 
is it measured at the Innovation Center (IC) and/ or Business Unit (BU) (for 
example, ROI, sales growth, IRR or cash burn rate) as well as to determine if 
there is a difference between these when developing incremental or radical 
innovation?  
Ranking Financial measure for Idea Generation Incr.|Month/Year | (IC/BU) Rad.| Month/Year | (IC/BU)
1    
2    
3    
Ranking Financial measure for Idea Selection  Incr.|Month/Year | (IC/BU) Rad.| Month/Year | (IC/BU)
1    
2    
3    
Ranking Financial measure for Project Execution  Incr.|Month/Year | (IC/BU) Rad.| Month/Year | (IC/BU) 
1    
2    
3    
Ranking Financial measure for 
Commercialization 
Incr.|Month/Year | (IC/BU) Rad.| Month/Year | (IC/BU) 
1    
2    
3    
 
18. Why do you consider these measures the most important financial measures? 
What are the challenges in measuring some of these variables? 
 
19. Do you measure Return on Investment [(sales-cost)/investment] and / or 
Residual Income [(sales-cost)-(cost of capital*investment)] for incremental 
and radical? 
 
20. What other reports do you use throughout the course of the projects? Are 
these different for incremental and radical projects? Are these reports 
formalized and documented? 
 
 
 
 
 
 
 
 
 
 
 
 
 
184 
 
21. What are the three most important non-financial measures that you use to 
evaluate the progress of innovation (for example, customer satisfaction or on-
time delivery)? 
Ranking Non-financial evaluation measure 
for Idea Generation 
Incr.|Month/Year | (IC/BU) Rad.| Month/Year | (IC/BU) 
1    
2    
3    
Ranking Non-financial measure for Idea 
Selection  
Incr.|Month/Year | (IC/BU) Rad.| Month/Year | (IC/BU) 
1    
2    
3    
Ranking Non-financial measure for Project 
Execution  
Incr.|Month/Year | (IC/BU) Rad.| Month/Year | (IC/BU) 
1    
2    
3    
Ranking Non-financial measure for 
Commercialization 
Incr.|Month/Year | (IC/BU) Rad.| Month/Year | (IC/BU) 
1    
2    
3    
 
22. Why do you consider these measures the most important non-financial 
measures? What are the challenges in measuring some of these variables? 
 
23. What is the longest time horizon set for these projections (for example, “We 
project one year into the future.”)? 
 Incremental longest time horizon years Radical longest time horizon years 
Cash flow 
projections 
  
Sales projections   
Operating budget   
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24. When developing incremental and radical innovation. At what stage of the 
innovation process idea generation (IG), idea selection (IS), project execution 
(PE) and commercialization (CO) is the following information generated and 
evaluated? 
 Incremental Radical 
 IG IS PE CO IG IS PE CO
Financial projections         
Market forecasts         
Competitor analyses         
Customer analyses         
Technology forecast         
Product positioning         
Investment plans         
Marketing plans         
Assess project strengths and 
weaknesses  
        
 
25. How often does the project innovation committee meet to review the different 
stages of the innovation process? Please specify time frame e.g. weeks, 
months. 
 Incremental Radical 
 IG IS PE CO IG IS PE CO
How often does the project 
innovation committee meet? 
        
 
Incentives 
26. Please indicate how often your Innovation Center (IC) and/ or Business Unit 
(BU) reviews the following evaluation systems. Indicate whether there is a 
difference between these when developing incremental or radical innovation:  
 Incr.| Month/Year | (IC/BU)
Rad.| Month/Year | (IC/BU)
Written performance objectives for 
managers 
  
Written performance evaluation reports   
Linking compensation to performance   
Individual incentive programs   
 
27. Is the process of awarding financial bonuses to employees for innovation 
performance formalized? Are these different for incremental and radical?   
 
28. How often does your company pay out financial bonuses to managers (for 
example, every quarter)? Are these different for incremental and radical?   
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29. Is the process of awarding non-financial incentives to employees for 
innovation performance formalized? Are these different for incremental and 
radical?   
30. How often does your company recognize employees with non-financial 
incentives (for example, every quarter)? Are these different for incremental 
and radical innovations? 
   
31. Is the process of awarding financial or non-financial incentives to external 
“partners” for innovation performance formalized? Are these different for 
incremental and radical?   
 
Organization 
32. How is the company organized for incremental innovation (functional, 
business unit, matrix)? Who proposed or structured the organization? 
 
33. How is the company organized for radical innovation (functional, business 
unit, matrix)?  Who proposed or structured the organization? 
 
Partnerships and alliances with “outsiders” for Innovation 
34. How do you identify important alliance partners? Formal scouting system vs. 
informal network. Are these different for incremental and radical projects? 
 
35. Which are the three main criteria your company uses to select its partners? 
Ranking Criteria 
1  
2  
3  
 
36. What are the three main measures that top management uses to evaluate the 
progress of partnerships (in other words, what are the milestones of a 
partnership based upon)? 
Ranking Measure How often does top 
management check it (weekly, 
monthly, quarterly)? 
1   
2   
3   
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Product development 
37. How are incremental project ideas generated in your organization? 
 
38. How are radical project ideas generated in your organization? 
 
39. How do new product development projects get selected? Is there a distinction 
in the process if the project is of an incremental or radical innovation nature - 
Why? E.g. Technology vs. market driven—customers, competitors. Individual 
product decisions vs. portfolio decisions. Intuition vs. analysis of customer 
needs / technology possibilities. 
 
40. Please indicate if your company, formalize each system below. “Formalized” 
is defined as having documented a process and / or periodically and 
purposefully executing and evaluating the process. 
 Incr.|Month/Year| (IC/BU)   Rad.| Month/Year | (IC/BU)
Project milestones   
Budget for development projects   
Reports comparing actual progress to plan   
Project selection process   
Product portfolio roadmap   
Project team composition guidelines   
Product concept testing process   
 
Sales and marketing 
41. How and at what stage of the innovation process (idea generation, idea 
selection, project execution and commercialization), do sales and marketing 
participate? What are the main challenges? Is Sales involvement different 
when developing incremental or radical innovation? 
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42. Please indicate at what stage of the process: idea generation (IG), idea 
selection (IS), project execution (PE) and commercialization (CO) does your 
company formalize each system below?  “Formalized” is defined as having 
documented a process and / or periodically and purposefully executing the 
process. 
 Incremental project                 Radical project 
Sales force training program    
Sales force hiring and firing policies   
Sales targets for salespeople   
Sales force compensation system   
Marketing collaboration policies   
Market research projects   
Reports on open sales processes   
Sales process manual   
Customer satisfaction feedback   
Customer Relationship Management (CRM) 
system 
  
 
43. What are the three most important measures that top management uses to 
evaluate the progress of the sales and marketing effort (for example, sales 
growth, customer satisfaction) for both incremental and radical innovation? 
 
Ranking Measure How often does top 
management check it (weekly, 
monthly, quarterly)? 
Incremental                  Radical 
1    
2    
3    
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Thesis Conclusions 
The aim of this dissertation is to study enablers such as MCS, processes, managerial 
practices, and organizational structures that can foster innovation. By studying these we also 
seek to provide evidence of their contribution to value creation. 
  
The main research questions, summaries, and conclusions are: 
 
I. What influences CVC activity?  
This study was motivated by limitations from existing research on CVC and the effect 
that internal and external determinants have on CVC activity in different CVC expansion and 
contraction periods. This study addresses these limitations and makes the following 
contributions. The external financial market conditions analyzed in this study reveal that 
CVC activity is highly volatile as demonstrated by fluctuations in investment activity over 
the past decades. Moreover, when studying the 1985 - 2008 period, our econometric analysis 
indicates strong and significant positive associations between CVC activity and our 
independent variables R&D expenditure and NASDAQ index. There is also an existing 
negative significant association between CVC and sales growth. Free cash flow proves to 
have a significant and positive association with CVC activity only for the 1985 – 1993, 2001 
– 2004, and 2005 - 2008 periods.  
By focusing on the characteristics and conditions in which established firms operate 
as CVC investors, we complement the work by Dushnitsky and Lenox (2005a) as we also 
found a significant positive coefficient on R&D influencing CVC activity, suggesting that 
internal R&D expenditure and external CVC investment are complementary. This supports 
previous literature on complementarity between internal R&D expenditure and external CVC 
investment (Cassiman & Veugelers, 2002; Ennen & Richter, 2010; Mitchell & Singh, 1992; 
Sahaym et al., 2010). In essence, CVC seems to provide large firms with a flexible way to 
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increase or decrease commitments to new technology depending on market and technology 
uncertainty and attractiveness (McGrath & Nerkar, 2004). 
We also found evidence that supports Bruton and Ahlstrom (2003) arguments, 
suggesting that external financial conditions influence the behavior of CVC managers, which 
can increase or decrease investments to minimize or maximize the financial and strategic 
goals. Despite financial market volatility, several large firms seem to maintain their CVC 
activity as a window on technology (Chesbrough, 2002a). 
 
II. What is the contribution of CVC and its interaction with R&D to value creation?  
This article examines the impact of CVC, R&D, and their interaction, on value 
creation across six business sectors and different regions between 1985 and 2000. Our 
findings suggest that the effects of CVC and its interaction with R&D on value creation are 
positive and significant. However, this relationship is contingent upon business sectors and 
regions.  
Some business sectors are more active in their use of CVC than others. CVC variance 
across business sectors suggests that the value of CVC depends on the sector context and its 
environment. Sahaym et al. (2010) found that business sectors with greater absorptive 
capacity developed by prior R&D investment display greater efforts towards pursuing 
innovations using CVC. These sectors include engineering & business services and ICT.  
Regarding profitability value creation (i.e. ROS) CVC presents a significant positive 
effect on machinery & electronics, and ICT. Hence, we suggest, along with Qualls et al. 
(1981) and Eisenhardt and Martin (2000), that firms operating in certain business sectors 
characterized by rapid technological change, are motivated to develop new alternative 
external sources of innovation that can influence value creation. 
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In terms of geography, we observe a more potent significant effect of CVC vs. R&D 
in USA & Canada, while for Asia only CVC proves significant. However in Europe only 
R&D shows a significant positive effect on value creation.  
Regarding the CVC and R&D interaction, when analyzing the whole sample, we 
noticed that the regression estimates indicate that R&D and CVC are complementary to value 
creation. When dissecting the sample in different business sectors and regions the results 
suggest that corporations operating in ICT, machinery & electronics, and engineering & 
business services, as well as North America and Europe, are better off engaging in R&D and 
CVC simultaneously. Hence, firms can combine CVC and R&D aiming to increase the 
probability of generating value creation. 
 
III. How is radical innovation organized and managed? 
Davila et al. (2009) developed arguments and new research opportunities on the 
relevance of MCS to foster innovation. Their view on such research opportunities is contrary 
to the traditional MCS paradigm, identifying MCS as detrimental to innovation. Our research 
takes the perspective that management of radical innovation constitutes a dynamic capability 
which fundamentally represents a firm’s ability to exploit and develop resources and 
processes that create and capture value, while operating in rapidly changing technological 
environments (Eisenhardt & Martin, 2000; Teece et al., 1997; Zahra et al., 2006). Moreover, 
our case study at Alcan EP focuses on the development and utilization of management 
systems and organizational structures as a source of dynamic capabilities to generate radical 
innovation via internal knowledge exploitation and external knowledge exploration through 
an open innovation approach. The observed interaction between Alcan EP and EPFL 
reinforces the complementarity between internal R&D and external partnerships described by 
Cockburn and Henderson (1998), and Cassiman and Veugelers (2002).  
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We found that the organizational structure at Alcan EP is dynamic and adjustable 
depending on the nature of the innovation project as suggested by Chandler (1962) who 
stated that organizational structures evolve to fit company strategies. Additionally, in line 
with O'Reilly and Tushman (2011), Chandy and Tellis (1998), and Teece (1986), we observed 
that in order for Alcan EP to generate radical innovation, an adaptable organizational 
structure is required to cope with technology and market uncertainties. 
The research findings are congruent with innovation management defined as the 
implementation of management practices, processes, structures, and techniques intended to 
generate inventions and reach organizational goals (Birkinshaw, Hamel, & Mol, 2008b). Our 
findings explain the different approaches of the innovation process, in which incremental and 
radical innovations need be managed through different processes, MCS, and organizational 
structures in order to optimize resource and outputs. Firms can almost guarantee a sub-
optimization of certain systems and resources by processing incremental and radical 
innovation through a one-size-fits-all process (Davila et al., 2006).  
More importantly, we observed that radical innovation can be generated in a 
systematic way through enablers such as processes, MCS, and organizational structures. 
Jelinek and Schoonhoven (1993) and Davila et al. (2007; 2006) found that innovative firms 
have institutionalized mechanisms for innovation, arguing that innovation cannot occur in an 
organic environment where flexibility and consensus are the main managerial mechanisms. 
We adhere to the notion that radical innovation requires a clear organizational structure and 
MCS, ensuring that both discipline and creativity are present when developing radical 
innovation.  
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